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Several functional polymers that can catalytically generate nitric oxide (NO) from 
naturally occurring substrates (S-nitrosothiols; RSNOs) in blood by means of 
immobilized catalytic sites within the polymers were synthesized and investigated.  Such 
polymers are termed NO generating polymers (NOGPs) and they have the potential to be 
used as more biocompatible polymeric coatings for biomedical devices (e.g., catheters, 
vascular grafts, indwelling sensors, etc.) owing to NO’s ability to inhibit platelet 
activation/adhesion and reduce smooth muscle cell proliferation. 
In this thesis, two distinctive catalysts were employed to develop the NOGPs: a) 
Cu(II)-cyclen (cyclen; 1,4,7,10-tetraazacyclododecane) complex, already recognized as 
 xx 
an NO generating catalyst via reductive decomposition of RSNOs; and b) 5,5’-ditelluro-
2,2’-dithiophenecarboxylic acid (DTDTCA), a newly synthesized organoditelluride 
(RTeTeR) species that was discovered, in this thesis work, to exhibit catalytic RSNO 
denitrosation to NO in the presence of thiol reducing agents (RSHs) at physiological pH.  
To optimize the catalytic function of the immobilized RTeTeR species, its catalytic 
mechanism toward RSNO was investigated.  Both NO generating catalysts were 
covalently linked to a variety of polymers including poly(2-hydroxyethyl methacrylate), 
thermoplastic polyurethane (PU), and poly(allylamine hydrochloride) using standard 
synthetic methodologies.  Loading of catalytic sites on such polymers ranged from 0.04 – 
7.5 wt % (Cu or Te content).   In addition, some of these catalytic polymers were also 
employed to create interpenetrating polymer networks using a 
cellulose membrane or PU base.  In all cases, NO generation from RSNOs by the new 
NOGPs, as measured by chemiluminescence, was found to be proportional to the amount 
of Cu(II)-cyclen or RTeTeR species linked to the polymeric backbone.  Further, it was 
found that all polymers retained significant catalytic function for at least two weeks, with 
< 10 -30 % loss of catalytic sites when bathed in buffer containing RSH/RSNO.  The 
ability of each new NOGP to generate NO when in contact with fresh animal blood was 
also investigated and confirmed by employing the polymers as outer coatings at the distal 
end of an amperometric NO sensor.  Finally, such a measurement configuration was 
shown to function as a useful RSNO sensor for direct detection of total RSNO species in 






Thrombus formation and restenosis are mainly responsible for causing clinical 
failure in the application of a variety of medical devices such as catheters, vascular grafts, 
stents, indwelling sensors, and extracorporeal blood-loop circuits when they are in 
contact with blood.1-4  The most biocompatible surface known is the host's own intact 
endothelium that lines the inner walls of all blood vessels.  Therefore, mimicking 
endothelial cellular activity has been suggested as a means to develop more 
hemocompatible synthetic materials.5-7  Indeed, since nitric oxide (NO) was recognized 
as the endothelium-derived releasing factor (EDRF), it has been shown to possess a 
variety of vasoprotection activities including inhibition of platelet adhesion/activation,8-10 
anti-proliferation of smooth muscle cells,11 anti-microbial,12 and wound healing.13-15  
Thus, NO releasing polymers have been developed and proven to exhibit improved blood 
compatibility.16-19  However, these polymers have a relatively short use-life because of 
the rapid depletion of NO from a relatively thin coating of polymeric NO-donor reservoir 
after they are implanted.  Therefore, a new strategy to prepare biomaterials that can 
produce NO for a prolonged time once implanted in vivo is needed.  Hence, this thesis 
introduces a novel idea of using NO generating polymers (NOGPs) that can 
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biomimetically/catalytically generate NO locally from endogenous substrates in blood for 
extended periods of time to potentially improve the biocompatibility of implanted 
biomedical devices. 
 
1.1. Biological roles of NO 
Nitric oxide (NO) is one of the most important physiological regulators,20 playing 
many biological roles in both cytoprotection and cytotoxicity.21, 22  For instance, the 
inhibition of platelet aggregation8, 10 and smooth muscle cell proliferation,11 as well as the 
involvement in  angiogensis,23 are well known examples of NO’s cytoprotection in blood 
vessels.  In contrast, the cytotoxicity of NO is associated with peroxynitrite (ONOO-) 
formation; is neurotoxic24 as well as DNA damaging.25  NO also plays a role in killing 
bacteria12 and cancer cells.26  Because NO participates in a variety of biological roles, 
many NO related studies are still continuing to unravel its complex and wide ranging 
biological actions, although most of the underlying molecular mechanisms remain poorly 
understood.  
Nonetheless, nitric oxide synthase (NOS) has been generally considered to be the 
primary source of NO in biological systems. NOS in endothelial cells (eNOS) is the 
enzyme that catalyzes the conversion of L-arginine and oxygen to L-citrulline and NO 
with the help of activated calmodulin and nicotinamide adenine dinucleotide phosphate 
(NADPH) (see Figure 1.1).  NO generated from eNOS diffuses into the blood (and into 
platelets) and the surrounding vascular smooth muscle cell, and binds to soluble 
guanylate cyclase (sGC),27, 28 a hemoprotein.  This binding event activates the enzyme, 
which catalyzes the conversion of guanosine 5’-triphosphate (GTP) to cyclic guanosine 
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3’,5’-monophosphate (cGMP).  This NO/cGMP pathway regulates platelet adhesion and 
























Figure 1.1 Scheme of NO production by nitric oxide synthase in the endothelial cells 
(eNOS): NO disseminates into vascular lumen and inhibits platelet activation and 
aggregation.  NO also diffuses into the smooth muscle cell and causes vasorelaxation as 
well as inhibition of proliferation and migration; NADPH (nicotinamide adenine 
dinucleotide phosphate), sGC (soluble guanylate cyclase), GTP (guanosine 5’-
triphosphate), cGMP (cyclic guanosine 3’,5’-monophosphate).  
 
The molecular mechanisms responsible for anti-platelet activation/adhesion are 
not fully known.  However, in platelets, it is reported that cGMP activates cGMP- 
dependent protein kinase (PKG)34 to phosphorylate an inositol 1, 4, 5- triphosphate (IP3) 
receptor,35 leading to a decrease in intracellular Ca2+ concentration, ultimately resulting 
in the deactivation of the platelet.36, 37   Indeed, it is known that an increase of 
intracellular free Ca2+ plays a key role during platelet activation.38   Platelet activation by 
all stimulatory agonists involves the elevation of intracellular Ca2+ levels. Cyclic GMP 
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also lowers cGMP-regulated phosphodiesterase (PDE) levels, leading to an enhancement 
in cyclic adenosine monophosphate (cAMP), in sequence, causing a reduction in 
intracellular Ca2+ concentration.36, 37  Another key process involved is cGMP’s ability to 
modulate the inhibition of a key platelet receptor, glycoprotein IIb/IIIa, which binds with 
fibrinogen, a critical step for the activation and adhesion of platelets onto surfaces.39 
With respect to the regulation of vascular smooth cell proliferation, which is 
mainly responsible for narrowing the lumen of blood vessels in coronary artery disease 
(i.e. restenosis), the molecular mechanisms involved are even more complicated, and are 
not well understood.40, 41  It has been reported that cGMP formed via activation of sGC 
by NO contributes to the inhibition of cAMP phosphodiesterase (PDE III), and in turn 
elevates intracellular cAMP concentration and stimulates protein kinase A (PKA).42, 43 
Such NO-dependent activation of PKA is thought to hinder smooth muscle cell 
proliferation by inhibition of Raf-1, a serine/threonine-specific protein kinase.44  In 
addition, the cGMP-independent mechanism of inhibition of cell proliferation by NO is 
known to be mediated by inhibition of arginase (I and II) and ornithine decarboxylase.45 
 
1.2. NO releasing polymers vs. NO generating polymers 
From a biomaterial scientist’s point of view, NO is a powerful hemostatic 
regulator, one of the smallest and simplest biosynthetic molecules.  Hence, NO is a very 
attractive agent to adapt into biomaterials to improve persistent hemocompatibility 
problems.  In fact, there are many known NO donors,16 some of which (e.g., 
diazeniumdiolates,19, 46 S-nitrosothiols,47 etc.) are cost-effective, and can be easily 
prepared and loaded into polymeric coatings of biomedical devices.  For instance, a 
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diazeniumdiolate-loaded polymer can release 2 equivalents of NO gas (per equivalent of 
parent diazeniumdiolate) into the blood phase upon contact with 1 equivalent of water via 
the protonation of amine sites in the polymer phase (see Figure 1.2).  In the case of 
polymers with immobilized S-nitrosothiols, NO release from the polymer phase can be 
initiated by photons, where the NO production is regulated by turning the light on/off 
(see Figure 1.2).  
 
 
Figure 1.2 Schemes for NO releasing polymers in contact with blood: two different types 
of NO donors; (1) proton-mediated NO release from diazeniumdiloates and (2) light-
initiated NO release from S-nitrosothiols. 
 
A number of NO releasing polymers that release NO at the blood/polymer 
interface have been investigated to enhance the blood compatibility of medical devices.  
While they have shown to exhibit greatly reduced platelet adhesion and thrombus 
formation in vitro and in vivo using animal models, 19, 48 and also the potential to inhibit 
restenosis after angioplasty,49-51 the ultimate biomedical applications of such materials 
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may be limited to short-term use (i.e., on the order of a few days) due to the relatively 
small reservoir of NO donors that can be loaded within thin coatings of the new 
polymeric materials.   
One plausible way to replenish the NO reservoir of biomedical devices after 
implantation is to create catalytic sites within the polymeric materials, which could keep 
generating NO locally upon contact with blood from endogenous NO precursors and 
reducing agents already present in blood.  Hence, such materials are termed NO 
generating polymers (NOGPs) (see Figure 1.3).  
 
 
Figure 1.3 Depiction of a NO generating polymer (NOGP); an oxidized form of catalyst 
(Cat(O)) created in polymeric materials can be reduced by endogenous reducing agents 
(Red.) into a reduced form of catalyst (Cat(R)) within the polymer phase, which is now 
able to decompose NO precursors to NO, while returning back to the original form, 
Cat(O).  
 
The combination of redox catalysts in the polymer and substrates in blood should enable 
such NOGPs to produce NO for long periods of time when in contact with blood 
provided that the catalytic activity of the polymer is maintained, and corresponding 








1.3. Biological NO production 
In order to assess the feasibility of proposed NOGPs, it is important to examine 
how NO is formed within our bodies.  The generation of NO by biological systems can 
be summarized into three pathways, depending on known NO sources and their enzymes 
required to produce NO as shown Figure 1.4.   
 
 
Figure 1.4 Three typical pathways of NO production in biological systems in which 
various enzymes such as NOS (nitric oxide synthase), NiR (nitrite reductase), NR (nitrate 
reductase), PDI (protein disulfide-isomerase), GPx (glutathione peroxidase), and Trxn 
(thioredoxin) are involved in NO synthesis from various NO sources such as L-Arg (L-
arginine), NO2- (nitrite), NO3- (nitrate), and RSNO (S-nitrosothiol). 
 
The first part of NO production involves NOS. NOS is known to exist as three 
isoforms, neuronal NOS (called nNOS, NOS1, or NOSI),52 inducible NOS (called iNOS, 
NOS2, or NOSII),53 and endothelial NOS (called eNOS, NOS3, or NOSIII).54 eNOS is 
the primary NO producing catalyst in biological systems.  Despite a homology of ~ 50 – 
60 % in sequence, the three NOSs are found to differ in size, intracellular location, and 
regulation;55 however, they are all members of a superfamily of heme-containing 
monooxgyenases including cytochrome P-450.  The main substrate of NOSs to generate 
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Nitrite and nitrate formed by oxidation of NO in vivo can also recycle back to NO 
via nitrite reductase (NiR) and nitrate reductase (NR) activities.56  Indeed, 
deoxyhemoglobin (dHb)57-59 and xanthine oxidase (XO)60-62 have recently been reported 
as NO recycling enzymes (dHb as a NiR, and XO as both NiR and NR).  Further, it is 
known that cytochrome cd163 and copper NiR64 in certain bacteria reduce nitrite to NO.  
It is worth noting that the catalytic redox chemistry of copper species plays a key role in 
generating NO from nitrite in copper NiR.  It is believed that Cu(II) is within the active 
site of copper NiR, which can be reduced to Cu(I) by reducing agents such as reduced 
adenine dinucleotide (NADH) and then the reduced Cu(I) species causes the reduction of 
nitrite to NO by the transfer of one electron.64 
Finally, there is a group of endogenous S-nitrosothiols (RSNOs) found in blood 
including, S-nitrosoglutathione (GSNO), S-nitrosocysteine (CySNO), S-nitrosoalbumin 
(AlbSNO), and S-nitrosohemoglobin (HbSNO), where GSNO and CySNO are low 
molecular weight (LMW) RSNOs (see Figure 1.5), and AlbSNO and HbSNO are high 













S-Nitrosocysteine (CySNO)  
Figure 1.5 Structures of low molecular weight S-nitrosothiols (RSNOs) such as S-
nitrosoglutathione (GSNO) and S-nitrosocysteine (CySNO) found in blood. 
 
These RSNOs are known to play a pivotal role in NO biochemistry,65-68  and are also 
identified as a source of biological NO.  Interestingly, Mutus and co-workers recently 
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reported that the platelet cell-surface protein disulfide-isomerase (csPDI, a protein that 
catalyzes thio–disulfide exchange reactions) consumes GSNO to liberate NO, and this 
function reduces platelet aggregation in the presence of GSNO.69  Thioredoxin (Trxn) 
that reduces disulfides and free radicals 70-72 is also known for catalytically denitrosating 
LMW and HMW RSNOs.73, 74  A selenium-containing enzyme, glutathione peroxidase 
(GPx), known as an antioxidant enzyme that reduces lipid hydroperoxides (LOOH) to the 
corresponding alcohols by the oxidation of reduced glutathione (GSH, L-γ-glutamyl-L-
cysteinylglycine),75 is also recognized for its ability to decompose RSNOs` to NO.76, 77 
 
1.4. Endogenous S-nitrosothiols as potential substrates for NOGPs 
There are several known biological pathways for the formation of RSNOs, 
typically from the NO-mediated S-nitrosation of thiol-containing amino acids, peptides 
and proteins (see Figure 1.6).78  
 
                     
RSH










Figure 1.6 Biological pathways for the S-nitrosothiol (RSNO) formation from NO and 
free thiols (RSHs) through (i) oxidative products (NxOy) such as nitrogen dioxide (NO2), 
dinitrogen trioxide (N2O3), and peroxynitrite (ONOO) -; (ii) the formation of a radical 
intermediate, (RS-N -OH); or (iii) nitrosylated metal centers such as copper or iron. 
 
The first pathway to form endogenous RSNOs is via an oxidative NO 
intermediate such as dinitrogen trioxide (N2O3) followed by nitrosation of free thiol 
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(RSH) such as GSH or CySH (L-cysteine)79, 80 as shown by pathway (i) in Figure 1.6 
(also see equations (1.1) – (1.6)).  It should be noted that this pathway requires two NO 
molecules to form a N2O3 intermediate, which suggests it is likely to occur at high 
concentrations of NO such as that found during inflammatory conditions.67  In contrast, 
the RSNOH radical intermediate81 as well as the metal-catalyzed82, 83 reaction (pathway 
(ii) and (iii), respectively) are first order with regard to NO concentration.  Therefore, 
these pathways are considered to take place more readily under normal physiological 
concentrations of NO.  Both the RSNOH radical and metal-catalyzed intermediate 
necessitate the abstraction of an electron and a proton.  Hemoglobin (Hb)82 and 
celuroplasmin83 (a plasma protein with multiple copper binding sites) have been reported 
to catalyze RSNO formation via their metal centers. 
 
NO  +  O2                      NO3                                                (1.1)
NO3  +  NO                   ONOONO                          (1.2)
ONOONO                     2 NO2                                             (1.3)
NO  +  NO2                    N2O3                                  (1.4)
N2O3  +  H2O                 2 H+  +  2 NO2-                         (1.5)
N2O3  +  RSH                 H+  +  RSNO  +  NO2-       (1.6)  
 
It is worth noting that endogenous RSNOs are known to reallocate NO to other 
thiols, which is a reversible reaction as shown in equation (1.7).84 
 
       RSNO  +  R'SH                           RSH  +  R'SNO             (1.7)  
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This transnitrosation reaction has been invoked as a method to transfer NO from species 
to species, and provides a potential mechanism for the modification of protein activity85-
88 as well as a signaling mechanism in which NO controls cellular processes.89, 90   
Endogenous RSNOs have been well recognized as transfer and storage agents of 
physiological NO;67, 78, 91-93 hence, they exhibit similar physiological functions of NO, 
such as inhibition of platelet aggregation94 and vascular smooth muscle relaxation.95  
They are also known to participate in host defense processes such as killing tumors96 and 
intracellular pathogens,97 in addition to intracellular signaling,98 ion channel 
regulation,99,100 apoptosis,101, 102 etc.  
Endogenous RSNOs are potentially useful NO precursors for NOGPs, since the 
decomposition of endogenous RSNOs to NO occurs relatively easily via certain catalysts 
compared to the transformation of nitrite, nitrate, or L-arginine to NO.  Although the 
exact concentrations of RSNOs in normal human blood are still in debate,103, 104 levels of 
RSNOs are thought to be in the nM - µM range;105, 106 however, very low levels of NO (< 
1 nM) can be effective in maintaining a non-thrombogenic surface.107  Therefore, even a 
small fractional conversion of endogenous RSNO species to NO at a polymer/blood 
boundary could be beneficial in reducing the risk of thrombus formation at the surface of 
biomedical devices.  
 
1.5. Potential catalysts for NOGPs 
There are also several known LMW chemicals that can catalytically decompose 
various RSNOs to NO in a beaker.  These chemicals can be widely categorized into two 
types; metal ions (Cu+, Fe2+, Hg2+, and Ag+)16 or chalcogenide (S or Se)-containing 
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compounds.77  It is very interesting that biological NO production from endogenous 
RSNOs is mediated by some enzymes containing metal ion centers (Cu and Fe) or 
chalcogenides (S or Se), as discussed above.  This is in line with observations made with 
LMW chemicals. It is worth noting that ascorbate, air, photon, and thermal-induced 
RSNO decomposition to NO has also been reported.108, 109  
Williams and co-workers reported that copper ions are the most efficient metal 
ion catalyst,110 liberating NO from RSNOs in the presence of reducing agents such as free 
thiols (RSHs) or ascorbate.111  The catalytic mechanism of the copper redox cycle has 
been suggested112 as shown Figure 1.7; where Cu2+ can be easily reduced by a reducing  
 
 
Figure 1.7 The redox chemistry of Cu(II/I) in generating NO from RSNOs.  Reduction of 
Cu(II) to Cu(I) induced by reducing agents (Red) results in NO generation from 
endogenous S-nitrosothiols (RSNOs).  
 
agent such as thiolate (RS-) or ascorbate to afford Cu1+ and an oxidized form of reducing 
agent such as a disulfide (RSSR) or dehydroascorbate (DHA).  Then, Cu1+ reduces 
RSNO to produce NO and RS-, as well as regenerating the original Cu2+ catalyst.  It 
should be noted that peptide and protein bound copper(II) ions are also known to be 
reduced to copper(I) by a thiol to generate NO from a RSNO.113  Furthermore, the 
Red                                 Oxi
+e-
-e-
NO + RS- RSNO
Cu2+ Cu1+
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Meyerhoff group has reported that poly(vinyl chloride) (PVC) films doped with Cu(II)-
dibenzo[e,k]-2,3,8,9-tetrapheny-1,4,7,10-tetraaza-cyclododeca-1,3,7,9-tetraene (Cu(II)-
DTTCT, see Figure 1.8(A)) catalytically decompose GSNO to NO at their interface in 
the presence of GSH.114  
 









                                   (A) Cu(II)-DTTCT                  (B) Cu(II)-cyclen 
Figure 1.8 Examples of copper ion-complexes liberating NO from RSNOs in the 
presence of reducing agents (DTTCT= dibenzo[e,k]-2,3,8,9-tetrapheny-1,4,7,10-tetraaza-
cyclododeca-1,3,7,9-tetraene; cyclen= 1,4,7,10-tetraazacyclododecane). 
 
In order to develop de novo NOGPs using copper ion complexes, some key 
factors should be taken into account. These include:  
a. A complex must have at least one open coordination site to interact with 
reducing agents and RSNOs (for example, square planar or pyramidal structures). 
b. A complex covalently attached to the polymer backbone would be ideal to 
prevent its possible leaching. 
c. The ligands must have strong Cu(II)/Cu(I) ion complexation constants so that 
little or no copper ions will be lost into the blood due to the transmetallation with 
a species having high affinity for copper ions. 
Between the two types of copper-complexes, Cu(II)-DTTCT and Cu(II)-cyclen (cyclen= 
1,4,7,10-tetraazacyclododecane, see Figure 1.8(B)) reported for NO generation from S-
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nitrosothiols,114, 115  the Cu(II)-cyclen complex is more beneficial for the development of 
NOGPs.  Even though both complexes have open axial sites to react with RSNO 
substrates, cyclen has a high Cu(II) ion binding constant (1023 M-1)116 comparable to that 
of EDTA (1024 M-1),117 while the DTTCT binding constant to Cu(II) is unknown; 
however, it is likely to be much lower 118 mainly due to the weak metal coordination of 
sp2 nitrogen in DTTCT versus the strong metal ion coordination of sp3 nitrogen in cylen. 
Further, the structure of cyclen is known to be more flexible than the rigid DTTCT ligand, 
allowing better response to a change of metal ion size after reduction.116  That is, the 
change of copper ion size from Cu(II) to Cu(I) should be accommodated by this ligand. 
Hence it is expected that cyclen will more tightly bind copper ions during a catalytic 
redox cycle than DTTCT.  In addition, cyclen can be easily modified to have a functional 
group that will allow covalent attachment to a polymer backbone.119  Furthermore, the 
binding stability of Cu(II)-cyclen would not be significantly changed after the 
modification of cyclen unless the amine groups in cyclen are altered to other groups, such 
as amide bonds, which would decrease the metal ion binding constant.  Therefore, Cu(II)-
cyclen is an attractive potential catalyst to study in the design of new copper ion 
complex-based NOGPs.  
Chalcogenide (S or Se) compounds have also been shown to decompose RSNOs 
to NO. For example, an application of transnitrosation chemistry using a free thiol 
compound into biomaterials has been demonstrated by Lewis and colleagues.120, 121   They 
employed polymers with appended CySH groups that transfer NO from endogenous 
RSNO species in blood to the CySH modified polymer, followed by the subsequent 
release of NO to exhibit its physiological effects such as a reduced platelet adhesion. 
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Wang and co-workers discovered that the organodiselenides (RSeSeR) catalytically 
liberate NO from RSNOs in the presence of thiols.77  Indeed, the Meyerhoff group 
covalently attached diselenide compounds such as selenocystamine, or dipropionic 
diselenide to polymeric materials, and the resulting polymers showed catalytic 
denitrosation of RSNOs.122, 123  The mechanism of organodiselenide-mediated RSNO 
decomposition remains unclear; however, it has been suggested that a seleno-sulfide 
(RSeSR’) is a main intermediate, and organoselenolate (RSe-) is the active reducing 
species that reacts with and liberates NO from RSNOs.77, 123, 124 
Meanwhile, the redox chemistry of organotellurium has been reported to be 
comparable to that of organoselenium.  For example, both organodiselenides (RSeSeR)125, 
126 and organoditellurides (RTeTeR)127-129 have  GPx like activity, which catalyzes GSH 
oxidation to GSSG (glutathione disulfide) by reducing organic peroxides (ROOH) or 
hydrogen peroxide (H2O2) to the corresponding alcohols (ROH) or water.  The 
mechanisms are known to be equivalent including the intermediate, chalcogeno-sulfide 
(RSeSR’ or RTeSR’).  Considering such parallel redox chemistry of the 
organodichalcogenides, organoditellurides are very likely to catalyze RSNO 
decomposition to NO as well.  Therefore, it is worth investigating a novel 
organoditelluride-mediated catalytic RSNO decomposition to NO and its potential 
application to NOGPs. 
It should be noted that in both copper complex-mediated and organochalcogenide-
mediated reactions, endogenous RSHs are known to be common reducing agents that 
reduce both catalysts, and then, the reduced catalysts can liberate NO from RSNOs. 
Hemoglobin (Hb), albumin (Alb), glutathione (GSH or Glu), and cysteine (CySH or Cys) 
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which possess free thiol moieties, are the predominant reducing species in circulating 
blood, where their concentrations (potential reducing agents for NOGPs) are known to 
range from µM to mM (see Table 1.1).106 
  
  Table 1.1 Concentrations of free thiol species in plasma (P) or blood (B). 
 
























1.6. Statement of dissertation research 
The goals of this dissertation include the design, synthesis and characterization of 
novel NO generating polymers (NOGPs) with covalently attached catalytic sites. 
Additionally, this work includes the evaluation of catalytic NO generation of various 
NOGPs from endogenous RSNOs and reducing equivalents in vitro, the assessments of 
the leaching of catalysts from the polymeric materials, as well as the demonstration of 
spontaneous NO generation of the NOGPs in fresh animal whole blood in vitro.  These 
investigations are pre-requisites for developing novel NOGPs that must be optimized 
further before applying these materials in biomedical devices.  To achieve such goals, the 
investigation of two types of potential NOGPs based on the NO generating catalysts is 
presented.  One includes attaching Cu(II)-cyclen complexes to polymers (Chapters 2 and 
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3) and the other approach is based on attaching organoditellurides to polymers (Chapters 
4 - 6).  
Chapter 2 describes the synthesis and characterization of a de novo Cu(II)-cyclen-
based NOGP consisting of crosslinked poly(2-hydroxyethyl methacrylate) (pHEMA) 
with a covalently linked Cu(II)-cyclen complex.  Local NO generation of the polymer 
from RSNO species is demonstrated via a chemiluminescence NO analyzer (NOA).  
Spontaneous NO generation by the new polymer in fresh whole sheep blood in vitro is 
also observed. Most of the content of this chapter is reorganized from a 2006 publication 
(Hwang, S.; Cha, W.; Meyerhoff, M. E., Angew. Chem. Int. Ed. 2006, 45, 2745-2748). 
Another example of a Cu(II)-cyclen based NOGP is presented in Chapter 3. In 
this work, a newly modified Cu(II)-cyclen is tethered to hydrophilic thermoplastic 
polyurethane (PU), a biomedical grade polymer.  This polymeric material successfully 
exhibits catalytic NO production from endogenous RSNOs in animal whole blood in vitro.  
Because of the good solubility of this polymer in organic solvents, it can be readily 
applied as a coating material for existing medical devices or implantable sensors.  This 
chapter is adapted from a manuscript in preparation for Biomaterials (2007). 
Chapter 4 describes the chemistry of organoditelluride-mediated catalytic RSNO 
decomposition to NO. A newly synthesized organoditelluride, 5,5’-ditelluro-2,2’-
dithiophenecarboxylic acid (DTDTCA), is discovered to have such catalytic activity 
under ambient conditions.  In addition, a suitable mechanism for this chemistry is 
proposed.  This work is reported in a recently published paper (Hwang, S.; Meyerhoff, M. 
E., J. Mater. Chem. 2007. 17. 1462-1465).  The focus of Chapter 4 is on the chemistry 
and mechanism of DTDTCA-mediated catalytic RSNO decomposition. 
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Chapter 5 illustrates a couple of examples of organoditelluride-based NOGPs.  
The first is the covalent attachment of DTDTCA to hydrophilic thermoplastic PU.  The 
second is based on DTDTCA coupling to poly(allylamine hydrochloride) (PAH), 
affording a water-soluble NOGP. The third is crosslinking the DTDTCA-tethered PAH 
within a cellulose membrane to yield an interpenetrating polymeric network (IPN).  The 
polymers obtained form these approaches display catalytic denitrosation of RSNO in the 
presence of RSH at physiological pH.  Further, spontaneous NO generation of the IPN 
from fresh animal blood in vitro has been observed via amperometric NO gas sensor 
measurements.  The research described in this chapter is taken, in part, from the 
manuscript published in Journal of Materials Chemistry (2007) as well as a manuscript to 
be submitted to Advanced Materials (2007). 
 Finally, an application of the organoditelluride-tethered polymers developed in 
this thesis is demonstrated in Chapter 6. In this chapter, the detection of various RSNOs 
including GSNO, CySNO, SNAP (S-nitroso-N-acetylpenicillamine), and AlbSNO is 
investigated using a new RSNO sensor that employs the DTDTCA-PAH-immobilized 
polymer within a cellulose membrane at the surface of an amperometric NO sensor.  The 
long-term stability and RSNO measurement in animal blood is presented as well.  The 
data presented in this chapter is adapted from a recently submitted manuscript to 
Electroanalysis (2007). 
 Conclusions of this dissertation are summarized in Chapter 7, with further 
dialogue on the future directions toward the applications of the NOGPs for vascular 
stents, implantable glucose sensors, and amperometric RSNO sensors to demonstrate the 
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true effectiveness of the newly proposed NOGPs in reducing thrombus formation when 
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Polymethacrylates with Covalently Linked Copper(II)-Cyclen Complex 
for In Situ Generation of Nitric Oxide from Nitrosothiols in Blood 
 
2.1. Introduction 
To develop the first nitric oxide generating polymer (NOGP) containing a metal 
ion complex as the catalytic site, the Cu(II)-cyclen (cyclen = 1,4,7,10-
tetraazacyclododecane) complex is evaluated as a potential pendant catalyst attached to a 
polymer as proposed in Chapter 1.  Cuprous ion (Cu+1) is known as the most efficient 
reactant for S-nitrosothiol (RSNO) decomposition.1  In order to maximize the NO 
generating efficacy of the Cu(II)-cyclen tethered polymer, where the polymeric matrix 
serves as the reaction environment for the catalyst to generate NO within the bulk phase 
of the polymer, the catalyst must be distributed throughout the polymeric matrix.  Then, 
potential NO generation by the NOGP could take place not only at the polymer/blood 
interface, but also within the bulk phase of the polymer because low molecular weight 
(LMW) biomolecules such as free thiols (cysteine (CySH), glutathione (GSH), ascorbate, 
etc.) and LMW RSNOs (S-nitrosocysteine (CySNO) and S-nitrosoglutathione (GSNO)) 
are likely to penetrate into the polymeric matrix.  
Based on the above comments, hydrogels, polymeric materials that can imbibe 
water up to a thousand times their dried weight without dissolution, are the most 
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desirable polymeric material for creating the new NOGPs.  Indeed, hydrogels have been 
of great interest to biomaterial scientists due to their unique characteristics including 
water swelling, permeation, and mechanics similar to the extracellular matrix (ECM).2, 3 
Because of the hydrophilicity of hydrogels, they have a low contact angle and low protein 
absorption on the surface as well.4  Owing to these features, hydrogels have been applied 
into a wide variety biomedical applications including tissue engineering,5, 6 drug 
delivery,7, 8 and contact lenses,12, 13 etc.  Hydrogels can be classified by the following 
three types:2 i) natural polymers and their derivatives (hyaluronate, alginate, dextran, 
chitosan, polylysine, collagen and gelatin, fibrin, agarose, etc.); ii) synthetic polymers 
(PAAc [poly(acrylic acid)], PEG [poly(ethylene glycol)], PEO [poly(ethylene oxide)], 
pHEMA [poly(2-hydroxyethyl methacrylate)], PLA [poly(lactic acid)], PNIPAAm 
[poly(N-isopropyl acrylamide)], PNVP [poly(N-vinyl pyrrolidone)], PVA [poly(vinyl 
alcohol)], etc.); and iii) combinations of synthetic and natural polymers (P (PEG-co-
peptides), collagen-acrylate, alginate-acrylate, hyaluronate-g-PNIPAAm, etc.).  
Poly(2-hydroxyethyl methacrylate) (pHEMA) has been the most widely 
investigated of all hydrogels for use in biomedical applications,9-11 especially after its use 
revolutionized the contact lens industry.12, 13  Since the first synthesis reported by 
Wichterle and Lim in 1960,14 the chemical and physical properties of pHEMA have been 
well characterized, including diffusion studies as a fully hydrated material.11, 15-19 An 
extra benefit of pHEMA is that the pore size of the crosslinked network can be controlled 
by adjusting amounts of various crosslinking agents and by altering the curing 
process.2,20-22   A tunable network of pHEMA allows a size selective permeation so that 
LMW blood components can diffuse into the polymeric matrix, but high molecular 
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weight (HMW) proteins and blood cells can not.  Therefore, pHEMA offers an excellent 
platform to initially evaluate as a matrix for development of novel NOGPs.  
In this chapter, the synthesis of a modified Cu(II)-cyclen complex covalently 
attached to a crosslinked pHEMA is reported (see Scheme 2.1).  The ability of this 
polymeric material to mediate catalytic decomposition of endogenous RSNOs to NO at 
physiological pH is demonstrated.  Various soaking experiments using this new material 
were also conducted to study its potential for copper leaching.  Further, it will be shown 
that spontaneous NO generation from RSNOs that exist in fresh sheep blood can be 
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Scheme 2.1 The synthetic scheme for preparing a crosslinked hydrogel, Cu(II)-cyclen-
pHEMA 7. a) Boc2O (3 eq.), Et3N (3 eq.), CHCl3, RT, 12h (y= 76%); b) 3-
Bromopropanol (3.4 eq.), Na2CO3 (1.2 eq.), NaI (1.3 eq.), CH3CN, 80 °C, 12h (y= 88%); 
c) Methacryloyl chloride (5.4 eq.), Et3N (9.5 eq.), THF, -20 °C, RT, 1h (y= 59%); d) TFA, 
CH2Cl2, 0 °C, RT, 12h (y= quantitative); e) 1. 2-Hydroxyethyl methacrylate (HEMA; 
66.0 wt %), ethyleneglycol dimethacrylate (EGDM; 2.1 wt %), AIBN (0.4 wt %), 65 °C, 
12h; 2. soaked and washed with the solution of aq. NaOH / EtOH (1 / 10, v / v, pH 11-





Cyclen was purchased from Aldrich (Milwaukee, WI) or Strem Chemicals Co 
(Newburyport, MA). CuCl2.2H2O was a product of Sigma (St. Louis, MO).  Hydrophilic 
polyurethane (HPU; Tecophilic, SP-93A-100) was a gift from Thermedics Inc. 
(Wilmington, MA).  The other reagents from Aldrich and all solvents from Fisher 
Scientific were used without further purification unless otherwise noted.  Distillation was 
used for the purification of Et3N, THF, CH3CN, and 2-hydroxyethyl methacrylate 
(HEMA) prior to use.  DI water was prepared by a Milli-Q filter system (18 MΩ cm-1: 
Millipore Corp., Billerica, MA, USA). 
2.2.2. Measurements 
1H and 13C NMR spectra were obtained on a Varian 400 MHz spectrometer. 
High-resolution (HR) mass spectra were obtained via a Waters Autospec Ultima 
Magnetic Sector mass spectrometer with electrospray interface.  FTIR spectra were 
collected with a Perkin-Elmer spectrum BX FT-IR system.  UV spectra were recorded by 
a Perkin-Elmer Lambda 35 UV/VIS spectrometer.  EPR spectra were taken by a Bruker 
EMX (Center field, 3300 G; Sweep Width, 2000 G; Frequency, 9.248 GHz).  Copper 
content of the polymers was measured by atomic absorption spectrophotometry (AA) or 
inductively coupled plasma emission-mass spectrometry (ICP-MS).  All NO generation 
measurements were made using a Sievers nitric oxide analyzer (NOA), model 280.  The 
current signals of the amperometric sensor were monitored by a microchemical sensor 
analyzer (Diamond General, Ann Arbor, MI).  
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2.2.3. Synthesis (see Scheme 2.1) 
1,4,7-Tris(tert-butyloxycarbonyl)-1,4,7,10-tetraazacyclododecane, 2: 
The synthetic method followed a reported procedure.23  To a solution of cyclen 
(0.22 g, 1.28 mmol) and Et3N (0.55 mL, 3.95 mL) in CHCl3 (12 mL) was added very 
slowly a solution of di-tert-butyl dicarbonate (0.79 g, 3.62 mmol) in chloroform (10 mL) 
over 3 h.  The reaction mixture was stirred overnight at RT and the solvent was 
evaporated under reduced pressure.  Then, the residue was purified by a column 
chromatography using silica gel (AcOEt/Hexanes=10/7) to yield the desired product, 
white solid (0.45 g, 76 % yield) 
m.p. 64 - 68 °C; 1H NMR (400 MHz, CDCl3, 25 °C, TMS): δ=3.53-3.75 (m, 4H; 2 
NCH2), 3.14-3.48 (m, 8H; 4 NCH2), 2.73-2.84 (m, 4H; 2 NCH2), 1.47 (s, 9H; 3 CH3), 
1.45 (s, 18H; 6 CH3); 13C NMR (100 MHz, CDCl3, 25 °C, TMS): δ=155.67, 79.33, 79.12, 
50.87, 49.50, 45.97, 45.41, 28.63, 28.46. 
1-(3-Hydroxypropyl)-4,7,10-tris(tert-butyloxycarbonyl)-1,4,7,10-tetraazacyclododecane, 
3: 
To a solution of compound 2 (30 mg, 63 mmol), Na2CO3 (8.0 mg, 76 mmol), and 
NaI (12 mg, 80 mmol) in CH3CN (1.0 mL), 3-bromopropanol (30 mg, 216 mmol) was 
added at RT.  The reaction mixture was stirred at 80 °C under a nitrogen atmosphere 
overnight.  The mixture was then concentrated under reduced pressure and the residue 
was purified by a column chromatography with silica gel (AcOEt/Hexanes=1/1) to afford 
3 as a white amorphous solid (30 mg, 88 % yield). 
m.p. 63 - 67 °C; 1H NMR (400 MHz, CDCl3, 25 °C, TMS): δ=3.62 (t, J= 5.6 Hz, 2H; 
OCH2), 3.21-3.59 (m, 12H; 6 NCH2), 2.85 (bs, 1H; OH), 2.51-2.73 (m, 6H; 3 NCH2), 
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1.70 (m, 2H; CH2), 1.47 (s, 9H; 3 CH3), 1.45 (s, 18H; 6 CH3); 13C NMR (100 MHz, 
CDCl3, 25 °C, TMS): δ=155.41, 79.75, 79.46, 59.97 55.17, 54.63, 49.90, 49.23, 48.06, 




To a stirred solution of compound 3 (30 mg, 0.057 mmol) and Et3N (55 mg, 0.54 
mmol) in THF (1.0 mL), methacryloyl chloride (30 µL, 0.31 mmol) was slowly added at 
-20 °C under the nitrogen atmosphere over 10 min, and then the reaction temperature was 
slowly raised to RT.  After 1 h, the reaction solvent was evaporated.  Then, the residue 
was diluted with Et2O and washed two times with DI water.  The separated organic layer 
was dried with anhydrous Na2SO4, filtered, and washed with Et2O.  After the collected 
filtrate was concentrated under reduced pressure, the residue was purified by column 
chromatography on silica gel (AcOEt/Hexanes=1/3) to afford 4 as a white amorphous 
solid (20 mg, 59 % yield). 
m.p. 65 - 70 °C; 1H NMR (400 MHz, CDCl3, 25 °C, TMS): δ=6.11 (d, J = 0.8 Hz, 1H; 
CHH=), 5.57 (m, 1H; CHH=), 4.16 (t, J=6.2 Hz, 2H; OCH2), 3.19-3.65 (m, 12H; 6 
NCH2), 2.54-2.79 (m, 6H; 3 NCH2), 1.95 (d, J = 0.8 Hz, 3H; C(CH2)CH3), 1.86 (m, 2H; 
(NCH2)CH2(CH2O)), 1.47 (s, 9H; 3 CH3), 1.45 (s,18H; 6 CH3); 13C NMR (100 MHz, 
CDCl3, 25 °C, TMS): δ=167.26, 155.69, 155.37, 136.19, 125.48, 79.58, 79.34, 63.03, 
54.56, 53.39, 49.96, 48.75, 47.85, 28.61, 28.43, 24.41, 18.25; MS (HR-ESI): m/z: 
[M+Na]+ calcd for C30H54N4O8, 599.4020: found 599.4023. 
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1-(3-Methacryloxypropyl)-1,4,7,10-tetraazacyclododecane TFA salt, 5: 
To a solution of compound 4 (20 mg, 0.033 mmol) in CH2Cl2 (1 mL), in a water-
ice bath, TFA (0.1 mL) was added.  The reaction mixture was stirred at RT overnight.  
The reaction mixture was then concentrated under reduced pressure and the residue was 
diluted with CH2Cl2 and again concentrated in the same manner.  Several repetitive 
cycles were performed to remove the excess of TFA from the residue.  Extensive drying 
of the residue under vacuum pump afforded the desired product as an off-white 
amorphous solid (quantitative yield) (this compound was very unstable even in the 
refrigerator, so it is recommended to be used immediately after preparation). 
m.p. 105 – 110 °C; 1H NMR (400 MHz, CD3OD, 25 °C): δ=5.92 (s, 1H; CHH=), 5.45 (s, 
1H; CHH=), 4.02 (t, J = 6.6 Hz, 2H; OCH2), 2.47–3.17 (m, 18H; 9 NCH2), 1.75 (s, 3H; 
CH3); 13C NMR (100 MHz, CD3OD, 25 °C): δ=168.83, 163.80, 137.65, 126.42, 115.71, 
63.82, 50.69, 45.62, 43.35, 43.23, 24.63, 18.37; MS (HR-ESI): m/z: [M+H]+ calcd for 
C15H30N4O2, 299.2447: found 299.2442. 
Crosslinked polymer, 6: 
2-Hydroxyethyl methacrylate (HEMA; 154 mg, 1.18 mmol), ethyleneglycol 
dimethacrylate (EGDM; 5.0 mg, 25 µmol), and compound 5 (73.5 mg, 97 µmol) were 
dissolved in methanol (2 mL) and purged with nitrogen gas.  After AIBN (1 mg, 6 µmol) 
was dissolved in the mixture, the solution was poured onto the two glass slides, and then 
cured at 65 °C overnight.  The formed film was soaked and shaken in ethanol/THF (1/1, 
v/v) at RT for 1 d.  After washing with the same solvents, the film was immersed and 
shaken in ethanol/aq. NaOH (10/1, v/v; pH 11-12) for 1 d.  The film was then soaked and 
washed with DI water until the rinsing water was pH 7.  The film was further washed in 
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DI water for 1 d, followed by washing in EtOH for 1 d.  Finally, the film was washed 
again with ethanol and dried by vacuum pump for 3 d to give a colorless cosslinked 
polymer 6. 
IR (KBr)= 3443 cm-1 (-OH), 2951 cm-1 (-CH3), 2886 cm-1 (-CH2), 1729 cm-1 (C=O), 
1274 cm-1 (C-O). 
Cu(II)-cyclen-pHEMA, 7: 
The crosslinked polymer 6 was added to a solution of CuCl2.2H2O (15 mg, 88 
µmol) in ethanol (20 mL) and warmed to 65 °C for 3 h.  The film was washed a few 
times with ethanol, placed into fresh ethanol and shaken at RT for 1 d.  The film was 
thoroughly washed with ethanol and dried by vacuum pump for 4 d to afford a green 
colored Cu(II)-cyclen-pHEMA 7.  The color of film was changed to a blue when it was 
soaked in DI water or PBS buffer, pH 7.4 (The swelling ratio, q= 1.6). 
IR=3439 cm-1 (-OH), 2952 cm-1 (-CH3), 2887 cm-1 (-CH2), 1730 cm-1 (C=O), 1273 cm-1 
(C-O); UV/Vis (the film itself hydrated with DI water or PBS buffer, pH 7.4): λmax= 621 - 
644 nm. 
2.2.4. Preparation of RSNO solutions 
CySNO and GSNO solutions were prepared by a modification of a previously 
reported method.24  A solution of 10 mM L-cysteine or L-glutathione in DI water 
containing 110 mM H2SO4 was well mixed with an equal volume of a 10 mM NaNO2 
solution in DI water for 5 – 10 min to give the corresponding 5 mM RSNO solution.  The 
reaction vial was completely wrapped with aluminum foil to avoid the light-induced 
decomposition.25  Because a tiny amount of NO (below pmole) naturally released from 
the original RSNO can be detected by the NOA, every RSNO solution was freshly 
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prepared from its corresponding stock solutions (10 mM of NaNO2 and acidified GSH) 
for each experiment. Stock solutions were prepared daily as needed. 
2.2.5. General procedure for the NO measurements using a nitric oxide analyzer 
(NOA) 
A nitrogen flow (positive pressure, 50 mL/min) continuously bubbles into a 
sample solution (usually 2 mL of 10 mM PBS buffer, pH 7.4; the same PBS buffer used 
unless otherwise noted) in a brown-colored amber cell, and flows into the NOA detector 
by an equipped vacuum pump (negative pressure, 200 mL/min).  Hence, any tiny amount 
of NO, if generated in the solution,  flows  into the chamber of the NOA, where NO 
reacts with ozone produced by an ozone generator built in the instrument to yield a 
chemiluminescence signal, which is converted to a NO concentration equivalent 







NO + O3 NO2* + O2






Figure 2.1 A general experimental configuration for NO measurements via a 
chemiluminescence NO analyzer (NOA). 
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A conversion constant for the mole number of NO (mol/ppb.sec) can be pre-calibrated by 
injecting a known amount of NaNO2 into a solution of excess KI in a diluted sulfuric acid 
solution.  Prior to the experiment, each measurement is also calibrated by an internal two-
point calibration (the nitrogen flow as zero gas and 45 ppm NO gas). Therefore, the 
number of moles of NO evolved during the experiment can be calculated by multiplying 
the peak area (ppb.sec) and the pre-calibrated conversion constant (mol/ppb.sec).  This 
data is further corrected by the basal NO signal that appears when measuring NO 
released from RSNO in solution phase before any NO generating species is added.  The 
baseline of NO for every experiment varies depending on the specific reaction conditions 
(usually up to 5 ppb); however, the baseline of given GSNO solutions do not change 
significantly over 12 h in the presence of EDTA (the µM concentration of EDTA is 
necessary to prevent any innate RSNO decomposition to NO by tiny amount of metal ion 
impurities present elsewhere).  Thus, the initial steady-state NO amounts already present 
in the absence of the catalytic species, which are the basal NO values, are subtracted to 
obtain the NO levels produced by the presence of the given catalyst.  In order to 
demonstrate the catalytic activity of a given polymer, a piece of polymer is pierced by a 
stainless steel needle (which does not affect RSNO decomposition).  Then, the polymer 
portion is fully immersed into an RSNO reaction solution in the cell.  After a newly 
increased steady-state of NO signal is observed, pulling the needle out from the reaction 
cell results in decrease in the NO level back to the original baseline signal. 
2.2.6. Sample preparation for the analysis of copper content in the polymer 
The typical procedure used for measuring the copper content in a polymer was as 
follows.  In brief, a given small piece of polymer (a few mg) was dissolved in conc. 
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sulfuric acid (0.5 mL) overnight at RT and then diluted with DI water (4.5 mL).  The 
resultant clear mixture was passed through a syringe filter (0.45 µm PTFE, a National 
Scientific Company product), and then the copper content in the filtrate solution was 
analyzed by AA or ICP-MS. 
2.2.7. Preparation of a interpenetrating polymer network (IPN) of Cu(II)-cyclen-
pHEMA 7 and HPU  
A modified procedure for the synthesis of Cu(II)-cyclen-pHEMA 7 was employed 
for the synthesis of an IPN of Cu(II)-cyclen-pHEMA 7 and HPU.  In brief, a thin film (< 
10 µm) of hydrophilic polyurethane (HPU; Tecophilic, SP-93A-100) was coated on one 
side of a glass slide.  Then, compound 5 was polymerized on the HPU coated glass slide, 
using the same reaction process employed for the synthesis of polymer 6 (refer to section 
2.2.3), resulting in a new IPN consisting of polymer 6 and HPU.  Finally, the 
incorporation of copper ions into this new IPN by the same method described for the 
synthesis of Cu(II)-cyclen-pHEMA 7 yielded the IPN of Cu(II)-cyclen-pHEMA 7 and 
HPU. 
2.2.8. Amperometric NO detection in blood  
Fresh sheep blood (obtained from Extracorporeal Membrane Oxygenation 
(ECMO) laboratory at the University of Michigan Medical School) was heparinized (to 
achieve 250 s of activated clotting time (ACT) post-heparin) and protected from ambient 
light by wrapping with aluminum foil.   The blood sample was kept at 37 °C before and 
during the experiments.  A control amperometic NO sensor mounted with a bare HPU 
film and a RSNO sensor prepared with a IPN of Cu(II)-cyclen-pHEMA 7 and HPU were 
assembled according to reported methods (see Figure 2.2).26   The sensors were pre-
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calibrated to obtain their intrinsic NO response in the stirred PBS buffer, pH 7.4, at 37 °C.  
Both the NO and RSNO sensors were immersed into a new PBS buffer (30 mL) prior to 
use.  The amperometric signal of each sensor was monitored after adding the fresh sheep 
blood (6 mL) into the solution.  The current signals of both sensors were converted into 
the NO equivalent concentration based on the prior NO calibration of each sensor. 
 
         
Figure 2.2 The configuration of amperometric NO sensor used for the direct detection of 
RSNOs in fresh sheep blood. 
 
 
2.3. Results and discussion 
2.3.1. Synthesis and characterization 
In brief (see Scheme 2.1), to synthesize the pHEMA material with appended 
Cu(II)-cyclen sites, three amines of cyclen were protected with Boc groups,23 and a 
hydroxyl propyl group was introduced on the remaining nitrogen via a substitution 
reaction with 3-bromopropanol.  Reaction of this derivative with methacryloyl chloride 
Porous PTFE 
membrane 
Ag cathode Glass capillary  





NO sensor: covered with only HPU film 
RSNO sensor: a IPN of Cu(II)-cyclen-pHEMA 
and HPU with a protective HPU film 
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yielded compound 4, possessing a polymerizable group.  Deprotecting the Boc groups of 
the compound 4 using trifluoroacetic acid (TFA) afforded a modified cyclen monomer 5 
(this compound is very unstable even in the refrigerator, so it is recommended to be used 
immediately after preparation).  Co-polymerization of the modified cyclen monomer 5, 2-
hydroxyethyl methacrylate (HEMA) and the crosslinking agent, ethylene glycol 
dimethacrylate (EGDM) was achieved using AIBN as the initiator.  This reaction was 
carried out using the reactants sandwiched as a thin liquid film layer between two glass 
plates.  The resulting crosslinked film 6 was soaked overnight and washed with various 
solvents including NaOH, DI water, THF, and ethanol to remove any residual TFA and 
small molecules.  The crosslinked film 6 was then reacted with CuCl2 in hot ethanol 
solution to form the Cu(II)-cyclen complexes within the polymeric matrix.  Again, 
extensive washing with various solvents to remove free copper ions non-specifically 
bound to the polymer backbone afforded the hydrogel, Cu(II)-cyclen-pHEMA 7 (see 
section 2.2 for details). 
  It has been suggested that square-pyramidal copper(II) complexes have an 
absorption band in the region 550–670 nm in the visible region of the spectrum.27   While 
the λmax of Cu(cyclen)Cl2 is known to be 594 nm in water27 and 608 nm in 10 mM PBS 
buffer, pH 7.4 (the concentration and pH of the PBS buffers used here are the same 
unless otherwise noted), the film of Cu(II)-cyclen-pHEMA 7 displayed a λmax  in the range 
of 621-644 nm after being fully hydrated with DI water or PBS buffer.  The 
bathochromic shift in λmax may be attributed to the substitution of hydroxide ions for 
chloride ions since Cu(II)-cyclen-pHEMA 7 was treated with aq. NaOH during 
preparation.  In addition, the surrounding polymer matrix as well as possible structural 
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distortion of the Cu(II)-cyclen complex in Cu(II)-cyclen-pHEMA 7 could also influence 
the visible absorption spectrum. 
Both frozen aqueous and PBS buffered EPR spectra of the Cu(II)-cyclen-pHEMA 
7 material exhibited the typical four-line patterns expected for a Cu(II)-cyclen complex 
(see Figure 2.3).28  Moreover, the extent of visible blue color of the Cu(II)-cyclen-
pHEMA 7 and the corresponding copper content determined by atomic absorption 
spectrophotometry (AA) after dissolving a given mass of film in sulfuric acid solution, 
correlated very closely with mole ratios of the modified cyclen monomer 5 to HEMA 
used in the polymerization reaction, as well as with the theoretical amount of copper 
expected (see Table 2.1 and Figure 2.4).  Taken together, the data suggest that most of 
cyclen sites covalently linked to the polymer are complexed with copper(II) ions in the 
final crosslinked pHEMA films. 
 










Figure 2.3 EPR spectra of Cu(cyclen)Cl2 and Cu(II)-cyclen-pHEMA 7 in DI water or 






Table 2.1 The correlation between the modified cyclen monomer 5 used in the 
polymerization reactions and the theoretical and measured copper content of films 
(Cu(II)-cyclen-pHEMA 7) as determined by atomic absorption spectrophotometer (AA) 
(see Figure 2.4). 
 
Samples A B C D 
The modified cyclen monomer 5 applied to the 
polymerization (mol %) 
0 0.07 0.5 3.8 
Theoretical copper content in the films (wt %) 0 0.03 0.21 1.7 





Figure 2.4 The pictures of crosslinked pHEMA and Cu(II)-cyclen-pHMEAs 7 with 
various copper content after being hydrated in DI water; the extent of blue color of films 
correlates well with the amount of the modified cyclen monomer 5 used in the 
polymerization, and therefore with copper content (see Table 2.1). 
 
2.3.2. Catalytic S-nitrosothiol decomposition to nitric oxide  
Figure 2.5 illustrates the NO generation that is achieved when a small piece of 
the film (Cu(II)-cyclen-pHEMA 7) is placed in and then removed from a solution of 
GSNO (or CysNO) and GSH (or CySH) in deoxygenated PBS buffer.  The NO generated 
is monitored continuously using a chemiluminescence NO analyzer (NOA).  As shown in 
Figure 2.5-a, a blank experiment in which a hydrogel film 6 (not reacted with copper) 
was placed in the test solution did not generate any detectable NO.  This demonstrates 
A; 0 mol % 
B; 0.07 mol % C; 0.5 mol % D; 3.8 mol % 
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that, as expected, copper ions are the key element for NO generation.  In a second blank 
experiment, the same size of a crosslinked pHEMA film, prepared by the reaction of 
HEMA, EGDM, and AIBN but without co-polymerization of the cyclen monomer 5, and 
further reacted with copper ions using the same method employed for the preparation of 
Cu(II)-cyclen-pHEMA 7, yielded only a small NO flux upon the very first immersion in 


























































































































Figure 2.5 The profiles of NO generation for the following disk polymers (thickness, 0.3 
mm; radius, 2.0 mm) in 2 mL of 10 mM deoxgenated PBS buffer, pH=7.4, monitored 
with a chemiluminescence NO analyzer (NOA) at RT after the following steps: (a) A, 
adding 10 µM EDTA; B, adding 30 µM GSH; C, adding 10 µM GSNO ; D, putting the 
crosslinked film 6 in; E, taking the crosslinked film 6 out; F, putting pHEMA in; G, 
taking pHEMA out, (b) H, adding 10 µM EDTA; I, adding 5 µM GSH; J, adding 5 µM 
GSNO; K, inserting Cu(II)-cyclen-pHEMA 7 in; L, removing Cu(II)-cyclen-pHEMA 7 
out, (c) M, adding 10 µM EDTA; N, adding 0.5 µM CySH; O, adding 0.5 µM CySNO; P, 
immersing Cu(II)-cyclen-pHEMA 7 in; Q, taking Cu(II)-cyclen-pHEMA 7 out; R, adding 
excess amount of free copper ion. 
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This is due to non-specifically adsorbed Cu(II) ions adhered to the pHEMA matrix. 
Indeed, little or no NO generation was observed for subsequent immersions of the same 
blank films (see Figure 2.5(a)).  In contrast, the first immersion of the same size of a 
Cu(II)-cyclen-pHEMA 7 film into the GSNO solution provides a slow increase in the NO 
flux that reaches a steady-state (see Figure 2.5(b)).  After this film was removed from the 
reaction cell, the NO flux decreased to the baseline quickly.  Subsequent 
immersion/removal cycles of the same film showed that the Cu(II)-cyclen-pHEMA 7 
material could reversibly achieve nearly the same steady-state NO flux on sequential 
immersions into fresh GSNO/GSH solutions.  
When CySNO at 10 times lower concentration than GSNO was examined as the 
RSNO substrate for the films, nearly equivalent fluxes of NO generation was achieved 
over a relatively short time periods (see Figure 2.5(c)), but the NO generation decreased 
quickly, as the bulk CySNO substrate was consumed by the more rapid catalytic reaction 
(any further NO signal was not detected when an excess of free copper ions was added 
into the solution right after removing the film).  The relatively higher short-term NO flux 
achieved in the case of CySNO compared to the behavior of GSNO (data not shown here) 
probably relates to their relative reaction rates with Cu(II)-cyclen-pHEMA 7.  The 
concentration of CySNO in blood is known to be higher than GSNO;29 hence, CySNO is 
more likely to contribute toward a larger fraction of the potential NO generating 





2.3.3. Stability tests 
To be effective as a thromboresistant coating for biomedical applications, the 
Cu(II)-cyclen-pHEMA material must be chemically stable and also maintain catalytic 
activity under physiological conditions for an extended time period.  Although pHEMA 
and its copolymers are known to be suitable biomaterials,30-32 the Cu(II)-cyclen complex 
attached to the pHEMA could potentially demetalate, and/or be deactivated by other 
ligands such as free thiols, proteins, and other blood components that have high binding 
affinities with the copper(II) sites of the complex.  To investigate the potential of copper 
ion leaching and deactivation of Cu(II)-cyclen-pHEMA 7, several soaking experiments 
with the new polymeric films were conducted.  First, copper leaching was examined by 
soaking the same size circular films (radius, 1.9 mm; thickness, 0.3 mm; initial average 
copper content, 0.64 µmol) in 10 mL of 2 µM EDTA in 10 mM phosphate buffer, pH 7.7 
(solution A), and also in 10 mL of solution containing 2 µM EDTA, 6 µM GSH, and 2 
µM GSNO in 10 mM phosphate buffer, pH 7.7 (solution B), at 37.5 °C.  The solutions 
were shaken continuously, and replaced with fresh solution daily.  After a fixed time 
period, the amount of copper remaining in the films was determined by AA.  Films 
soaked in solution A retained 73 % of their original copper content after 15 d, while films 
soaked in solution B had 64 % of the original copper levels after the same period of 
soaking (see Figure 2.6).  This data suggests that the copper ions are bound quite tightly 
to the cyclen on the pHEMA structure, since even the presence of a very strong 
copper(II) chelator such as EDTA in the soaking solution had a relatively small effect on 
the total copper remaining in the films.  
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 To determine whether the NO generating catalytic activity Cu(II)-cyclen-
pHEMA 7 films can be deactivated by free thiols, such as GSH (a reducing agent), as 
well as disulfides (such as glutathione disulfide (GSSG), a by-product of the NO 
generation reaction), both strong ligands for copper ions,33, 34 a small piece of Cu(II)-
cyclen-pHEMA 7 (initial copper content, 0.26 µmol) was immersed and shaken in a 
solution containing 0.25 µmol GSH and 0.25 µmol GSNO in 10 ml PBS buffer at RT for 





















Figure 2.6 Copper leaching from Cu(II)-cyclen-pHEMA 7 after soaking experiments: the 
films (radius, 1.9 mm; thickness, 0.3 mm; copper content, average 0.64 µmol) were 
soaked and shaken in a 10 ml solution of 2 µM EDTA in 10 mM phosphate buffer, pH 
7.7 (solution A; ◊) and in a 10 ml solution of 2 µM EDTA, 6 µM GSH, and 2µM GSNO 
in 10 mM phosphate buffer, pH 7.7 (solution B; □) at 37.5 ˚C. The solutions were 
replaced with fresh one everyday, and a sample film at a given time interval was 
dissolved in sulfuric acid to measure the residual copper content by AA at that time point. 
 
The solution was replaced daily with fresh solution (except on day 6 of the 8 day 
experiment).  It was found that there was an approx. 50% decrease in the apparent NO 
flux (using 5 µM GSH/GSNO reaction solution) for the film soaked in the solution (after 
8 d) compared to a control of the same film (not soaked in GSH/GSNO solution) that was 
tested for NO generation prior to soaking.  Inductively coupled plasma-mass 
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spectrometric (ICP-MS) data confirmed that a 20 mol % of total copper was removed 
from the polymer after 8 d of soaking.  In a second experiment, a small piece of a new 
Cu(II)-cyclen-pHEMA 7 (initial copper content, 0.46 µmol) film was placed into a 
solution containing a large concentration of GSH only (50 µmol GSH in 10 ml of PBS 
buffer) and incubated overnight at RT.  The goal was to determine whether such higher 
levels of GSH alone, inhibit catalytic activity over shorter time periods.  In this case, 
there was approx. a 25% decrease in the apparent NO flux under the normal conditions 
use to test NO generation after this one day incubation.  In addition, the UV-Vis λmax of 
the film did not change in location before and after such soaking in the excess of GSH, 
suggesting that GSH does not bind irreversibly as a ligand to the complex.  These data 
suggest that the loss of NO flux most likely results from leaching of copper ions from the 
polymer rather than deactivation by GSH and/or GSSG.  
A more critical test is to examine the NO generation of films of the new Cu(II)-
cyclen-pHEMA 7 material (radius, 2.8 mm; thickness, 0.2 mm; disk type) from GSNO 
before and after the exposure to animal blood for a finite period.  It was found that NO 
generation from GSNO is maintained after soaking such films in 10 mL of the sheep 
plasma for 3 d at 4 °C, or whole blood for 1 day at 4 °C (see Figure 2.7).  These results 
indicate the deactivation of Cu(II)-cyclen-pHEMA 7 caused by endogenous free thiols, 
proteins, and other blood components may not be a significant issue with these new 
hydrogel materials.  Clearly, a large number of in vivo studies over varying time periods 
will be required to fully assess the true NO generation ability and resultant 






































































Figure 2.7 The NO generation profiles of Cu(II)-cyclen-pHEMA 7 before and after 
soaking in the sheep plasma or whole blood over the various time periods were recorded 
by the NOA: the films (radius, 2.8 mm; thickness, 0.2 mm; disk type) were tested in a 
solution of 2 µM GSNO and 75 µM GSH in 2 mL PBS buffer, pH=7.4, in the presence of 
5 µM EDTA, before and after soaking in 10 ml of the sheep plasma or whole blood at 
4 °C under various time intervals; a, unsoaked film; b, after 3 h in plasma; c, after 1 d in 
plasma; d, after 3 d in plasma; e, after 1 d in whole blood. 
 
2.3.4. Spontaneous NO generation in contact with blood in vitro 
To further demonstrate that the Cu(II)-cyclen-pHEMA polymer can generate NO 
spontaneously in fresh whole blood, an amperometric RSNO sensor was constructed 
using an interpenetrating network (IPN) film of Cu(II)-cyclen-pHEMA 7 and hydrophilic 
polyurethane (HPU, Tecophilic, SP-93A-100) as an outer film on a NO selective 
electrochemical sensor (see Figure 2.2).  The response of a control NO sensor without 
the polymer containing Cu(II)-cyclen (but with an HPU outer membrane) was also 
monitored in the same blood samples.  Each sensor was pre-calibrated for intrinsic direct 
amperometric response to NO (see Figure 2.8), and then respectively measured NO and 






















Figure 2.8 Calibration responses for RSNO sensor (a) and NO sensor (b) toward the 
different NO levels: Current levels of both sensors were plotted for the intrinsic direct 
amperometric response upon the addition of standard NO solution (A, 20 nM; B, 40 nM; 
C, 80 nM). 
 
 



















Figure 2.9 The direct amperometric detection of endogenous RSNOs in fresh sheep 
blood using a NO sensor (A) as a control and a RSNO sensor (B) upon injection of 6 mL 
of fresh sheep blood ( ) into 30 mL of 10 mM PBS buffer, pH 7.4, at 37 ˚C under 
nitrogen stream. 
 
Figure 2.9 shows that the NO sensor without the catalytic Cu(II)-cyclen-pHEMA 
polymer site in the outer membrane has relatively little amperometric response when 
placed in the blood sample, whereas the difference of NO responses between RSNO and 
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NO sensor (equivalent to ~25 nM NO calculated from calibration curves) was due to the 
decomposition of RSNO species in the sheep blood via the IPN film of Cu(II)-cyclen-
pHEMA 7 and HPU.  Therefore, Cu(II)-cyclen complex covalently attached to pHEMA 
generates NO from endogenous substrates in the sheep blood in vitro. 
 
2.4. Conclusions 
The aim of this work was to create and evaluate a novel NOGP containing an 
immobilized Cu(II)-cyclen complex as NO generating catalytic sites in a polymeric 
material.  To maximize the catalytic efficiency of the NOGP, pHEMA that can highly 
swell in water was used as the polymeric matrix to covalently attach the catalyst.  In this 
study, Cu(II)-cyclen was successfully linked with a crosslinked pHEMA and the resulting 
material was found to be capable of generating NO from naturally occurring RSNO 
species, both in buffer and also directly when in contact with fresh whole blood.  The 
presence of endogenous reducing equivalents is required to observe such catalytic 
chemistry.  Assessment of the stability of the new Cu(II)-cyclen-pHEMA 7 material 
suggests that the slow leaching of copper ions from the polymer film may cause a 
measurable decrease of NO generation with time, but copper deactivation is not a 
significant problem.  Although fundamental questions with respect to the exact 
mechanism by which Cu(II)-cyclen-pHEMA 7 generates NO remain, the data presented 
herein suggest that this new material may prove beneficial as a potentially new 
thromboresistant blood contacting polymer for biomedical applications with contact 
times of hours to several days.  
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Polyurethanes with a Tethered Copper(II)-Cyclen Complex: Synthesis 
and  Catalytic Generation of Nitric Oxide From S-Nitrosothiols 
 
3.1. Introduction 
Thermoplastic polyurethanes (PUs) are considered to offer relatively good 
hemocompatibility and mechanical properties when compared to the other synthetic 
materials for biomedical applications (e.g., poly(vinyl chloride) and silicone rubber).1-3 
Hence, they have been used to prepare a variety of medical devices including blood bags, 
catheters, vascular grafts, and portions of artificial hearts.2, 4, 5  However, PUs  are  not 
free from biocompatibility problems such as platelet adhesion/activation and thrombus 
formation when in contact with blood and used for extended periods of time.2, 6-8   
Thermoplastic PUs are block copolymers composed of a hard segment (A) and 
soft segment (B) blocks arranged in an (AB)n type structure (see Scheme 3.1).1   The hard 
segment (HS) block is composed of a diisocyanate (aromatic diisocyanate such as 4,4’-
methlyenediphenyl diisocyanate (MDI) or aliphatic diisocyanate such as hydrogenated 
MDI (HMDI)) and a chain extender (usually a low molecular diol such as 1,4-butanediol 
(BDO) or diamine such as ethylene diamine (ED)).  The soft segment (SS) is usually a 
macrodiol (M.W. 600 – 2000) such as poly(tetramethyleneoxide) (PTMO), the one
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mostly employed in recent medical-grade PUs (see Scheme 3.1).2   Utilizing a variety of 
chemical compositions of PUs (the diisocyanates, the chain extenders, and the 
macrodiols), synthetic polymer chemists are now able to tailor their structures to meet 

































Soft segment            Hard segment
OH
 
Scheme 3.1 The typical synthetic scheme for preparing a thermoplastic polyurethane 
(PU) using HMDI (hydrogenated 4,4’-methlyenediphenyl diisocyanate) as the 
diisocyanate agent, PTMO (poly(tetramethyleneoxide)) as the macrodiol, and BDO (1,4-
butanediol) as the chain extender, where the soft segment (HS) is composed of the 
macrodiol and the hard segment (SS) is composed of the diisocyanate and chain extender. 
 
We recently introduced a new hydrogel (pHEMA with appended Cu(II)-cyclen 
catalytic sites) polymeric material that can catalytically generate nitric oxide (NO) from 
S-nitrosothiols (RSNOs) known to exist in blood (see Chapter 2).  Owing to the well 
known biological activities of NO, such as the inhibition of platelet activation/adhesion 
as well as smooth cell proliferation,9-12 such NO generating polymers (NOGPs) that can 
produce locally elevated NO levels at the blood/polymer interface may be useful to 
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enhance the hemocompatibility of various biomedical devices.  However, the NO 
generating catalyst in any NOGP occupies a very small portion of the total volume (or 
surface) of the polymer.  Thus, the polymeric matrix used to prepare the NOGP will 
dictate the physical properties of this polymeric material, which are also critical factors to 
be considered for any implanted biomaterial.  Given this circumstance, research on ways 
to tailor a medical grade PU to exhibit NO generating activity seems warranted.   That is, 
PU materials with covalently linked sites that can generate NO from endogenous blood 
components will incorporate the combined benefits of the base PU’s mechanical 
properties with NO’s biological activities, yielding a new biomaterial with, hopefully, 
enhanced hemocompatibility.  
Therefore, we now report a new NOGP, in which a medical-grade hydrophilic 
thermoplastic PU (Tecophilic, SP-93A-100, see Scheme 3.1 for its structure) is 
covalently linked with a NO generating catalyst, Cu(II)-cyclen complex.   In this chapter, 
the synthesis and characterization of this new NOGP, Cu(II)-cyclen-PU (5) are presented 
(see Scheme 3.2).  Similar to the previous work described in Chapter 2, the catalytic NO 
generation activities of this new polymeric material are examined using RSNOs and 
RSHs as substrates at physiological pH.  This study also includes examination of the 
potential copper(II) ion leaching from the polymer under various soaking conditions. 
Furthermore, the spontaneous NO generation using this polymer in animal whole blood is 
demonstrated via use of the polymer to construct an amperometric RSNO sensor.   Hence, 
based on the data presented herein, this new PU material is likely to provide an attractive 
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Scheme 3.2 The synthesis of a polyurethane possessing covalently appended Cu(II)-
cyclen complex (Cu(II)-cyclen-PU (5)) from a modified cyclen derivative (1) and 





1,4,7,10-Tetraazacyclododecane (cyclen) was purchased from Strem Chemicals 
(Newburyport, MA).  N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
(EDC), N-hydroxysuccinimide (NHS), glutathione (GSH) and cysteine (CySH) were 
products of Sigma (St. Louis, MO).  Theromplastic polyurethane (Tecophilic, SP-93A-
100) was a gift from Lubrizol Advanced Materials, Inc. (formerly Noveon Inc.) 
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(Cleveland, OH).  Dipropylamine-PEO (DPA-400E, F.W.= 573.73) was donated from 
Tomah products (Milton, WI).  Other chemical reagents from Aldrich (Milwaukee, WI), 
all solvents from Fisher Scientific (Fair Lawn, NJ), and NMR reagents from Cambridge 
Isotope Laboratories, Inc. (Andover, MA) were used without further purification unless 
otherwise noted.  Distillation was employed for the purification of hexamethylene 
diisocyanate (HDI), N,N’-dimethyl acetamide (DMAC), triethylamine (Et3N), 
acetonitrile (CH3CN) and tetrahydrofuran (THF) prior to use.  DI water was prepared by 
a Milli-Q filter system (18 MΩ cm-1; Millipore Corp., Billerica, MA, USA).  
3.2.2. Measurements 
1H and 13C NMR spectra were recorded using either a Varian 400 or 500 MHz 
spectrometer.  High-resolution (HR) mass spectra were obtained on a Waters Autospec 
Ultima Magnetic Sector mass spectrometer with an electrospray interface.  FTIR spectra 
were collected with a Perkin-Elmer spectrum BX FT-IR system.  EPR spectra were taken 
with a Bruker EMX (Center field, 3300 G; Sweep Width, 2000 G; Frequency, 9.248 
GHz).  The copper content of the polymers was analyzed by inductively coupled plasma-
high resolution mass spectrometry (ICP-HRMS), using a Thermo Finnigan Element.  NO 
generation measurements were made using a Sievers Nitric Oxide Analyzer (NOA), 
model 280.  The current signals of amperometric NO/RSNO sensors were monitored by a 
microchemical sensor analyzer (Diamond General, Ann Arbor, MI). 
3.2.3. Synthesis 
 (Boc)3-cyclen-N-acetic acid (1): 
(Boc)3-cyclen-N-acetic acid (1) (see Scheme 3.2), was synthesized by modifying 
a reported procedure.13 In brief, to a stirred solution of cyclen (3.0 g, 17.4 mmol) in 
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anhydrous CH3CN (40 mL) was slowly added a solution of benzyl 2-bromoacetate (1.5 
mL, 9.2 mmol) in anhydrous CH3CN (50 mL) over 6.5 h at 85 °C under a nitrogen 
atmosphere.  After additional stirring for 1 h, the mixture was cooled down to RT. 
Without further purification, an excess amount of Et3N (10 mL) was poured into the 
mixture at 0 °C, followed by the addition of di-tert-butyl-dicarbonate (Boc2O, 14.8 g, 
65.8 mmol), and then the mixture was stirred overnight at RT.  The mixture was then 
concentrated, and the residue was extracted with Et2O/water.  The separated organic layer 
was washed with diluted HCl, water, sat’d NaHCO3, and water sequentially.  The organic 
layer was dried with anhydrous Na2SO4, filtered, and washed with Et2O.  After the filtrate 
was concentrated, the crude material was dissolved in MeOH (20 mL) and stirred at RT, 
and then a solution of 2 N NaOH (10 mL) was dropped into the solution over a 2 h period.  
The solvent was evaporated under a reduced pressure, and then the residue was extracted 
with Et2O/water.  The separated water layer was acidified with citric acid to adjust it to 
between pH 3 – 4.  After the extraction with ethyl acetate (EA) 3 times, the combined 
organic layers were dried with Na2SO4, filtered, and washed with EA.  After the filtrate 
was concentrated, the crude product was purified by a column chromatography using 
silica gel (EA, then MeOH/CH2Cl2 = 1/8) to afford the desired product, an amorphous 
white solid (1.4 g, overall yield = 15%).  
1H NMR (500 MHz, CDCl3): δ=3.90 ~ 3.06 (m, 14H; 7 NCH2), 2.86 (bs, 4H; 
(CH2)NCH2CO2), 1.40 (s, 9H; 3 CH3), 1.37 (s, 18H; 6 CH3); 13C NMR (125 MHz, 
CDCl3): δ=155.92, 155.34, 79.77, 79.43, 53.77, 51.34, 49.68, 47.30, 28.59, 28.39; 
HRMS(EI): m/z: [M + Na]+ calcd. for C25H46N4O8Na, 553.3213, found 553.3207. 
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Aminated PU (2): 
A procedure adopted from previous reports14, 15 was employed to prepare the 
aminated PU polymer.  Thermoplastic PU (Tecophilic, SP-93A-100) was purified by 
soxhlet extraction with methyl tert-butyl ether (MTBE) for 3 d prior to use.  A dried PU 
(20 g, ca. 80 mmole of urethane group) was dissolved in anhydrous DMAC (400 mL). 
This solution was slowly dropped into a stirred solution of HMDI (39 mL, 241 mmole) 
and DBTDL (0.72 mL, 1.2 mmole) in DMAC (40 mL) at 40 °C over a 3.5 h period, and 
then stirred for 1.5 d.  The mixture was cooled to RT and slowly added into anhydrous 
Et2O (4 L) under a nitrogen atmosphere.  The resultant solid was filtered and washed with 
anhydrous Et2O (600 mL).  After the filter cake was dried by blowing N2, it was further 
vacuum dried to give a colorless polymer.  This polymer (19.3 g) was again dissolved in 
anhydrous DMAC (400 mL) and slowly added into a stirred solution of dipropylamine-
PEO (15.5 g) in anhydrous DMAC (40 mL) at 40 °C over 3 h.  The mixture was stirred 
for 4 d at 40 °C, and then slowly added into Et2O (4 L) to form a solid, which was filtered 
and washed with Et2O (600 mL).  The filter cake was soxhlet extracted with MTBE for 3 
d, and then cooled to RT.  The remaining polymer was dried under a vacuum pump for 4 
d to yield an aminated PU (2) (19.4 g, see Scheme 3.2).  The amount of free amine sites 
created in the aminated PU (2) was analyzed by a colorimetric method to vary depending 
on the reaction scale and time used (see section 3.2.4).  The given method described 
above afforded ca. 80 µmole of amine sites per one gram of the polymer. 
IR (neat) = 3323 cm-1 (N-H), 2916, 2857 cm-1 (CH2), 1715 cm-1 (C=O), 1614 cm-1 




 EDC (0.4 g, 2.1 mmole), Et3N (0.8 mL, 5.7 mmole), and NHS (0.26 g, 2.3 
mmole) were sequentially added into a stirred solution of (Boc)3-cyclen-N-acetic acid (1) 
(0.8 g, 1.5 mmol), in THF/water (10 mL/10 mL).  After 30 min, this mixture was poured 
into a clear solution of aminated PU (2) (19.1 g, ca. 1.53 mmole of amine sites) in THF 
(500 mL).  The reaction mixture was stirred for 5 d at 30 °C, and then concentrated to 
one-fifth volume under a reduced pressure.  The gradual addition of the residue into 
stirred solvents of DI water/Et2O (0.25 L/3.75 L) yielded a solid polymer.  The polymer 
was sieved and washed with DI water.  The residual polymer was immersed and stirred in 
Et2O (1 L) for 1 d at RT.  The resulting polymer was filtered and washed with Et2O, and 
then dried by a vacuum pump to give a polymer, (Boc)3-cyclen-PU (3) (18.5 g, see 
Scheme 3.2).   
To remove the Boc groups from the appended cyclen moieties, without further 
purification, TFA (10 mL) was added into the polymer (17 g) solution in CHCl3 (500 
mL) at 0 °C, and the mixture was stirred for 3 d at RT.  The reaction mixture was then 
concentrated using a rotary evaporator and the residue was diluted with CHCl3.  The 
same procedure was repeated 3 times to remove any remaining TFA.  The solid polymer 
formed in Et2O was filtered and washed with Et2O.  The filtercake was soaked in diluted 
NaOH (pH ~12) for 6 h at RT, and then filtered and washed with DI water until the pH of 
the filtrate reached pH 7.  The polymer was washed with Et2O and MTBE and then 
soxhlet extracted with MTBE for 3 d to afford a slightly yellowish polymer, cyclen-PU 
(4) (16 g, see Scheme 3.2), after drying via a vacuum pump.   
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In order to incorporate Cu(II) into the deprotected cylen-PU, to a stirred solution 
of cyclen-PU (4)  (15 g) in THF (500 mL) was added a clear solution of cupric chloride 
dihydrate (2.9 g) in EtOH (100 mL) at 50 °C.  The mixture was stirred overnight and 
cooled to RT.  The solvents of the mixture were evaporated to one-third the original 
volume under reduced pressure, and then the residue was slowly added into a mixed 
solvent of EtOH/Et2O (0.5 L/2 L) to form a green-colored solid polymer.  After this 
polymer was filtered and washed with EtOH/Et2O (0.5 L/2 L), the filtercake was fully 
immersed and stirred in EtOH and then filtered and washed with EtOH/Et2O (0.5 L/2 L).  
The filtercake was soaked and stirred in DI water for 1 d, and the residual solid was 
filtered and washed with DI water and MTBE sequentially.  Finally, the polymer was 
purified by soxhlet extraction with MTBE, and dried via a vacuum pump for 3 d to give a 
slightly blue-tinted polymer, Cu(II)-cyclen-PU, 5 (10 g, see Scheme 3.2). 
IR (neat) = 3325 cm-1 (N-H), 2919, 2863 cm-1 (CH2), 1715 cm-1 (C=O), 1530 cm-1 (C-N, 
N-H), 1109 cm-1 (CH2-O-CH2). 
3.2.4. Determination of free amine equivalents in the aminated PU (2) 
Amine equivalents in the aminated PU (2) were determined by a conventional 
colorimetric titration.  Three different solutions were prepared as follows; i) colorimetric 
indicator: 0.1 N NaOH solution was slowly dropped into a solution of bromophenol blue 
(0.1 g) in MeOH (100 mL) until the solution color changed from pale purple to blue; ii) 
samples: three solutions of aminated PU (2) (73.1, 73.6, and 71.6 mg, respectively) 
dissolved in DMAC (5 mL), and a blank solution having only the solvent; iii) titrating 
agent: 1.0 mM p-toluenesulfonic acid monohydrate dissolved in isopropanol.  Each 
sample solution (including the blank sample) was diluted with isopropanol (5 mL) and 
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mixed with one drop of the indicator solution.  Finally, this mixture was titrated by a 
solution of p-toluenesulfonic acid until the color disappeared.  The average value of free 
amine sites in the polymer was obtained after correction for the endpoint of the blank 
solution. 
3.2.5. Measurements of copper content in polymers 
To assess the copper content of the various PU-Cu(II)-cyclen polymers, the same 
method described in Chapter 2 was followed.  
3.2.6. NO measurements via a chemiluminescence NO analyzer (NOA) 
All NO generation measurements from RSNO species for the new PU-based 
NOGP were carried out using the NOA via the same methodology presented in Chapter 2. 
3.2.7. Pre-conditioning of NOGP by soaking in a GSH/GSNO solution  
Prior to soaking, the NO generation flux of a small disk-shaped film of Cu(II)-
cyclen-PU (5) (r= 3.2 mm, θ= 65 µm) was determined in presence of 10 µM 
GSH/GSNO solution dissolved in 2 mL of 10 mM PBS buffer, pH 7.4, containing 3 µM 
EDTA at RT via the NOA.  This film was then fully bathed and shaken under relatively 
harsh conditions with high concentration of GSH/GSNO (0.1 mM) and low pH solution 
in 2 mL of PBS buffer, pH 6.6, overnight at RT.  The film was removed from the mixture 
and placed into 10 mL of a fresh PBS buffer, pH 7.4.  Then, the same procedure to wash 
the film was carried out a couple of times using fresh PBS buffer.  The resulting film was 
stored in fresh PBS buffer to ensure that the film was in a hydrated state immediately 
before use in the NOA experiments.  Finally, this film was retested to assess whether this 
soaking treatment changed the levels of NO generation that could be achieved (compared 
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to the initial test, before extensive conditioning) using the same test reaction conditions 
(10 µM GSH/GSNO). 
3.2.8. Soaking in sheep plasma 
The NO generation from a small disk of the Cu(II)-cyclen-PU (5) (r= 2.6 mm, θ= 
30 µm) was also monitored in a solution of 0.5 µM CySH/CySNO in 2 mL of 10 mM 
PBS buffer, pH 7.4, containing 3 µM EDTA.  Simultaneously, several same-sized films 
were separately immersed in platelet-rich sheep plasma obtained by centrifuging (1300 
rpm for 18 min at 4 °C) whole blood from sheep (purchased from Lampire Biological 
Lab; Pipersville, PA), and then stored at 4 °C.  After a given time interval, the typical 
washing procedure (see section 2.9) was carried out.  Then, the NO generation ability of 
each film was examined under the same reaction conditions (0.5 µM CySH/CySNO) as 
the film that had not been soaked in sheep plasma.  
3.2.9. Fabrication of amperometric NO/RSNO sensors 
Each amperometric sensor was constructed in a manner analogous to that reported 
in Chapter 2.  In brief, a platinized Pt working electrode (Pt disk with 250 µm o.d.) sealed 
in glass wall tubing was surrounded by a coiled Ag/AgCl wire reference/counter 
electrode, and these two electrodes were integrated behind a PTFE gas-permeable 
membrane (GPM) treated with 0.5 µL of 1 % Teflon AF solution (Dupont 
Fluoroproducts, Wilmington, DE).16   A thermoplastic PU film (Tecophilic®, SP-93A-
100) was used as a control layer for one sensor (control sensor with no NO generation) by 
mounting it on the GPM of a NO sensor using an O-ring.  To make the RSNO sensor, a 
piece of the Cu(II)-cyclen-HPU (5) was mounted over the GPM of the NO sensor.  
66 
Finally, both sensors were polarized at +0.75 V vs Ag/AgCl for at least 12 h prior to use.  
All amperometric measurements were performed using the same applied potential.  
3.2.10. Amperometric NO detection in blood 
The amperometric NO measurements in blood using both the NO and RSNO 
sensors were carried out using the procedures described in Chpater 2.  In these 
experiments, 70 mL of PBS buffer, pH 7.4, containing 5 µM EDTA and 10 µM GSH was 
used to dilute 30 mL of whole sheep blood.  
 
 
3.3. Results and Discussion 
3.3.1. Synthesis and characterization 
In order to conjugate the Cu(II)-cyclen complex to an existing medical grade 
hydrophilic thermoplastic PU (Tecophilic, SP-93A-100), the two key precursors, (Boc)3-
cyclen-N-acetic acid (1) and aminated PU (2) were prepared by methods  analogous to 
those reported elsewhere13-15 (see scheme 3.2).  Since the strong Cu(II) complexation 
ability of  the cyclen ligand needs to be maintained after covalent linkage to the polymer 
(without any loss of basicity in the cyclen compound), a carboxylic group was introduced 
via N-alkylation of the (Boc)3-protected cyclen using 2-bromoacetic acid to yield (Boc)3-
cyclen-N-acetic acid (1) (see section 3.2.3 for details).   
To link this species to the polymer, free amine sites were created in the 
thermoplastic PU by an isocyanation reaction, followed by amination in dilute conditions 
to form the aminated PU (2).  The total amount of free amines in the resultant aminated 
PU (2) was 80 µmole per g of the polymer, as determined by the colorimetric titration 
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method.  It should be noted that the amount of amine sites created in the polymer can be 
varied by controlling the reaction conditions (i.e., such as scales, reagent equivalents and 
times) and ranged from 80 – 200 µmole per g.  IR spectra of the polymers clearly showed 
the expected characteristic absorption band patterns as reported elsewhere,17 in which the 
newly formed isocyanate and urea bands appeared in the isocyanated PU-intermediate.  
The  isocyanate band disappeared after free amine sites were formed in the final aminated 
PU (2) while the urea group still remained (see Figure 3.1).  
After the conjugation of (Boc)3-cyclen-N-acetic acid (1) with the aminated PU (2) 
using EDC coupling chemistry, the Boc-groups were deprotected with TFA and the 
mixture was treated with dilute NaOH to remove TFA. Copper ions were then 
incorporated into the polymer.  The extensive washing procedures with various solvents 
to remove the non-specifically bound copper ions in the polymer backbone ultimately 









Figure 3.1 IR spectra of (A) thermoplastic PU (Tecophilic, SP-93A-100); (B) 
isocyanated intermediate; and (C) aminated PU (2), where two distinguishable peaks 
corresponding to the newly formed (α) isocyanate group and (β) urea group appeared in 
the (B) spectrum, while the (α) peak disappeared in the (C) spectrum; these spectra were 
recorded for the polymer containing the highest amine sites (200 µmole per g poymer). 
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Generally, when an aminated polymer (2) containing higher free amine sites was 
employed in the reaction, the resulting polymer 5 had higher copper content, as 
determined by ICP-HRMS, to range from 0.08 to 0.4 wt %, depending on the specific 
reaction conditions.  This low copper content in all polymer 5 formulations suggested that 
only a very low percentage of cyclen was actually covalently attached to the polymer.  
Consequently, identifying the cyclen groups within the isolated polymers using NMR or 
IR was difficult.  However, the UV and EPR spectra, as well as the NOA experiments 
(see below), support the fact that Cu(II)-cyclen complexes are linked to the hydrophilic 
thermoplastic PU.  Indeed, the Cu(II)-cyclen complex is known to have a square 
pyramidal structure with an absorption band in the region 550–670 nm in the visible 
region of the spectrum.18   While the λmax of Cu(II)(cyclen)Cl2 has been reported to be 
594 nm in water,18 a film of Cu(II)-cyclen-PU (5)  was found to have an absorption 
maximum at 617 nm when in a fully hydrated state (see Figure 3.2).  
 







e (A) Cu(II)-cyclen-PU, 5 
(B) Cyclen-PU, 4
 
Figure 3.2 UV spectra of two films in fully hydrated states: (A) Cu(II)-cyclen-PU (5), 
and (B) cyclen-PU (4); Although the two spectra have a high background absorbance, 




Such a bathochromic shift in λmax was also observed in the previous study (Chapter 2) 
where the Cu(II)-cyclen complex was covalently attached within a  crosslinked poly(2-
hydroxyethyl methacrylate) (pHEMA) film.  This change of UV-Vis absorption may be 
influenced by the surrounding polymer matrix, a possible structural distortion of the 
Cu(II)-cyclen complex in the polymer matrix, as well as the substitution of chloride ion 
for  hydroxide ion as a ligand for the Cu(II)-cyclen-PU (5) during the preparation process. 
Nonetheless, the EPR spectrum of Cu(II)-cyclen-PU (5) was quite similar to that of the 
small molecule Cu(II)-cyclen complex (see Figure 3.3), suggesting successful copper ion 
complexation with the cyclen moieties appended to the polymer.  Again, any non-
specifically bound copper ions within the polymer backbone are not likely to yield a 
significant contribution to the NO generating ability of the new polymer, and this was 
indirectly proven by subsequent NOA experiments using a blank film (copper ion-treated 
(Boc)3-cyclen-PU (4) ; see below). 
 





Figure 3.3 EPR spectra of (A) the polymer of Cu(II)-cyclen-PU (5), and (B) the solution 
of Cu(II)-cyclen complex, both in PBS buffer, pH, 7.4, at 77K: Center field, 3300 G; 




3.3.2. Catalytic NO generation from S-nitrosothiols via Cu(II)-cyclen-PU (5) 
The estimated NO flux of healthy endothelium cells that line in all blood vessels 
is approximately 10-10 mole/cm2.min.  In fact, only a very low concentration of NO (< 1 
nM) is known to be effective in reducing thrombus formation on the surface of a foreign 
material.19-22   Endogenous RSNOs are known to exist in blood in the range of nM to µM 
levels, although their exact concentrations are still in question.23, 24   Low molecular 
weight (LMW) endogenous RSHs such as CySH and GSH are also present at 10 – 30 µM 
concentrations in human plasma.24   Therefore, even a small fractional decomposition of 
endogenous RSNOs to locally produce the biologically relevant NO levels at the 
polymer/blood boundary should be effective to improve a polymer’s hemocompatibility. 
Indeed, a small piece of PU material containing a low percentage of the Cu(II)-
cyclen complex (Cu(II)-cyclen-PU, 5) was able to catalytically produce a biological 
relevant NO flux in the presence of µM concentrations of RSNO/RSH at physiological 
pH (see Figure 3.4).  The amount of NO produced from a given reaction solution by the 
Cu(II)-cyclen-PU (5) was continuously monitored by the NOA.  First, a small disk 
shaped polymer film of 5 (radius= 2.5 mm, thickness= 30 µm, copper content= 13 nmole 
(0.14 wt %)) was placed into a solution of 10 µM GSNO/GSH in 2 mL of a phosphate 
buffered saline (PBS), pH 7.4, containing 3 µM EDTA.  A burst of NO signal was 
initially detected (see Figure 3.4) and then the NO flux slowly decreased to reach a 
steady-state NO level (approximately 1 x 10-10 mole/cm2.min).  When the film was 
removed from the solution, the NO signal returned to the original baseline, implying that 
the presence of this polymer initiated the NO liberation from GSNO.  The continual 
insertion/removal of the film demonstrated that the polymer could generate a comparable 
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steady-state NO flux after each immersion and removal from the test solution (see Figure 
3.4(A)).  The same film 5 was also tested in a solution of 0.5 µM CySNO/CySH in PBS 
buffer.  Upon addition of the film into the reaction solution, the NO signal increased to 
reach given NO flux (approximately 1 x 10-10 mole/cm2.min), and then gradually 
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Figure 3.4 The NOA measurement of catalytic NO production by a small disk film of 
Cu(II)-cyclen-PU (5) (radius= 2.6 mm, thickness= 30 µm, Wd (weight at a dried state) = 
0.6 mg, Cu content= 0.15 wt %), in the solution of (A) 10 µM GSNO/GSH, and (B) 0.5 
µM CySNO/CySH in PBS buffer, pH 7.4, containing 3 µM EDTA; a similar sized film of 
(C) cyclen-PU (4) and (D) copper ion-treated 3Boc-cyclen-PU (3) in 10 µM GSNO/GSH 
solution in PBS buffer, pH 7.4, containing 3 µM EDTA; Arrows indicate the moment 
when a given species is added or removed. 
 
To demonstrate that copper ions are the key active species to denitrosate the 
RSNO species, as a control experiment, a similar sized film of cyclen-PU (4) that was not 
treated with copper ions was tested for its NO generation ability.  When this blank film 
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was soaked in a solution of 20 µM GSNO/GSH in the PBS buffer, the NO baseline was 
slightly increased and soon decreased to essentially the original baseline (see Figure 
3.4(C)).  To prove whether free copper ion can non-specifically bind to the polymeric 
backbone, a same sized film of 3-Boc-cyclen-PU (3), which was treated with copper ions 
by the same method employed to prepare the polymer 5, was immersed into the 20 µM 
GSNO/GSH solution.  Similar to the previous control film, the baseline was initially 
elevated, but then quickly returned to the original baseline (see Figure 3.4(D)).  
Therefore, this data supports the fact that the copper ions complexed with the cyclen 
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Figure 3.5 Substrate dependency on the NO generation from the same film (Cu(II)-
cyclen-PU (5)) used in the experiments as shown Figure 3.4, where the parenthesis in the 
graph indicates the number of times when the same polymer film was sequentially used; 
(A) reducing agent dependency (10 µM) at a 10 µM GSNO solution, (B) RSH/RSNO 
variation with both at 10 µM concentrations in the PBS buffer. 
 
Ascorbate has previously been identified as a good reducing agent for the copper 
ion-mediated RSNO decomposition.25   As shown in Figure 3.5(A) the reducing ability 
of ascorbate using this NOGP (Cu(II)-cyclen-PU (5)) is clearly observed to be equivalent 
to GSH.  When the different species at equal concentrations were tested as the reducing 
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agent for NO generation by polymer 5, the highest NO flux was achieved in the presence 
of CySH.   In addition, the reaction of CySNO with this NOGP was greater than GSNO 
at the same concentration of GSH and/or CysH (GSNO/GSH < GSNO/CySH < 
CySNO/GSH, see Figure 3.5 (B)).  This confirms why the lower concentration of 
CyNO/CySH (0.5 µM) could achieve a similar NO flux as higher concentrations of 
GSNO/GSH (10 µM) (see Figure 3.4 (A) and (B)).  Thus, CySNO and CySH are 
apparently better substrates for the new NOGP in terms of catalytic NO generation 
efficiency.  
3.3.3. Copper leaching studies 
Ideally, a useful NOGP must be designed to generate NO for long periods of time 
once implanted.  To achieve this goal, the catalytic NO generation activity of the Cu(II)-
cyclen-PU should be maintained under the physiological conditions for an extended 
period of time.  The stability of Cu(II)-cyclen complex within the polymer is the primary 
concern in this type of NOGP because any blood components such as free thiols and 
proteins that have high binding affinities with copper ions may facilitate demetalation 
and/or deactivation of the complex.  For example, low molecular weight endogenous 
RSHs as well as their oxidized forms (disulfides, RSSRs) are known to bind tightly  with 
copper ions.26, 27   In fact, the previous work presented in Chapter 2 proposed that free 
thiols such as GSH can influence the copper ion leaching from the Cu(II)-cyclen complex 
immobilized in the crosslinked poly(2-hydroxyethyl methacrylate), but does not  
deactivate the copper sites of Cu(II)-cyclen complex in the polymer.  
Although the new NOGP developed here (Cu(II)-cyclen-PU (5)) has a different 
polymer matrix, thermoplastic PU, the potential leaching of copper ion from the polymer 
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remains.  Thus, this possibility has been examined using the same metholology described 
in Chapter 2.  First, the film of Cu(II)-cyclen-PU was repeatedly tested for its NO 
generation using the RSH/RSNO solutions under typical test conditions, showing that the 
maximum steady-state NO level was continuously decreased with every trial until it 
reached a certain NO level after 12 sequential uses (ca. 50 % reduction compared to the 
original NO flux (see Figure 3.6(A)).  Further experiments examined whether the Cu(II)-
cyclen-PU polymer was still able to liberate NO from GSNO even after soaking in 
harsher conditions.  For example, a new piece of polymer 5 was fully bathed and shaken 
in a high concentration of GSH/GSNO solution (0.1 mM) and a low pH (pH= 6.6) 
overnight at RT (see section 3.2.7 for details), conditions that are expected to accelerate 
the demetalation and/or deactivation reactions.  However, after such soaking and 
subsequent washing, the polymer is still able to generate NO from GSNO, albeit at a 
reduced flux (see Figure 3.6(B)).  Taken together, the demetalation of Cu(II)-cyclen-PU, 
5, may occur under physiological conditions; however, the deactivation of the new 
NOGP caused by the strong coordination of small molecular RSH and/or RSSR species 
onto the metal center may not be a serious issue.   
To evaluate how the NO generation profiles of the Cu(II)-cyclen-PU in a given 
RSNO/RSH solution can be changed before and after contact with sheep plasma for a 
finite time period, the same sized films of Cu(II)-cyclen-PU were separately immersed 
into the platelet-rich sheep plasma for a given time interval at 4 °C.  Then, the NO 
production profiles mediated by these films from CySNO/CySH solution were measured 
by the NOA (see section 3.2.8 for details).  The NO generation by these test films 
exhibited very similar behavior regardless of the exposure time to sheep plasma (see 
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Figure 3.6(C)).  This result suggests that the blood components do not have a significant 




































































































































Figure 3.6 (A) A disk type of film (Cu(II)-cyclen-PU (5) radius= 2.6 mm, thickness= 30 
µm, Wd= 0.6 mg, Cu content= 0.15 wt %) was continuously used with various substrates, 
where the parenthesis in the graph indicates the number of times the polymer film was 
sequentially used, then its NO flux at a steady-state was monitored in a solution of 10 µM 
GSNO/GSH in PBS buffer, pH 7.4, containing 3 µM EDTA; (B) a new film (Cu(II)-
cyclen-PU (5) radius= 3.2 mm, thickness= 65 µm, Cu content= 0.4 wt %)-mediated NO 
generation was compared in the same reaction condition (10 µM GSNO/GSH in the PBS 
buffer) before (a) and after (b) this film was soaked in the solution of 0.1 mM 
GSNO/GSH in PBS buffer, pH 6.6; (C) The comparisons of new films of Cu(II)-cyclen-
PU (5) (radius= 2.6 mm, thickness= 30 µm, Wd= 0.6 mg, Cu content= 0.15 wt %) for the 
NO generation profiles in a solution of 0.5 µM CySNO/CySH in the PBS buffer before 
(a) and after soaked in a platelet-rich sheep plasma at 4 °C for 1 d (b) and 3 d (c); all NO 
measurements were monitored via the NOA. 
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The various soaking experimental results carried out here with polymer 5 are 
consistent with the prior study (Chapter 2) where Cu(II)-cyclen was appended to pHEMA, 
and indicates that the demetalation and/or deactivation of the Cu(II)-cyclen complex in 
the polymeric matrix by various blood components may not be a serious concern, 
although  LMW endogenous RSH and/or RSSR species likely can affect the rate of 
copper ion demetalation in this new polymer.  More intensive in vivo studies for the 
various time periods are required to fully assess whether copper leaching from the new 
NOGP (Cu(II)-cyclen-PU, 5) will be a problem for practical biomedical applications of 
this new material.   
3.3.4. Spontaneous nitric oxide generation by polymer 5 when in contact with fresh 
blood 
  To further assess the potential biomedical utility of new Cu(II)-cyclen-PU, it is 
essential to prove that the polymer can generate NO in the presence of fresh whole blood.  
One experimental strategy to demonstrate this NO generation is to measure the additional 
NO levels produced by the Cu(II)-cyclen-PU in blood when a polymer film of this 
material is coated over the distal end of  an amperometric NO sensor.  This approach was 
utilized in Chapter 2 to prove that the Cu(II)-cyclen-pHEMA material can generate NO in 
fresh blood.   In brief, two sensors need to be constructed for this experiment. One is a 
control NO sensor where a thin film of the bare thermoplastic PU (Tecophilic, SP-93A-
100) is used as an outer membrane of the electrochemical NO selective sensor.  The other 
sensor is an RSNO sensor where a similar sized film of Cu(II)-cyclen-PU (5) is employed 
as an outer membrane of the NO sensor (see section 3.2.9 for details).  Prior to 
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experiments, the inherent amperometric responses of both sensors toward NO are 
determined using pure NO gas standard solution (see Figure 3.7).     
  


















Figure 3.7 The calibration curves of both sensors ((A) NO and (B) RSNO) were plotted 
for their intrinsic direct amperometric responses to NO upon the addition of standard NO 
solution into 100 mL of 10 mM PBS buffer, pH 7.4, at 36 oC; the numbers in the graph 
indicate the accumulated NO concentrations after aliquots of the stock NO solution was 
added. 
 
Two sensors were simultaneously placed into the fresh sheep whole blood diluted 
with the PBS buffer at 36 °C, and their amperometric responses (see section 3.2.10) were 
recorded.  While the control NO sensor showed a small background signal in the fresh 
whole blood, the RSNO sensor exhibited a significantly higher NO signal (see Fig. 3.8), 
indicating that the Cu(II)-cyclen-PU rendered the NO levels locally elevated at the 
membrane phase by contact with the fresh blood. As the experiment continued, the 
addition of a standard GSNO solution into the same fresh blood sample clearly confirmed 
that the RSNO sensor (with the Cu(II)-cyclen-PU polymer on the surface) responded to 
the exogenous RSNO while the NO sensor did not (see Figure 3.8).  Consequently, in 
situ NO generation in the fresh sheep whole blood by the Cu(II)-cyclen complex tethered 

























Figure 3.8 The direct detection of endogenous RSNOs in fresh sheep blood using the 
amperometric (A) NO sensor and (B) RSNO sensor by injecting 30 mL of fresh sheep 
blood into 70 mL of 10 mM PBS buffer, pH 7.4, at 36 ˚C; the intrinsic amperometric 
responses of two sensors toward the exogenous RSNO were demonstrated by adding the 





In summary, a biomedical grade thermoplastic PU (Tecophilic, SP-93A-100) has 
been utilized as a polymeric matrix to prepare an NOGP by covalently linking a Cu(II)-
cyclen complex to the backbone.  A combination of typical synthetic procedures, 
including the modification of a small molecule and a polymer, the chemistry of protection, 
coupling, and deprotection, as well as copper ion complexation were applied to the 
synthesis of Cu(II)-cyclen-PU (5)(see Scheme 3.2).  The copper content was measured 
via ICP-HRMS to be a relatively low concentration, ranging from 0.08 to 0.4 wt %, that 
can be varied by the reaction conditions.  The new NOGP (Cu(II)-cyclen-PU (5)) 
exhibited the catalytic denitrosation of LMW RSNOs in the presence of LMW RSHs or 
ascorbate at physiological pH, while two control films (cyclen-PU (4) and the copper 
treated (Boc)3-cyclen-PU (3)) did not yield any significant NO generation in the same test  
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solutions of RSNOs/RSHs.  In addition, the potential demetalation and/or deactivation of 
the Cu(II)-cyclen-PU was evaluated by various soaking experiments using excess 
amounts of GSNO/GSH or the platelet-rich sheep plasma, and results indicate that the 
presence of  blood components do not significantly influence the demetalation and/or 
deactivation of this NOGP, although high levels of LMW endogenous RSHs and/or 
RSSRs are likely to accelerate the copper ion leaching from the polymeric film.  Most 
importantly, it was shown that the new Cu(II)-cyclen-PU material can generate 
significant levels of NO when in contact with fresh animal whole blood, as determined  
via use of the polymer to construct an amperometric RSNO sensor.  Hence, this new 
polymer is a potential candidate for in vivo animal testing as a coating material for a wide 
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Organoditelluride-Mediated Catalytic S-Nitrosothiol 
Decomposition to Nitric Oxide 
 
4.1. Introduction 
Hou et al. first reported the organodiselenide (RSeSeR)-mediated catalytic 
decomposition of S-nitrosothiols (RSNOs) to nitric oxide (NO) in the presence of free 
thiols (RSHs) as a reducing agent.1  More recently Meyerhoff and co-workers have 
applied this chemistry to polymeric materials in order to develop a new type of nitric 
oxide generating polymer (NOGP), and successfully demonstrated that catalytic activity 
comparable to solution phase is possible using organodiselenide linked polymers.  
Although the mechanism of organodiselenide-mediated RSNO decomposition remains 
unclear, it has been suggested that seleno-sulfide (RSeSR) is a key intermediate, and 
organoselenolate (RSe-) is the active reducing species that reacts and liberates NO from 
RSNOs1-3 via the proposed oxidized form of the catalyst (RSeNO).4   This suggests that 
the redox chemistry of organoselenium species plays a key role in the catalytic cycle. 
The redox chemistry of organoditellurides (RTeTeR) has been reported to be 
analogous to that of RSeSeR.  For example, both RSeSeR5, 6 and RTeTeR7-9 have shown 
thiol peroxidase activity as a  glutathione peroxidase (GPx) mimic (see Figure 4.1 for the 
proposed mechanism of RTeTeR-mediated thiol peroxidase activity8), which catalytically 
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reduces organic  peroxides (ROOH) to the corresponding alcohols (ROH) by the 
oxidation of reduced glutathione (GSH) to glutathione disulfide (GSSG).  In this reaction, 
chalcogeno-sulfide (RSeSR or RTeSR) and chalcogenic acid (RSeOH or RTeOH) are the 











Figure 4.1 The proposed mechanism for thiol peroxidase acivity (glutathione peroxidase 
mimic) of organoditelluride (RTeTeR).8  
 
When comparing the RSeSeR-mediated catalytic RSNO denitrosation with the 
RSeSeR (or RTeTeR)-mediated thiol peroxidase activity, the redox chemistry is quite 
analogous where the catalyst (RSeSeR), the reducing agent (RSH), the key intermediate 
(RSeSR), and the active reduced form of the catalyst (RSeH) are all equivalent in 
function.  Additionally, the oxidized substrates used (RSNO or H2O2) are similar; hence, 
the oxidized form of the catalyst is proposed to be RSeNO4 or RSeOH.5, 6   This 
coincidence strongly supports the idea that RTeTeR is expected to catalyze the NO 
liberation from RSNOs as well.  In this chapter, this possibility will be evaluated by 
studying the reaction of RSNOs with a newly synthesized RTeTeR species.  
Herein, is reported the synthesis of 5,5’-ditelluro-2,2’-dithiophenecarboxylic acid 
1 (see Scheme 4.1), and it is demonstrated that this compound catalyzes RSNO 
decomposition to NO in the presence of endogenous reducing agents such as glutathione 
84 
(GSH) or cysteine (CySH) at physiological pH.  Based on the various studies and the 
known chemistry of RTeTeR, the mechanism of RTeTeR-mediated catalytic RSNOs 

















Organoditelluride 1 (DTDTCA)  
 
Scheme 4.1 The synthetic scheme of organoditelluride (1), 5,5’-ditelluro-2,2’-
dithiophenecarboxylic acid (DTDTCA) using 2-thiophene carboxylic acid.   
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Figure 4.2 The proposed mechanism for organoditelluride-mediated catalytic RSNO 
decomposition to NO (ArTeTeAr, organoditelluride; RS-, thiolate; ArTeSR, 
tellurosulfide; ArTe-, tellurolate; RSSR, disulfide; RSNO, S-nitrosothiol; ArTeNO, 
nitrosotellurol; NO, nitric oxide; O2, oxygen). 
 
It is expected that this research can expand the redox chemistry of 
organotellurium, and further provide a new type of NO generating catalyst that can be 
widely applied to a variety of biomedical areas such as RSNO sensors,14 anti-cancer 




Glutathione (GSH) and cysteine (CySH) were products of Sigma (St. Louis, MO). 
Other reagents from Aldrich, solvents from Fisher Scientific, and NMR reagents from 
Cambridge Isotope Laboratories, Inc. (Andover, MA) were used without further 
purification unless otherwise noted.  Distillation was employed for the purification of 
THF prior to use. DI water was prepared by a Milli-Q filter system (18 MΩ cm-1: 
Millipore Corp., Billerica, MA, USA).  
4.2.2. Measurements 
1H and 13C NMR spectra were obtained on a Varian 400 or 500 MHz 
spectrometer.  High-resolution (HR) mass spectra were recorded using a Waters 
Autospec Ultima Magnetic Sector mass spectrometer with an electrospray interface.  
FTIR spectra were collected with a Perkin-Elmer spectrum BX FT-IR system.  UV 
spectra were recorded by a Perkin-Elmer Lambda 35 UV/VIS spectrometer.  Tellurium 
content of the polymers was measured by inductively coupled plasma emission-mass 
spectrometry (ICP-MS).  Melting points were determined by Mel-Tempo® Laboratory 
Devices Inc. (USA).  All NO measurements were made using a Sievers nitric oxide 
analyzer (NOA), model 280, and the instrument was calibrated as reported in Chapter 2.  
4.2.3. Synthesis of 5,5’-ditelluro-2,2’-dithiophenecarboxylic acid (DTDTCA, 
organoditelluride 1) 
To a stirred solution of 2-thiophencarboxylic acid (2.0 g, 15.6 mmol) in THF (200 
mL) was added NaH (95 %, 0.66 g, 15.7 mmol) at 0 °C.  After 10 min, n-BuLi (2.5 M 
solution in hexanes, 6.3 mL, 15.7 mmol) was slowly dropped into the above solution and 
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stirred for 10 min. The reaction mixture was warmed to RT and stirred for 50 min. 
Tellurium (1.9 g, 14.9 mmol) was quickly added into the reaction mixture under a strong 
stream of nitrogen.  After stirring for 2 h, the mixture was concentrated under reduced 
pressure to yield about 20 mL of reddish brown slurry.  The slurry was poured into a 
solution of DI water (300 mL) and CH2Cl2 (200 mL) at 0 °C while adjusting the pH of 
solution to approx. 1 using 1.5 N HCl.  The entire mixture was vigorously mixed by 
blowing air through it at 0 °C.  The mixture was filtered to remove an undissolved solid 
and the filter cake was washed with CH2Cl2.  The separated water layer was extracted 2 
times more with CH2Cl2.  The combined organic layers were dried with anhydrous 
Na2SO4, filtered and washed with CH2Cl2.  The filtrate was concentrated to give a dark 
reddish solid under a reduced pressure.  The crude residue was triturated with CH2Cl2 (50 
mL), then filtered and washed with CH2Cl2 to give a reddish brown solid (0.93 g, 25 % 
yield). 
Decomposition temperature 168 - 172 °C; 1H NMR (500 MHz, DMSO-d6, 
25 °C): δ=13.17 (bs, 2H; 2 COOH), 7.54 (d, J= 4.5 Hz, 2H; 2 CCH), 7.43 (d, J= 4.5 Hz, 
2H; 2 TeCCH); 13C NMR (125 MHz, DMSO-d6, 25 °C): δ=162.28, 142.13, 140.12, 
134.53, 106.19.; 125Te NMR (MHz, DMSO-d6, 25 °C): δ=497.60; IR (KBr)= 3426 cm-1 
(COO-H), 2959, 2554 cm-1 (=C-H), 1667 cm-1 (C=O), 1516 cm-1 (C=C), 1422 cm-1 (=C-
H); HRMS(EI): m/z: [M]+ calcd. for C10H6O4S2Te2, 513.7832: found 513.7835.; EA. 




4.2.4. 5-Deuteriated 2-thiophene carboxylic acid; Identification of the regioisomer of 
organoditelluride 1 
The product of organoditelluride 1 (50 mg) was put into a NaOD solution (1 mL, 
40 %, w/w in D2O) and stirred at 60 °C overnight.  The solution color changed into a 
dark brown and then yellow color.  After cooling to RT, the mixture was diluted with DI 
water.  The product was extracted three times with CHCl3 after the pH of the solution 
was adjusted to 1 by adding diluted HCl at 0 °C.  The combined organic layer was dried 
with anhydrous Na2SO4, filtered and washed with CHCl3.  The filtrate was concentrated 
under reduced pressure, then, dried with vacuum pump to give a partially deuterium-
substituted product (see Figure 4.3). 
 
 
Figure 4.3 The NMR identification for the regioisomer of organoditelluride 1 via the 
partial substitution of Te with a deuterium using NaOD. 
 
4.2.5. Preparation of RSNO solutions 
S-Nitrosocysteine (CySNO) and s-nitosoglutathione (GSNO) solutions were 
prepared according to a reported procedure10 as described in brief in Chapter 2.  
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4.3. Results and discussion 
4.3.1. Design, synthesis and characterization of 5,5’-ditelluro-2,2’-
dithiophenecarboxylic acid (DTDTCA, organoditelluride 1) 
For the development of a new organoditelluride catalyst that can be incorporated 
into NOGPs, this molecule requires a functional group (such as carboxylic acid, free 
amine, etc) that can easily be covalently linked to a polymeric backbone.  Good stability 
during a catalytic cycle at physiological pH is also a necessity that has already shown in 
the thiol peroxidase catalytic activity of diaryl dicalcogenides (ArSeSeAr or 

































































Figure 4.4 (A) UV spectroscopy of 5,5’-ditelluro-2,2’-dithiophenecarboxylic acid 
(DTDTCA, organoditelluride 1) at different concentrations from 0 - 53.3 µM in 10 mM 
PBS buffer, pH 7.4, containing 0.5 mM EDTA under ambient condition; (B) calibration 
curve at maximum absorbance (306 nm); (C) the stability test of 22 µM organoditelluride 
1 in the same PBS buffer at RT; the change of absorbance at 306 nm is recorded as a 
function of time; (D) the calculated decomposition rate of organoditelluride 1 in the same 
PBS buffer (first order, k= 9 x 10-5 min-1). 
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Hence, the designed molecule, 5,5’-ditelluro-2,2’-dithiophenecarboxylic acid (DTDTCA, 
organoditelluride 1, see Scheme 4.1) possessing carboxylic acid groups and aryl groups, 
likely satisfies these requirements.  Indeed, organoditelluride 1 was synthesized from a 
commercially available 2-thiophene carboxylic acid by modifying a previously reported 
procedure (see Scheme 4.1).12   The 5, 5’-positioned regioisomer was isolated as the 
major product, as identified by NMR through the substitution of a deuterium on the Te 
site using NaOD (see 4.2.4 and Figure 4.3).  Organoditelluride 1 is fairly stable (first 
order decomposition, k= 9.0 x 10-5 min-1; see Figure 4.4) and soluble in 10 mM 
phosphate-buffered saline (PBS) buffer, pH 7.4, as designed. 
4.3.2. The measurements of catalytic NO generation by the organoditelluride 1 via a 
chemiluminescence NO analyzer (NOA) 
The NO generated from a reaction solution containing RSNO, free thiol (RSH), 
and the catalytic amount of organoditelluride 1 was continuously monitored using a 
chemiluminescence NO analyzer (NOA).  As shown in Figure 4.5 (A), a relatively large 
signal appears quickly upon adding organoditelluride 1 (2.5 µM) into a solution containing 
GSNO (25 µM) and GSH (100 µM) in deoxygenated PBS buffer.  However, the rate of NO 
generation slowly decreases with time to reach a near steady-state level that lasts until all of 
the GSNO is consumed.  It was found that organoditelluride 1 also decomposes GSNO to 
NO without adding GSH to the reaction mixture (see Figure 4.5 (B)). 
Upon the addition of organoditelluride 1 (2.5 µM) into a solution of GSNO (50 
µM) in deoxygenated PBS buffer without GSH, approximately 1.5 equivalents (after 
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baseline correction) of NO relative to the catalyst are quickly evolved. The NO generation 






































Figure 4.5 The measurements of catalytic NO generation by 2.5 µM 5,5’-ditelluro-2,2’-
dithiophenecarboxylic acid (DTDTCA, organoditelluride 1) in a solution of (A) 25 µM 
GSNO and 100 µM GSH, and (B) 50 µM GSNO and 100 µM GSH in PBS buffer, pH 7.4 
(0.5 mM EDTA) via chemiluminescence NO analyzer (NOA). Arrow indicates addition 


















Figure 4.6 The measurements of catalytic NO generation by 2.5 µM 5,5’-ditelluro-2,2’-
dithiophenecarboxylic acid (DTDTCA, organoditelluride 1) in a solution of 50 µM 
CySNO and 100 µM CySH in 2 mL of 10 mM PBS buffer, pH 7.4, containing 0.5 mM 
EDTA, via chemiluminescence NO analyzer (NOA). Arrow indicates addition of each 
species into the test mixture. 
 
The exact number of moles of NO initially liberated is variable depending on the 
reaction conditions employed; however, the amount produced always ranges from 1 to 2 
equivalents of the initial organoditelluride level when a reducing agent is not added.  Upon 
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addition of GSH (100 µM) to the mixture, NO generation resumes and reaches a 
relatively low steady-state level.  Similar patterns were observed using catalytic amounts 
of organoditelluride 1 and CySNO/CySH substrate solution (see Figure 4.6). 
4.3.3. Mechanistic considerations 
This behavior is quite similar to that observed in a previous report regarding 
organodiselenide-mediated RSNO decomposition.3  Although the mechanism is still 
under study, the work of Cha3 suggested that organodiselenides could directly decompose 
GSNO without GSH at pH 7.4.  However, another report demonstrated that 
organodiselenides do not directly decompose S-nitroso-N-acetyl-D-penicillamine 
(SNAP) or GSNO in the absence of N-acetyl-D-penicillamine or GSH at the same pH.1 
Even though organoditellurides could display a different chemistry for RSNO 
decomposition, it appears unlikely that such an oxidized form of the organoditelluride 
species could directly react with RSNO.   
 
RSH  +  HNO2                           RSNO  +  H2O                           (4.1)
                 RSH                            RS-  +  H+                                    (4.2)
H+
ArTeTeAr  +  RS-                           ArTeSR  + ArTe-                      (4.3)
   ArTeSR  +  RS-                            RSSR  + ArTe-                         (4.4)  
 
Since there is always a low concentration of thiolate (RS-) present in RSNO 
solutions at pH 7.4 (see rxns 4.1 and 4.2),13 and the thiol form (RSH) is much less 
nucleophilic than the corresponding thiolate (RS-), it is probable that the exchange 
reaction of RS- and organoditelluride (ArTeTeAr) can rapidly occur as follows (rxns 4.3 
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and 4.4),8  yielding tellurolate (ArTe-), a highly reactive and reduced form of the original 
ditelluride.  This species is more likely to be responsible for RSNO decomposition rather 
than the direct reaction of oxidized organoditelluride 1 (ArTeTeAr) with RSNO.  
This pathway is supported by several experiments.  First, as shown Figure 4.7, 
UV measurements reveal that the absorption band (λmax = 306 nm) of organoditelluride 1 
(32 µM) in the presence of GSH (320 µM) in PBS buffer rapidly decreases (over 10 min 
period); however the absorption band of organoditelluride 1 (32 µM) in the presence of 
GSNO (320 µM) (λmax = 311 nm; the wavelength slightly shifted because of the 
interference with the significant GSNO absorption band at λmax = 335 nm) decreases very 
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Figure 4.7 (A) UV-Vis spectrophotometric data for (a) 32 µM 5,5’-ditelluro-2,2’-
dithiophenecarboxylic acid (organoditelluride 1; λmax= 306 nm), (b) 320 µM GSH, (c) 
320 µM GSNO (λmax= 335 nm), (d) 320 µM GSH/GSNO (λmax= 335 nm), and (e) 32 µM 
organoditelluride 1, 320 µM GSH/GSNO (λmax= 311 nm) in 2.35 mL PBS buffer, pH 7.4, 
containing 0.5 mM EDTA. (B) Their absorbance changes (at 306 nm) as a function of 
time; (f) 80 µM organoditelluride 1, ; (g) a solution of 32 µM organoditelluride 1 and 
320 µM GSH, . (C) Absorbance changes (at 311 nm) of each solution; (f), ; (c), ; (d), 
x; (h) 32 µM organoditelluride 1 and 320 µM GSNO, O; (e), . 
 
In addition, in both UV experiments, a new absorption band (272 or 279 nm) 
increases as the 306 or 311 nm bands decrease.  This new species is likely the ArTeSR 
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intermediate species.8  In fact, the formation of the ArTeSR species was confirmed by 




Figure 4.8 ArTeSR species was detected by mass spectrometry (electrospray) from a 
mixture of 5,5’-ditelluro-2,2’-dithiophenecarboxylic acid (organoditelluride 1)/GSH 
(1/14, mole/mole) in CH3CN/water (1/1, v/v). 
 
Therefore, this UV and mass spectrometry data support the fact that ArTeTeAr 
does not directly react with RSNO, but a very small portion of ArTe- which is known to 
be immediately formed in the presence of RS- (by rxn 4.3)8  likely reacts with RSNO to 
generate NO.  Furthermore, the kinetics of the initial burst of NO generation as well as 
the level of NO at steady-state in the NOA experiment is pH dependent (pH 6< 7 < 8; see 
GSH in acetonitrle / water    Electrospray 



































predicted isotope pattern for [M+H]+
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Figure 4.9). The addition of ascorbate (100 µM) as a reducing agent in place of free 
thiols does not generate additional NO in the NOA experiment when a fresh solution of 





























Figure 4.9 pH dependent NO generation of 1.25 µM 5,5’-ditelluro-2,2’-
dithiophenecarboxylic acid (DTDTCA, organoditelluride 1) depending on the various pH 
values of test solution (a= pH 6, b= pH 7, or c= pH 8) in 2 mL buffer containing 0.5 mM 





















Figure 4.10 The measurements of NO generation by 2.5 µM 5,5’-ditelluro-2,2’-
dithiophenecarboxylic acid (DTDTCA, organoditelluride 1) in a solution of 50 µM 
GSNO and 100 µM ascorbate (Asc) in 2 mL of 10 mM PBS buffer, pH 7.4, containing 
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Figure 4.11 The GSH/GSNO concentration-dependent NO generation of 2.5 µM 5,5’-
ditelluro-2,2’-dithiophenecarboxylic acid (DTDTCA, organoditelluride 1) as a function 
of varied concentrations (a= 12.5, b= 25, and c= 100 µM) of GSH in the 100 µM GSNO 
(A), or (a= 12.5, b= 25, and c= 100 µM) of GSNO with 100 µM GSH (B) in 2 mL of 10 
mM PBS buffer, pH 7.4, containing 0.5 mM EDTA.  
 
 
Moreover, the level of NO at steady-state in the NOA experiment increases as a 
function of the RSH concentration in the reaction solution (see Figure 4.11 (A)), but not 
in proportion to the initial RSNO concentration (see Figure 4.11 (B)).   
All data clearly indicate that a free thiol is the critical reducing agent required to 
maintain the catalytic reaction cycle, a free thiol is involved in the rate determining step, 
and again ArTe- formed in the presence of free thiol is the most reduced and reactive 
species in this redox chemistry (see rxns 4.3 and 4.4), and is thus responsible for NO 
generation. Considering that the NO generating reaction is irreversible because of NO(g) 
evolution, all the UV and NOA experimental results suggest that the equilibrium rxn 4.4 
lies far to the left as reported in earlier work.8  Thus, this reaction (rxn 4.4) is likely to be 
a rate-determining step for NO generation. 
Alternate pathways can also exist to produce the ArTeTeAr species.  It has been 
recognized that ArTeSR may disproportionate to ArTeTeAr and RSSR (rxn 4.5).8,9   In 
addition, oxygen competes with RSNO to oxidize ArTe- back to ArTeTeAr (rxn 4.6), a 
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well known method to synthesize organoditelluride compounds,12 which likely takes 
place under the ambient conditions during the UV spectrophotometric experiments. 
Therefore, the mechanism for the organotellurium-mediated RSNO decay in the presence 
of oxygen will, in fact, be more complicated. Nontheless, when organoditelluride 1 is 
immobilized on an amperometric NO sensor,14 NO liberation from GSNO still occurs 
under ambient codititons (see Figure 4.12). 
 
     ArTeSR                           ArTeTeAr  +    RSSR                  (4.5)


















Figure 4.12 The current changes of amperometric NO sensor mounted with an 
organoditelluride 1-immobilized membrane upon adding 20 µL of 5 mM GSNO solutions 
into 100 mL PBS buffer containing 50µM GSH and 0.1 mM EDTA under ambient 
oxygen; arrow indicates the addition of GSNO solution into the mixture.  
 
However, based on reported studies, 1,3,4,7, 8  the following two reactions  (rxn 4.7 
and/or 4.8) are most likely responsible for the  RSNO decomposition.  
 
ArTe-  +  2 RSNO                         ArTeSR  +  RS-  +  2 NO                      (4.7)
 ArTe-  +  RSNO                         1/2 ArTeTeAr  +   RS-  +  NO                 (4.8)  
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First, the denitrosation of RSNO by ArTe- might directly form the ArTeSR species via 
rxn 4.7, and this intermediate (ArTeSR) could continuously participate in the catalytic 
cycle without further regeneration of ArTeTeAr.  In contrast, rxn 4.8 reforms the 
ArTeTeAr species, which is the most stable form of organotellurium species in the 
catalytic cycle; hence, this reaction is a thermodynamically favorable pathway.  Further 
investigations are needed to determine whether a plausible intermediate, a nitrosotellurol 
species (ArTeNO), can in fact be formed during this reaction, as suggested for the similar 
organoselenium-mediated RSNO decomposition.4   Nonetheless, it is difficult to 
differentiate between ArTeTeAr and ArTeSR species in the presence of RSH and/or 
RSNO probably due to the fast equilibria reactions involving all of these species (rxns 
4.3 - 4.8).  However, when considering the transnitrosation chemistry between RSH and 
RSNO,15 the transnitrosation of RSe- and RSNO (or RTe- and RSNO) also likely occurs 
to form RSeNO4 (or RTeNO), which is an unstable species compared with RSNO; hence 
it immediately liberates NO to turn into the original form, RSeSeR (or RTeTeR). This 
plausible transnitrosation supports the pathway of rxn 4.8 as the primary NO generation 
reaction.   
Based on the discussion and reactions outlined above, most of NOA experimental 
results can be interpretated.  That is, any trace amounts of ArTe- initially formed via the 
rxn 4.3 will quickly react with RSNO to generate NO via rxn 4.8 (and/or rxn 4.7), which 
keeps the equilibrium for rxn 4.3 shifted to the right.  In proportion to NO evolved, 
ArTeTeAr will diminish as ArTeSR accumulates regardless of the reformation of 
ArTeTeAr via the rxns 4.5, 4.6, and 4.8, because the NO liberation reaction(s) should be 
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fast and irreversible, and the equilibrium for rxn 4.4 favors the reactants.  Therefore, the 
burst of NO initially detected in the absence of added reducing agent depends on the 
amount of thiolate species initially available  based on levels provided by the original 
nitrosothiol substrate (rxn 4.1 and 4.2). 
 
4.4. Conclusions 
5,5’-Ditelluro-2,2’-dithiophenecarboxylic acid (DTDTCA, organoditelluride 1) 
was synthesized, and fully characterized by 1H, 13C, and 125Te NMR, IR, and HRMS 
(high resolution mass spectrometry).  It was found that organoditelluride 1 (ArTeTeAr) 
catalytically denitrosates RSNO to NO in the presence of free thiols at physiological pH 
(see Figure 4.2 for the proposed mechanism).  Various experiments including NOA, UV, 
and mass spectrometry clearly indicate that organoditelluride 1 does not directly react 
with RSNO, but the tellurolate (ArTe-) species formed by thiolate (RS-) that always exists 
in an RSNO solution at physiological pH due to the equilibrium process (rxn 4.1 and 4.2) 
does react with RSNO.  The key intermediate, tellurosulfide (ArTeSR) is also produced 
when ArTeTeAr reacts with RS-.  More complicated reactions are reported to be involved 
in the organoditelluride redox chemistry, such as the disproportion reaction (rxn 4.5) and 
oxidation in the presence of oxygen (rxn 4.6).  
Two different pathways to liberate NO from RSNO are plausible (rxn 4.7 and 
4.8), but rxn 4.8 is more likely responsible for this reaction, which is thermodynamically 
favorable. In this preferred pathway, a nitrosotellurol (ArTeNO) may be formed as an 
intermediate which is an unstable species and immediately liberates NO as proposed for 
organodiselenide-mediated RSNO decomposition.4  Although further investigation is 
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necessary to fully understand all possible reactions involved, this discovery is considered 
significant, as it explores potential new applications of organoditelluride redox chemistry.  
This new catalyst is expected to be useful for preparing different types of NOGPs, which 
can be applied to prepare new  RSNO selective electrochemical sensors14 and potentially 
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Organoditelluride-Tethered Polymeric Materials as New Nitric 
Oxide Generating Polymers (NOGPs) 
 
5.1. Introduction 
Nitric oxide generating polymers (NOGPs) possess catalytic sites that can 
catalytically liberate nitric oxide (NO) from S-nitrosothiols (RSNOs) such as S-
nitrosoglutathione (GSNO) or S-nitrosocysteine (CySNO) in the presence of reducing 
equivalents such as free thiols (RSHs; glutathione (GSH), cysteine (CySH), etc.) or 
ascorbate,1, 2 where all substrates (RSNOs, RSHs, and ascorbate) are already present in 
blood.3   Hence, NOGPs are expected to locally produce enhanced NO levels for 
prolonged time periods at any polymer/blood interface, mimicking the endothelium cell 
layer that lines the inner walls of all healthy blood vessels.  Because NO is known to play 
a key role in vasoprotection, such as the inhibition of platelet adhesion/activation,4-6 and 
smooth cell proliferation,7 NOGPs are potentially useful biomimetic materials that can be 
adapted into a variety of biomedical devices such as catheters, vascular grafts, 
extracorporeal circuits, and indwelling sensors, etc. to improve their inherent 
hemocompatibility. 
Efforts to discover new NOGPs has focused on the use of the known chemistry of 
copper ions8 and organodiselenides (RSeSeR)9 with respect to their catalytic 
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decomposition of RSNOs to NO.  For example, polymeric materials have been covalently 
modified with Cu(II)-cyclen2 or selenocystamine,10 and these new materials have been 
shown to generate NO when in contact with a fresh animal blood in vitro, supporting the 
potential usefulness of the basic concept of NOGPs.  Therefore, it is now worthwhile to 
investigate a variety of other types of catalysts in order to provide many potentially useful 
NOGP polymeric materials for diverse applications within the biomedical area.  Besides, 
known chemicals (Cu+, Fe2+, Hg2+, Ag+, and RSeSeR) for the catalytic RSNO 
denitrosation,9, 11 a new chemistry based on use of organoditellurides (RTeTeR) has been 
introduced in Chapter 4, suggesting the use of such compounds for the preparation of  
additional NOGPs. 
In order to utilize organoditelluride chemistry for creating NOGPs, we herein 
report novel polymeric materials possessing covalently attached organoditelluride species, 
specifically 5,5’-ditelluro-2,2’-dithiophenecarboxylic acid (DTDTCA) (see Scheme 5.1). 
Various base polymeric materials are examined in this work: hydrophilic thermoplastic 
polyurethane (PU; Tecophilic, SP-93A-100) as well as an interpenetrating polymer 
network (polymer 5) consisting of a water soluble poly(allylamine hydrochloride) (PAH) 
with covalently linked DTDTCA and a cellulose membrane (see Scheme 5.1).  The 
catalytic NO generation of these new materials (polymers 3, 4 and 5) from endogenous 
RSNOs and RSHs at physiological pH are demonstrated.   Tunable NO fluxes from 
polymer 5 are achieved by adjusting the amounts of catalytic sites (the polymer 4) loaded 
within the cellulose membrane.  The leaching of tellurium (Te) species from polymer 5 is 
examined as well.  Finally, polymer 5-mediated spontaneous NO generation when in 
contact with fresh sheep blood in vitro is demonstrated via use of an electrochemical 
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RSNO sensor in which polymer 5 is employed as an outer catalytic membrane.  Results 
from this study suggests that new types of NOGPs based on appending an 
organoditelluride catalyst are potentially useful for applications in a variety of biomedical 
areas such as the development of RSNO sensors,12, 13  as well as the preparation of 






    DBTDL,
    DMAC
2) Dipropylamine-PEO





































































            
























Scheme 5.1 Synthetic schemes used for preparing new types of nitric oxide generating 
polymers (NOGPs; polymers 3, 4, and 5) covalently attached with an organoditelluride 
species (DTDTCA, 1), where different polymeric matrices are used; hydrophilic 
thermoplastic polyurethane (PU) for polymer 3, a water soluble poly(allylamine 
hydrochloride) (PAH) for polymer 4,  and an interpenetrating polymer network (IPN) 






2-Thiophene carboxylic acid, tellurium, dibutyltin dilaurate (DBTDL), 
hexamethylene diisocyanate (HDI), and N,N’-dimethyl acetamide (DMAC), were 
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purchased from Aldrich (Milwaukee, WI).  N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC.HCl), N-hydroxysuccinimide (NHS), glutathione 
(GSH) and cysteine (CySH) were products of Sigma (St. Louis, MO).  Hydrophilic 
thermoplastic polyurethane (Tecophilic, SP-93A-100) was a gift from Lubrizol Advanced 
Materials, Inc. (formerly Noveon Inc.) (Cleveland, OH).  Dipropylamine-PEO (DPA-
400E, F.W.= 573.73) was a gift from Tomah products (Milton, WI).   Other reagents 
from Aldrich, solvents from Fisher Scientific (Fair Lawn, NJ), and NMR reagents from 
Cambridge Isotope Laboratories, Inc. (Andover, MA) were used without further 
purification unless otherwise noted.  Distillation was employed for the purification of 
HDI, Et3N, THF, and DMAC prior to use.  DI water was prepared by a Milli-Q filter 
system (18 MΩ cm-1: Millipore Corp., Billerica, MA).  Dialysis membranes were 
purchased from Spectrum Laboratory Inc. (Rancho Dominguez, CA).  
5.2.2. Measurements 
FTIR spectra were collected with a Perkin-Elmer spectrum BX FT-IR system.  
UV-Vis spectra were recorded by a Perkin-Elmer Lambda 35 UV/VIS spectrometer.  The 
tellurium (Te) content of the polymers was determined by inductively coupled plasma-
high resolution mass spectrometry (ICP-HRMS), using a Thermo Finnigan Element.  NO 
measurements were made using a nitric oxide analyzer (NOA) (Sievers, model 280).  
5.2.3. Synthesis 
Polymer 2: 
The preparation of polymer 2 was performed by a modified method from the 
reported procedures19, 20 as well as Chapter 3.  In brief, the well-dried hydrophilic 
thermoplastic polyurethane (Tecophilic, SP-93A-100; 2.0 g; ca 4.8 mmole of urethane 
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group) purified by the soxhlet extraction was dissolved in anhydrous DMAC (40 mL).  
This solution was added dropwise into a stirred solution of HDI (3.89 mL, 24 mmole) 
and DBTDL (72 µL, 0.12 mmole) in DMAC (4 mL) at 40 - 45 °C for 3 h.  After 1.5 d, 
the mixture was cooled to RT and then slowly added into anhydrous Et2O (400 mL).  The 
solid formed was filtered and washed with anhydrous Et2O (600 mL).  The filter cake 
was dried with N2 blowing followed by vacuum drying to afford a white polymer.  This 
polymer (1.86 g) was dissolved in anhydrous DMAC (30 mL), and then slowly added 
into a stirred solution of dipropylamine-PEO (10.4 g) in DMAC (12 mL) at 40 °C for 3 h.  
The mixture was stirred for 1 d at 40 °C and then slowly added into Et2O (400 mL).  The 
yellowish polymer formed was filtered and washed with Et2O (600 mL).  The filter cake 
was soxhlet extracted with MeOH for 2 d.  After cooling to RT, the solid cake was again 
washed with MeOH and then dried by vacuum pump for 2 d to yield polymer 2 (0.82 g).  
A solution of aminated polymer 2 in DMAC was titrated by a colorimetric method using 
bromophenol blue and p-toluenesulfonic acid in isopropanol (0.2 mmole of amine sites/g 
of polymer 2, see section 5.2.4 for details). 
IR (neat)= 3323 cm-1 (N-H), 2916, 2857 cm-1 (CH2), 1715 cm-1 (C=O), 1614 cm-1 
(HNCONH), 1529 cm-1 (C-N, N-H), 1102 cm-1 (CH-O-CH). 
Polymer 3: 
An organoditelluride compound (DTDTCA, 1, see Scheme 5.1, 17 mg, 33 µmole), 
which was synthesized as described in Chapter 4, was dissolved in THF (5 mL), and 
mixed with EDC.HCl (15 mg, 78 µmole) in DI water (5 mL).  The cloudy mixture was 
stirred and became clear by adding Et3N (20 mg, 198 µmole).  Then, NHS (9 mg, 78 
µmole) was added into the mixture at RT.  A solution of polymer 2 (0.34 g, 68 µmole of 
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free amine) in THF (12 mL) was then mixed with the above solution and stirred at RT 
overnight.  The mixture was slowly added into Et2O (900 mL) to form a slightly reddish 
yellow polymer.  The solid was washed with Et2O and DI water.  The filter cake was 
stirred in MeOH at RT overnight.  The residue was again filtered and washed with MeOH 
and then dried with a vacuum pump to give a yellowish polymer 3 (0.2 g).  Based on the 
ICP-HRMS analysis, the total tellurium amount in the prepared polymer was 5.3 mg per 
g of polymer, which corresponds to 10.5 mg/cm3 of DTDTCA, 1, if the density of 
polymer is considered as 1 g/cm3. 
IR (neat)= 3320 cm-1 (N-H), 2915, 2849 cm-1 (=C-H), 1715 cm-1 (C=O), 1616 cm-1 
(HNCONH), 1526 cm-1 (C-N, N-H), 1445 cm-1 (=C-H), 1099 cm-1 (CH2-O-CH2). 
Polymer 4: 
To a solution of 5,5’-ditelluro-2,2’-dithiophenecarboxylic acid (DTDTCA, 1; 82 
mg, 0.16 mmole), Et3N (130 mg, 1.28 mmole), EDC (76 mg, 0.40 mmole), and NHS (50 
mg, 0.43 mmole) in THF/water (2 mL/0.1 mL) was added a solution of PAH (0.3 g, 
equivalent to 3.2 mmole of amine groups in the polymer, Mn= 15,000 g/mol) and 
triethylamine (130 mg, 1.28 mmole) in DI water (8 mL).  After the reaction mixture was 
stirred overnight at RT, the mixture was filtered with membrane filters (MWCO= 5 kD) 
and washed with DI water several times using a centrifuge to remove any low molecular 
weight compounds.  The filtercake was collected and freeze-dried to give a light reddish 
brown colored polymer 4.  The color and UV-Vis spectrum of polymer 4 exhibited the 
characteristics of DTDTCA, 1 (λmax= 306 nm).[13]  ICP-HRMS analysis yielded 7. 5 wt % 
Te content in polymer 4, which corresponds to ca. 0.3 mmole DTDTCA, 1, in 1 g of the 
polymer 4 (y= 56%).  On the other hand, due to the dicarboxylic acid groups of 
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DTDTCA, 1, it also acts as a crosslinking agent during the coupling reaction; hence, this 
affects the water solubility of resulting polymer 4.  Nonetheless, under the given reaction 
conditions described above, most of polymer 4 was found to be soluble when used as a 
diluted solution (0.1 mg/mL). 
IR (KBr)= 3424 cm-1 (COO-H, N-H), 2924, 2864 cm-1 (=C-H), 1635 cm-1 (C=O), 1559 
cm-1 (HNCONH), 1457 cm-1 (C-N, N-H), 1406 cm-1 (=C-H). 
Polymer 5:  
A cellulose membrane (Spectra/Por, MWCO = 50 kD) was cut into smaller square 
sized films (1 cm x 1 cm).  After they were extensively washed with 0.1 M EDTA in DI 
water to remove any metal ion impurities, they were separately put into three different 
concentrations of polymer 4 solutions (0.9, 2.7, and 9 wt % in 1 mL of DI water), and 
then shaken overnight at RT.  Each film was placed on a glass slide.  Three different 
solutions of polymer 4 (0.2 mL of 0.9, 2.7, and 9 wt % solution respectively) containing 
triethylamine (ca. 10 wt %) were individually placed onto each film, followed by addition 
of a glutaraldehyde solution (0.1 mL of 5 wt % in DI water).  The resultant films were 
allowed to stand for 2 d at RT.  Each film was then washed extensively with DI water and 
then shaken in a NaBH4 solution (0.1 M in 5 mL DI water) for 1 h at RT.  Each film was 
then stirred in a buffered solution, pH 4.3, overnight at RT to remove any residual NaBH4, 
and then stored in PBS buffer, pH 7.4, prior to NOA experiments. 
5.2.4. Determination of free amine equivalents in polymer 2 
Free amine equivalents in polymer 2 were determined by a titration method as 
described in Chapter 3.  
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5.2.5. Preparation of RSNO solutions 
S-nitrosocysteine (CySNO) and s-nitosoglutathione (GSNO) solutions were 
prepared according to the method described in Chapter 2 and in the literature.12, 21 
5.2.6. Procedure for the treatment of polymer 3 with excess of GSH/GSNO 
A small film of polymer 3 (3.92 mg; size, 0.9 cm X 1.8 cm; thickness, < 5 µm) 
was soaked in a solution of GSH/GSNO (100 µM/100 µM) in 10 mL of PBS buffer (10 
mM), pH 7.4, containing 0.5 mM EDTA (the same PBS buffer used for all experiments 
unless otherwise noted).  After the mixture was shaken overnight at RT, the film was 
removed from the mixture.  This film was again shaken in a fresh solution of GSH/GSNO 
(200 µM/200 µM) in 10 mL of PBS buffer for 6 h.  The film was removed from the 
solution and placed into a fresh solution of 10 mL PBS buffer.  The same procedure to 
wash the film was carried out a couple of times to ensure that the film is in a fully 
hydrated state immediately before testing in the NOA experiments. 
5.2.7. Sample preparation for analyzing Te content in the polymers  
A procedure similar to that employed for the analysis of copper content in the polymer 
films described in Chapter 2 was followed for analysis of the Te content of the new 
polymers reported here.  In brief, a given amount of polymer was dried using the vacuum 
pump, and completely dissolved in 0.5 mL of concentrated HNO3, and then diluted with 
DI water to give a 5 mL solution.  Each solution was then quickly filtered with a syringe 
filter (a product of National Scientific Company; Rockwood, TN), and the filtrate was 




5.2.8. General procedures for the NO measurements using a chemiluminescence NO 
analyzer (NOA) 
 The typical procedure for all NO measurements (to assess NO generated from 
RSNO species) using the NOA was described in Chapter 2.   
5.2.9. Tellurium (Te) leaching study 
 A polymer film (polymer 5) was fully immersed in a solution of 10 µM 
GSH/GSNO solution in 5 mL of PBS buffer, pH 7.4, for 1 d at RT.  After a small amount 
of sample (30 µL) was withdrawn from the mixture, and a fresh solution of concentrated 
GSH/GSNO was added into the mixture (the total volume was maintained).  This process 
of sampling and injecting fresh GSH/GSNO solutions was carried out daily for 15 d.  
The Te content in some of sample solutions were then determined by ICP-HRMS.  
5.2.10. Amperometric NO detection in blood 
Amperometric NO sensors were fabricated and used for RSNO detection in whole 
sheep blood, according to the procedure described in Chapter 3.  A small piece of 
polymer 5 was mounted at the surface of the NO sensor as the outermost layer, while a 
blank cellulose membrane was similarly employed at the surface of a second “control” 
NO sensor placed in the same blood sample. 
 
5.3. Results and discussion 
5.3.1. Synthesis and characterization 
5.3.1.1. Preparation of polymer 3 
A modification of biomedical grade thermoplastic polyurethane (PU) (Tecophilic, 
SP-93A-100) was initially tried for the development of an organoditelluride-immobilized 
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NOGP because of the multiple advantages of PU materials, including good mechanical 
properties, processability, and relatively good inherent biocompatibility.  
 
                  
Figure 5.1 Comparison of IR spectra between 5,5’-ditelluro-2,2’-dithiophenecarboxylic 
acid; DTDTCA, 1 (a), the aminated thermoplastic PU; polymer 2 (b), and the conjugated 
product with (a) and (b); polymer 3 (c). Arrows indicate that all of characteristic peaks of 
DTDTCA, 1, appears in the spectrum of polymer 3 as shown the regions (A) and (B), 
corresponding to the stretching and bending of (=C-H) and (C=O) groups.  
 
First, DTDTCA (1) was synthesized as described in Chapter 4, and the aminated 
polymer 2 was prepared as described in Chapter 3, in which the free amine sites were 
created at a level of 0.2 mmole per 1 g of the polymer, as determined by the colorimetric 
titration (see section 5.2.4).  The EDC coupling chemistry of DTDTCA, 1, with polymer 
2, yielded polymer 3, possessing the characteristic IR bands of DTDTCA in the IR 
spectrum (see Figure 5.1).  This suggests the successful incorporation of 
organoditelluride species within the PU matrix.  Polymer 3 was analyzed via ICP-HRMS 
to contain 5.3 mg of tellurium per gram of polymer, which corresponds to 10.5 mg/cm3, 
assuming a polymer density of 1 g/cm3. 
5.3.1.2. Preparation of polymer 4 
DTDTCA, 1, was covalently linked into a water soluble polymer, poly(allylamine 
hydrochloride) (PAH,  Mn= 15,000) through the EDC coupling chemistry, resulting in the 
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formation of polymer 4 (see section 5.2.3 for details) possessing 7.5 wt % of tellurium 
(Te) as analyzed by ICP-HRMS.  Several new IR bands including those at 2924 cm-1 
(=C-H), 2864 cm-1 (=C-H), 1635 cm-1 (C=O), 1559 cm-1 (-NHCO-), 1406 cm-1 (=C-H) 
appeared in the product, revealing the presence of the newly incorporated DTDTCA, 1, in 
polymer 4 (see Figure 5.2(A)).  This polymer displayed the characteristic color (light 
reddish brown) and absorption band (λ= 306 nm) of DTDTCA, 1 (see Figure 5.2(B)).22 
 
              
Figure 5.2 IR and UV spectra of polymer 4, PAH, and DTDTCA (1); (A) The IR 
spectrum of polymer 4 (c) matches with most of the bands in DTDTCA (1) (a) (the 
dashed line 1, 2, and 5 for the aromatic C-H stretching and bending; 3 for the C=O 
stretching), poly(allylamine hydrochloride) (PAH) (b), as well as a new band indicating 
the amide bond formation between PAH and DTDTCA (the dashed line 4); (B) UV 
spectra of polymer 4: (a) shows the distinctive absorption band (shoulder, λ= 306 nm)  of 
DTDTCA (1) (b) in the UV-Vis spectrum after immobilizing DTDTCA on PAH (c). 
 
5.3.1.3. Preparation of polymer 5 
In order to maximize the catalytic NO generation of polymer 5, polymer 4 
possessing the catalyst (DTDTCA, 1) was crosslinked within a small piece of cellulose 
membrane (the bulk phase as well as the surface).  Since the small molecules RSNOs and 
RSHs could diffuse into a porous cellulose membrane, the NO generation is likely to 
occur throughout the film. Further, by varying the concentration of polymer 4 (0.9 wt % 
(L): 2.7 wt % (M): 9.0 wt % (H)= 1: 3: 10) when loaded in the same sized cellulose 
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membrane, the resulting polymer 5 can possess different densities of polymer 4 as 
determined by the amount of tellurium (Te) found within the resultant films (see Table 
5.1), as well as the slight color differences observed, in proportional to the amount of 
applied polymer 4 (see section 5.2.3 for details).  
  
Table 5.1 Comparison of three different polymers (5) prepared by altering the amounts of 
polymer 4 (0.9 wt % (L): 2.7 wt % (M): 9.0 wt % (H)= 1: 3: 10) when loaded in the 
cellulose membrane (size= 1 cm x 1 cm x 50 µm). The analyzed data were obtained by 
ICP-HRMS.[a] 
 
Polymer 5 L M H 
The ratio of the amounts of polymer 4 when loaded 
in the cellulose membrane = the theoretical Te ratio   
1 3 10 






The density of DTDTCA, 1 (µg/cm3) in the polymer 
5[b] 
1.1 3.2 8.7 
The density of polymer 4 (µg/cm3) in the polymer 
5[c] 
7.3 21.2 58.0 
[a] See section 5.2.7 for the sample preparation; [b] based on the molecular weight of 
DTDTCA, 1, (509 g/mol) consisting 2 equivalents of Te, and the volume of polymer 5 
(0.005 cm3); [c] based on the 7.5 wt % of Te in the polymer 4. 
 
Because polymer 4 has inherent color, the more that was added during the 
crosslinking, the darker the color of the final polymer 5.  ICP-HRMS analysis of the 
various polymer 5 samples yielded a ratio of Te in three different samples (polymer 5) 
that was close to the ratio of the loaded amounts of polymer 4 (see Table 1).  The 
analyzed ratio of Te within polymer 5 samples suggests that the yield of the loading 
process is slightly decreased at higher loading concentrations, which is reasonable to 
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expect in preparing this type of IPN given the limited pore size and total internal volume 
of the cellulose membrane matrix. 
(A) Blank film                                                                (B) Film L 
       
 
(C) Film M                                                                     (D) Film H 
      
 
Figure 5.3 Scanning electron microscopy (SEM) image of a part of the intersected 
polymer 5 film in a dried state after gold coating; the blank (A), L (B), M (C), H (D) film. 
Polymer 4 is scattered everywhere (bulk phase and surface) in the L, M, and H films (the 
polymer 5) in proportional to the amount of polymer 4 loaded in the polymerization 
process. 
 
As shown Figure 5.3, images of the intersected parts of the films (blank, L, M, 
and H) as captured by scanning electron microscopy (SEM) showed that the various 
amounts of polymer 4 were scattered (as observed brighter islands in the film) within L, 
M, and H, while the blank cellulose membrane had a clean surface.  The brighter 
polymers in the IPN were proven to possess Te (ca. 8 %) as measured by energy 
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dispersed X-ray analysis (EDX), where the Te content is very close to the value (7.5 %) 
determined by the ICP-HRMS, further confirming that polymer 4 contains the catalyst 
(DTDTCA, 1).  The sizes of polymer 4 regions varied up to several µm, and they were 
dispersed in the interior as well as exterior of polymer 5 along with an increased relative 
density of polymer 4 from the film L to H, as desired.  Taken together, all data including 
IR, UV, ICP-HRMS, and SEM support that polymer 4 with the appended 
organoditelluride species was successfully immobilized within the cellulose membrane to 
form a new IPN. 
5.3.2. Catalytic NO generation from RSNO species 
5.3.2.1. Polymer 3-mediated NO production 
To remove any unbound species, or any half of the original DTDTCA species not 
covalently linked to the PU backbone in polymer 3, a small piece of film (polymer 3) was 
treated with a solution of excess GSH/GSNO (see section 5.2.6 for details) prior to 
testing for catalytic NO generation from RSNO species.  The catalytic NO generation 
mediated by the resulting polymer in a solution of GSH/GSNO in phosphate-buffered 
saline (PBS) solution, pH 7.4, containing excess EDTA (0.5 mM, which can entirely 
block any metal ion-induced RSNO decomposition by impurities) was demonstrated via 
NOA measurements (see Figure 5.4).  
In brief, the first immersion of the polymer film into a fresh solution of 
GSNO/GSH yields an increase in the NO flux, which reaches a relatively low steady-
state level.  The NO flux returns to baseline by removing the polymer film from the 
solution.  Subsequent re-immersion/removal cycles of the same film demonstrate that this 
polymer reversibly achieves nearly the same steady-state NO generation. The 
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demonstration of such catalytic behavior by means of the polymeric material with the 
appended organoditelluride species again reinforces the proposed mechanism of 
organoditelluride-mediated catalytic RSNO denitrosation as suggested in Chapter 4, and 
also supports the potential usefulness of this polymeric material as a novel NOGP.  By 
utilizing the inherent advantages of polymer 3, the catalytic production of biologically 
active NO from the surface of a biomedical grade polymeric matrix has been achieved.   
Hence, polymer 3 is a potential candidate NOGP for coating a variety of existing 
biomedical devices to improve their inherent hemocompatibility since only a very low 
concentration of surface NO (< 1 nM) is known to be effective to provide a 
thromboresistive surface.23-26  
 
 
Figure 5.4 The catalytic NO generation mediated by a piece (ca. 3.9 mg and 3.2 cm2) of 
polymer 3 in a solution of 100 µM GSH and 25 µM GSNO in PBS buffer, pH 7.4, (with 
0.5 mM EDTA) as monitored using a chemiluminescence NO analyzer. 
 
5.3.2.2. Polymer 4-mediated NO production 
The catalytic activity of a water-soluble polymer 4 for generation of NO from 
RSNO was tested as well.  When a catalytic amount of polymer 4 in DI water solution 
(50 µL of the 0.1 mg/ml solution, corresponding to ca. 0.75 µM of DTDTCA, 1) was 
added into a mixture of GSH (50 µM) and GSNO (10 µM) in the PBS buffer, pH 7.4, all 
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NO equivalents corresponding to GSNO concentration in the reaction mixture were 
detected via the NOA (see Figure 5.5).  
 
 
Figure 5.5 The complete denitrosations of S-nitrosothiols (10 µM) catalyzed by the water 
soluble polymer 4 (~0.75 µM DTDTCA, 1) were observed via the NOA ((a) and (b)); the 
same amount of poly(allylamine hydrochloride) (PAH) did not catalyze the reaction (c); 
nitrite (1 mM NaNO2) was not reduced by polymer 4 (d) (in 2 mL of PBS buffer, pH 7.4, 
containing 0.5 mM EDTA and 50 µM RSH). 
 
The results obtained with a CySNO/CySH substrate solution under similar 
conditions also demonstrated the activity of polymer 4, but with somewhat faster kinetics.  
It is worthwhile to note that nitrite (NaNO2, 1 mM) was not reduced to NO under the 
same experimental conditions, implying that this polymer is a selective catalyst toward 
RSNO decomposition whereas copper ion catalysts can reduce both RSNOs and nitrite.27   
As a control experiment, when the equivalent amount of PAH (50 µL of the 0.1 mg/mL 
in DI water solution) was added into a new GSNO/GSH solution, a change of NO 
baseline was not observed, verifying that the organoditelluride species in polymer 4 is the 
real catalytic species (see Figure 5.5). 
5.3.2.3. Polymer 5-mediated NO production 
Polymer 5 was also studied for its catalytic denitrosation of RSNOs under 
comparable conditions.  Indeed, several experiments with the films L, M, and H revealed 
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their high catalytic function in conjunction with their ability to generate diverse NO 
fluxes (see Figure 5.6) based on Te content.  First, in the presence and absence of a blank 
film (cellulose membrane) in a GSNO/GSH solution, the baseline level of NO produced 
from the GSNO was not significantly changed, as shown Figure 5.6(A).  Trivial changes 




                
 
 
                
 
Figure 5.6 The NO generation profiles using the blank (A), film L (B), M (C), and H (D) 
(1 cm x 1 cm x 50 µm, polymer 5) from GSNO (50 µM) and GSH (50 µM) in the 2 mL 
of PBS buffer (10 mM), pH 7.4, containing EDTA (0.5 mM) monitored via a 
chemiluminescence NO analyzer (NOA). Arrow indicates additions/removals of given 
species/film into the mixture.  
 
Alternatively, placing the polymer 5 film L into the reaction mixture under the same 
conditions caused the NO signal to reach a higher steady-state value, and withdrawing the 
film L from the solution induced a decrease in the observed NO signal to a near baseline 
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value.  Such a slight increase of baseline might originate from the natural decomposition 
of GSNO or be caused by any catalytic species leached from the membrane; e.g., a tiny 
amount of half of DTDTCA, 1, in which only one carboxylic group had been linked to 
the PAH backbone.  This species is expected to separate from the polymer backbone 
during the catalytic process and dissolve into the aqueous phase of the reaction mixture 
according to the proposed catalytic mechanism (see Figure 4.2 in Chapter 4).22   
However, continuing the insertion/removal cycles of film L yields a similar level of NO 
signal at a steady-state, indicating that this film catalytically liberates NO from GSNO at 
physiological pH (see Figure 5.6(B)). Both films M and H display similar catalytic 
GSNO decomposition to NO under the same conditions, as shown Figures 5.6(C) and 
(D).  Additionally, the maximum NO flux at a steady-state was gradually enhanced from 
the film L to H (L < M < H), where the density of polymer 4, i.e., DTDTCA, 1, in the 
polymer 5 also increases in the same order, although the apparent NO flux does not seem 
to increase in direct proportion to the amount of catalyst in the various polymer 5 
compositions.  This is likely related to the heterogeneous nature of the catalytic process, 
and hence mass transfer or RSNO and RSH to the surface may become the rate-limiting 
step, not amount of bound catalyst.  Nonetheless, this study proposes a useful approach to 
preparing a new type of NOGP based on IPN type films with an ability to adjust the level 
of NO flux emitted in the presence of a given amount of RSNO species.   
5.3.4. Tellurium leaching experiment 
To evaluate any potential leaching of catalytic species from polymer 5, a soaking 
experiment using the H film was conducted (see section 5.2.9 for details).  
Approximately 10 % of Te in the film was found in the GSH/GSNO solution after 1 d, as 
120 
determined by the ICP-HRMS analysis.  Thereafter, the total amount of Te leached from 
the film slowly increased to up to 20 % of the original amount, and apparently levelled 
off after 15 d (see Figure 5.7).  
 
 
Figure 5.7. A plot of soaking time vs. the accumulated Te amount in sample solution 
which was withdrawn daily from the solution of 10 µM GSH/GSH with the fully 
immersed polymer 5, while a fresh solution of 10 µM GSH/GSNO was correspondingly 
added into the original solution resulting in an increasing concentration of GSH. 
 
This result can be explained by considering the proposed mechanism of the 
organoditelluride-mediated RSNO decomposition in which RSH added reduces an 
organoditelluride species to break the ditelluride bond.  Therefore, any half side of 
DTDTCA, 1, species in which only one carboxylic acid group is attached to the polymer 
backbone can be freed from the polymer in the presence of GSH/GSNO solution to 
dissolve in the aqueous phase.  Further, in the same manner, even when both carboxylic 
groups in the DTDTCA, 1, are linked covalently to the PAH, the GSH-mediated 
disconnection of ditelluride bond causes the molecular weight of polymer 4 to partially 
decrease; hence, some physically crosslinked polymers and/or relatively small molecular 
weight polymers (> 50 kD, MWCO of cellulose membrane) that have good water 
solubility may slowly dissolve into the GSH/GSNO solution phase until all of such 
polymeric species are removed from the IPN (polymer 5).  Indeed, the rate of Te leaching 
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was opposite to the concentration changes of GSH/GSNO solution (because of 
continuous addition of RSH/RSNO solution into the original solution), excluding the 
probability of a direct and continuous decomposition of the organoditelluride catalyst in 
this environment.  This reinforces the proposed mechanism of organoditelluride-mediated 
RSNO denitrosation described in detail within Chapter 4.  The result of this study 
suggests that effective catalytic NO production activity of polymer 5 can be achieved for 
extended periods of time, indicating the potential usefulness of such polymers for 
biomedical applications.  It is clear that a large number of in vivo studies over varying 
time periods are required to fully assess the effectiveness as well as the life-time of this 
type of NOGP in such potential applications. 
5.3.5. Spontaneous NO generation in blood 
Finally, to further assess whether these new polymeric materials (polymer 5) can 
mediate spontaneous NO generation in fresh whole blood, an amperometric RSNO sensor 
was assembled using polymer 5 (H film) as an external film on the surface of a NO 
selective electrochemical sensor.  A control NO sensor was also fabricated with a 
cellulose blank film instead of the polymer 5 in analogous fashion as the experiments 
described in Chapters 2 and 3, to test NO generation in blood using the Cu(II)-cylcen 
appended polymers.  Each sensor was calibrated for the intrinsic direct amperometric 
response to NO prior to use (see Figure 5.8(A)), and then simultaneously and 
respectively measured NO and RSNO levels in fresh sheep blood diluted with PBS buffer 
at 35 °C.  As shown in Figure 5.9, each sensor exhibits independent amperometric 
signals, which were converted to NO equivalents by the prior NO calibration curve.  The 
difference of NO equivalents between the two sensors indicates that the spontaneous  
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Figure 5.8 (A) Calibration curves for the inherent NO responses of both RSNO (a) and 
NO sensors (b) in the PBS buffer (pH 7.4, 100 mL) at 35 °C; (B) calibration curve for the 
inherent RSNO response of RSNO sensor (a) in a blood sample (30 mL) diluted in PBS 
buffer (pH 7.4, 70 mL) at 35 °C. 
 
 
Figure 5.9. The amperometric NO measurements in a fresh sheep whole blood (30 mL) 
diluted with PBS buffer (70 mL, pH 7.4) at 35 °C using two sensors; RSNO (a) and NO 
sensor (b), where the amperometric signals were converted to the NO or GSNO 
equivalents (nM) from their calibration curves (see Figure 5.8). 
 
denitrosation of endogenous RSNO species in the blood locally occurs at the outer 
membrane of RSNO sensor (but not the control sensor) in which the catalyst in the 
polymer 5 is exposed to the blood components  (see Figure 5.9). Thus, this value should 
be proportional to the total concentration of all RSNO species in the blood, which 
corresponds to ~500 nM (based on GSNO calibration of the RSNO sensor from a post-
calibration curve continuously obtained in the same blood sample) (see Figure 5.8(B)).  
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The ability of polymer 5 in generating NO in contact with blood in vitro was, herein, 
clearly demonstrated via the RSNO sensor measurements.  
 
5.4. Conclusions 
In summary, various polymeric materials possessing covalently linked 
organoditelluride species (DTDTCA, 1) were prepared and studied for their catalytic NO 
generation abilities. In this work, the thermoplastic PU used to prepare polymer 3, the 
water-soluble PAH for creating polymer 4, and the IPN using the cellulose membrane for 
developing polymer 5, were all shown to be useful polymeric matrices for creating 
NOGPs. Their catalytic activities were successfully demonstrated using the 
RSNOs/RSHs solutions at physiological pH via the NOA measurements.  Especially 
exciting is the ability to the tune NO fluxes of polymer 5 materials by varying the amount 
of polymer 4 employed during the crosslinking reaction in the cellulose membrane.  The 
Te leaching experiments conducted with polymer 5 indicate that most of the catalyst 
remains in the polymer phase even after soaking in high concentrations of fresh 
GSH/GSNO solution for two weeks, reinforcing the proposed mechanism for 
organoditelluride-mediated RSNO denitrosation as well as reflecting the potential long-
term utility of the new polymers.  Finally, the spontaneous NO generation in a fresh 
sheep blood in vitro mediated by polymer 5 was clearly demonstrated via amperometric 
NO gas sensor measurements, suggesting the usefulness of the NOGP because 
endogenous RSNOs and free thiol reducing agents in blood would provide the substrates 
necessary for such polymers to generate a surface enhanced level of NO, which could 
prevent platelet activation and adhesion and hence reduce the risk of thrombosis on 
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medical devices possessing such polymers.  For example, polymer 3 can be used as a 
coating for the already existing biomedical devices, while the water-soluble polymer 4 
may be effective as an anti-cancer agent29, 30 as well as an alternative of anticoagulant 
used in a hemodialysis membrane,31 and the polymer 5 can be applied to a membrane 
layer such as in the hemodialysis or in construction of RSNO sensors,12, 13   Obviously, 
extensive in vivo studies must be carried out to fully test the effectiveness, life-time, as 
well as any toxicity of those new NOGPs.  An RSNO sensor prepared with 
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Amperometric Nitrosothiol Sensor Using Immobilized 





 S-Nitrosothiols (RSNOs) are an important group of molecules found in blood and 
consist of both low molecular weight (LMW) species such as S-nitrosoglutathione 
(GSNO) and S-nitrosocysteine (CySNO), as well as high molecular weight (HMW) 
RSNO macromolecules such as S-nitrosoalbumin (AlbSNO) and S-nitrosohemoglobin 
(HbSNO).1   The typical biological pathway to form RSNOs is nitric oxide (NO)-
mediated S-nitrosation of sulfhydryl groups in amino acids, peptides, and proteins.  For 
example, one of the identified processes for RSNO formation involves reactions with 
intermediates of the NO oxidation pathway such as nitrogen dioxide (NO2) and 
dinitrogen trioxide (N2O3) as nitrosating agents of free thiols (RSHs).2, 3   Nitrosylated 
metal centers (copper or iron)4, 5 as well as a radical adducts of RSH and NO (RS-N•-
OH)6 are also recognized intermediates in the production of RSNOs in the presence of an 
electron accepter. Additionally, another important conduit for RSNO formation is the 
reallocation of NO from species to species through exchange with sulfhydryl groups, 
which is termed transnitrosation.7 
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Endogenous RSNOs have been recognized as a molecular vehicle to transfer and 
store transient NO molecules produced enzymatically by nitric oxide synthase (NOS) 
within endothelial and other cells.  Nitric oxide participates in many physiological 
processes ranging from cytoprotection to cytotoxicity.  In fact, endogenous RSNOs 
exhibit many of the same physiological functions as NO, such as inhibition of platelet 
aggregation8 and relaxation of vascular smooth muscles.9   RSNOs are also known to 
participate in host defense processes such as killing tumors10 and intracellular 
pathogens,11 in addition to intracellular signaling,12 ion channel regulation,13, 14 
apoptosis,15, 16 etc.  Hence, the decrease or increase in the physiological production of 
NO, which appears to occur in certain diseases such as atherosclerosis, hypertension, and 
diabetes, has been associated with not only a dysfunctional endothelium cell layer,17-20 
but also the improper storage and/or delivery of NO by means of RSNOs.21, 22   Indeed, 
an inverse correlation between NO and RSNO concentrations have been recently reported 
in specific NO-related disorders.  For instance, the suppressed NO levels due to the 
endothelial dysfunction caused by oxidative stress (typically by lack of adequate 
ascorbate) are characteristic of preeclampsia,23, 24 a pregnancy-specific syndrome known 
for the major cause of both maternal and fetal morbidity and mortality, where the RSNO 
levels in preeclampsia plasma were found to be higher compared with normal pregnancy 
and nonpregnancy plasma.22   Further, it has been reported that while NO concentrations 
are generally higher in the expired air of asthma patients (vs. controls), a recent study 
showed that the average RSNO levels of the expired air in asthmatic children were lower 
than in normal children.21   In addition, a recent report demonstrated that patients who 
had more risk factors for heart attacks and strokes had a lower level of RSNOs in their 
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blood, presumably since these risk factors (high cholesterol, high blood pressure, 
smoking, etc.) contributed to endothelial dysfunction in these individuals.25  Therefore, 
the detection and monitoring of endogenous RSNO levels have become of great interest 
for the purpose of disease diagnosis and treatment as well as risk assessment. 
There are several known approaches to measure RSNO species.  Fundamentally, 
NO oxidative products (NO, NO2-, and/or NO3-) resulting from the reductive reaction of 
RSNOs using redox-active species (iodine/iodide, cysteine/CuCl2, VCl3/HCl, or 
ferricyanide, etc.) can be detected by chemiluminescence or electrochemical methods.26-29 
 Sometimes, these NO products react with reagents to form a detectable product (Griess 
nitrite reagent or fluorescent chemicals) that can be quantitated by spectrophotometric or 
flourometric assays.30, 31 Despite the good sensitivity of present approaches (especially 
chemiluminescence based assays), their ability to quantify RSNOs accurately are often 
doubted because all existing methods require a number of tedious pretreatment or 
separation steps to eliminate interfering substances (e.g., nitrite, antioxidants, and/or 
proteins, etc.).30, 32-34   Since RSNOs are known to be highly labile molecules that can 
decompose in the presence of light or trace metal ions,35, 36 such pretreatment steps can 
lead to loss of the analyte. 
To deal with the accuracy problems as well as existing complicated procedures, 
recent research in this laboratory has proposed the direct measurement of RSNO levels in 
fresh whole blood samples via planar amperometric RSNO sensors.37, 38   These sensors 
are prepared by immobilizing a nitric oxide generating polymer (NOGP) at the surface of 
a highly selective amperometric NO sensor.39, 40   As described in this thesis, the NOGP, 
a polymeric material appended with an NO generating catalyst, can spontaneously 
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denitrosate RSNOs to NO when in contact with blood to locally increase the NO 
concentration at the surface of the polymer layer.  Hence, the amperometric NO sensor 
with the immobilized NOGP can detect the locally elevated NO levels in proportional to 
RSNO concentrations in blood.  Thus far, a variety of polymeric materials immobilized 
with copper(II) species and organodiselenides (RSeSeR), compounds known for their NO 
generating capability,41, 42  have been utilized to fabricate RSNO sensors.37, 38   Results 
have indicated that the sensor performance is largely dependent on the characteristics of 
the NO generating catalyst.  For example, the copper based RSNO sensors exhibit 
significantly different amperometric sensitivities to various LMW RSNO species,37 while 
the organodiselenide-based RSNO sensor displays comparable sensitivities to all LMW 
RSNOs.38   Hence, research regarding the fundamental reaction chemistry between 
RSNO species and potential NO generating catalysts is very important with respect to 
understanding the potential reactivity of endogenous RSNOs as well as to develop 
NOGPs for a variety of biomedical applications, including the preparation of new RSNO 
sensors.  
Polymeric materials linked with an organoditelluride (RTeTeR) species have 
recently been developed as a new type of NOGP (see Chapter 5).  In this chapter, a 
detailed study on the use of such an organoditelluride-tethered polymer as an 
immobilized selective catalytic layer for the development of a useful RSNO sensor is 
presented.   Amperometric NO sensors fabricated as described previously38 (and in 
Chapter 3) are modified with a dialysis membrane consisting of an impregnated 
organdoditelluride-linked hydrogel (see Figure 6.1), in which poly(allylamine 
hydrochloride) (PAH) with covalently attached 5’-ditelluro-2,2’-dithiophenecarboxylic 
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acid (DTDTCA) is further crosslinked on a dialysis membrane support.  The NO gas 
produced from the RSNO decomposition via this polymeric layer diffuses through a gas 
permeable membrane (teflon) of the NO sensor to a platinized platinum anode, where it is 
oxidized and the resulting current in proportional to the RSNO levels present.   
 
 















Figure 6.1 (A) Schematic of RSNO detection using the proposed amperometric sensor 
modified with a NO generating catalytic layer; (B) the schematic structure of 
organoditelluride-linked hydrogel used in this work.  
 
It will be shown that this new RSNO sensor configuration is able to directly detect 
various LMW RSNO species at 0.1 µM levels, with an excellent operational life-time (up 
to a month).  In addition, speculation regarding transnitrosation between RSNO/RSHs is 
discussed with respect to the potential to detect higher molecular weight RSNOs.  
Finally, the measurement of RSNO species in the fresh animal blood sample is 






Dialysis membranes were purchased from Spectrum Laboratory Inc. (Rancho 
Dominguez, CA).  Bovine serum albumin (BSA, gamma-globulin and protease free, fatty 
acid content = 0.005 %), glutaraldehyde (25 wt %), N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC.HCl), N-hydroxysuccinimide (NHS), N-acetyl-
penicillamine (NAP), glutathione (GSH) and cysteine (CySH) were products of Sigma 
(St. Louis, MO).  All other chemicals including poly(allylamine hydrochloride) (PAH, 
Avg. M.W.= 15 kD) from Aldrich (Milwaukee, WI) and solvents from Fisher Scientific 
(Fair Lawn, NJ) were used without further purification unless otherwise noted.  
Distillation was employed for the purification of Et3N, and THF prior to use.  DI water 
was prepared by a Milli-Q filter system (18 MΩ cm-1: Millipore Corp., Billerica, MA, 
USA).  
6.2.2. Preparation of S-nitrosothiols 
S-Nitrosocysteine (CySNO), S-nitroso-N-acetyl penicillamine (SNAP), and S-
nitosoglutathione (GSNO) solutions were prepared according to the method described in 
the literature (see also Chapter 2).43   All solutions were freshly prepared in a timely-
manner as needed from stock solutions prepared daily.  S-Nitroso-albumin (AlbSNO) 
was also prepared using BSA as previously reported.44   The concentration of AlbSNO 
was determined by using a chemiluminescence NO analyzer (NOA) (Seivers 280, 




6.2.3. Preparation of the organoditelluride-linked hydrogel 
The conjugation of 5’-ditelluro-2,2’-dithiophenecarboxylic acid (DTDTCA, refer 
to Figure 6.1 for the structure; prepared as described in Chapter 4) with  poly(allylamine 
hydrochloride) (PAH) was carried out via an EDC coupling chemistry according to the  
method described in Chapter 5.  The resulting polymer was analyzed to possess 7.5 wt % 
of Te, as determined by inductively coupled plasma-high resolution mass spectrometry 
(ICP-HRMS).  The general method used to prepare the catalytic hydrogel layer within a 
dialysis membrane that could be mounted over the outer gas permeable membrane of the 
amperometric sensor was a slightly modified procedure of that described in Chapter 5.  In 
brief, a small volume (40 µL) of a mixture (DTDTCA-tethered PAH (0.2 mL, 4 wt %), 
Et3N (0.1 mL, 1 wt %), and glutaraldehyde (0.1 mL, 1 wt %) in DI water) was placed 
onto a dried dialysis membrane (MWCO, 50 kD; 1 cm2) previously purified by 
extensively washing with 0.1 mM EDTA solution to eliminate metal ion impurities 
within the membrane, and then further washing with DI water.  The resulting membrane 
was allowed to stand a few days at RT and washed with DI water prior to use. 
6.2.4. Fabrication of amperometric RSNO/NO sensors 
Amperometric NO sensors were fabricated according to the procedures described 
in Chapters 3 and 5.  A control NO sensor was fabricated by mounting a plain dialysis 
membrane over the gas permeable membrane of the NO sensor, while the 
organoditelluride-linked hydrogel impregnated dialysis membrane was employed as the 
outer layer to fabricate the RSNO sensor.  
 
6.2.5. Detection of S-nitrosothiols 
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 All measurements of RSNO solutions were carried out in PBS buffer (10 mM, pH 
7.4) containing 0.1 mM EDTA (necessary to sequester metal ion impurities, especially 
copper ions known to be an excellent catalyst for RSNO decomposition) in a brown 
amber vial (100 mL) at RT.   Prior to use, calibration curves for both the RSNO and NO 
sensors were obtained by measuring their intrinsic amperometric responses toward a NO 
standard solution.  The background NO levels in bulk RSNO solutions were also 
monitored via the NO sensor, as needed, by simultaneously placing both the RSNO and 
NO sensors into the same solution and then converting to NO concentrations based on the 
prior calibration curve for each sensor using the standard NO solutions.  The long-term 
stability of the RSNO sensor was determined by assessing the sensitivity of amperometric 
response toward GSNO (using GSH as reducing agent) every few days.  
6.2.6. Detection of RSNOs in blood 
 The experimental methods for the detection of endogenous RSNOs in animal 
blood were analogous to those reported previously in the literature37, 38 (and as described 
in Chapters 2 – 5).  In brief, heparinzied fresh sheep blood (obtained from Extracorporeal 
Membrane Oxygenation (ECMO) laboratory at the University of Michigan Medical 
School) was kept at 35 °C before and during the experiments.  Both NO and RSNO 
sensors were pre-calibrated to determine their inherent amperometric NO response in 
stirred PBS buffer (pH 7.4) at 35 °C.  Then, the amperometric signal of each sensor was 
monitored by adding the fresh sheep blood (30 mL) into the PBS buffer, pH 7.4 (70 mL, 
saturated with N2) containing GSH and EDTA (final concentrations of 50 µM and 0.1 
mM, respectively, after the blood was added).  For the estimation of RSNO 
concentrations in blood, the RSNO sensor’s inherent response to the exogenous GSNO 
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was post-calibrated by injecting the GSNO standard solution in the same blood sample 
(i.e., standard addition method). 
 
 
6.3. Results and discussion 
6.3.1. RSNO sensor performance  
 Due to the catalytic activity of organoditelluride species and corresponding 
polymeric materials that possess covalently linked RTe sites in denitrosating RSNOs (see 
Chapters 4 and 5), an amperometric NO sensor with an external dialysis membrane 
containing an organoditelluride-linked polymer is expected to detect NO and RSNO 
levels in test samples.  An electrochemical NO sensor covered with a “blank” dialysis 
membrane should only detect NO concentrations in the same samples.  Thus, to evaluate 
the basic analytical performance of the proposed RSNO sensor, both an RSNO and NO 
sensor were prepared and tested for their direct response toward NO and various RSNO 
species.  
For preliminary studies, both sensors were concurrently placed in a working 
buffer solution containing a suitable reducing agent (50 µM GSH) (along with 0.1 mM 
EDTA in phosphate buffered saline (PBS), pH 7.4) and were monitored for their 
amperometric responses toward added NO or GSNO solutions as shown in Figure 6.2. 
The expected current responses of both sensors toward added NO standard solution 
confirmed their suitable function for amperometric NO detection (see Figure 6.2(A)). 
The intrinsic NO sensitivities obtained from this experiment can be used to prepare 
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calibration curves for each sensor to convert the current values recorded for each device 
into NO equivalent levels.   
Upon adding increasing concentrations of GSNO into a fresh working buffer 
solution (with added GSH), the RSNO sensor displays a significant current change in 
proportional to the GSNO levels present (see Figure 6.2(B)), while the current of the 
“control” NO sensor in the same solution does change appreciably.  This confirms that 
the presence of the organoditelluride polymer immobilized within the dialysis membrane 
mounted over the gas permeable membrane is responsible for the catalytic conversion of 
GSNO to NO at the surface of the RSNO sensor. 
  
        
Figure 6.2 The inherent amperometric responses of (a) NO and (b) RSNO sensor 
monitored by intermittently adding a small aliquots of a standard (A) NO or (B) GSNO 
solution into the stirred solution of PBS buffer, pH 7.4, containing 0.1 mM EDTA and 50 
µM GSH at RT (the working buffer solution); the numbers in the graph indicate the 
accumulated concentrations of the given species in the working buffer solution. 
 
Such catalytic function of the organoditelluride-linked hydrogel on the surface of 
the RSNO sensor was also demonstrated by performing a real-time reversibility test.  As 
shown in Figure 6.3, the RSNO sensor dynamically responded to the change of GSNO 
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concentrations in real-time as concentration is increased and then decreased within the 
same test vessel. 
 
 
Figure 6.3 The dynamic amperometric response and reversibility of RSNO sensor by 
exchanging three different concentrations (0, 2, and 4 µM) of GSNO in working buffer 
solution at RT. 
 
When comparing the relatively short response times (2 - 4 min) for both sensors 
to reach the steady-state current levels with respect to NO concentrations (see Figure 
6.2(A)), a somewhat slower response (4 – 8 min) toward changes in GSNO 
concentrations was observed with the RSNO sensor, suggesting that the dialysis 
membrane filled with the crosslinked catalytic polymer (thickness, 20 - 40 µm) acts as a 
diffusion barrier for mass transfer of GSNO/GSH species into the catalytic layer, and this 
leads to the slower dynamic response.  A design in which the catalyst is immobilized 
directly on the outer surface of dialysis membrane of the NO sensor would likely yield 
better dynamic response times.  It is important to note, however, that the response time of 
the proposed RSNO sensor reported herein is comparable to a previously reported 
organdodiselenide-based RSNO sensor38  also prepared using an outer dialysis membrane 
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to immobilize the polymeric catalyst (i.e., the catalytic layer was between the gas 
permeable membrane and dialysis membrane, see Figure 6.1).   
The main advantage of the RSNO sensor prepared with the immobilized 
organoditelluride species is a very long operational lifetime (up to a month), which was 
determined by frequently monitoring the sensitivity (nA/µM) changes in response to both 
NO and GSNO.  Remarkably, the sensitivity for the GSNO response is nearly maintained 
with time while only a slight decrease in the NO response originating from the platinized 
platinum working electrode.  Hence, this behavior yields a small increase in the relative 
sensitivity for GSNO vs. NO response as a function of time 
(SensitivityGSNO/SensitivityNO) (see Figure 6.4).  
 
 
Figure 6.4 Stability of RSNO sensor, plotted as relative sensitivity (SGSNO/SNO) of the 
RSNO sensor as a function of time, where SGSNO is the sensitivity (nA/µM) of RSNO 
sensor toward GSNO and SNO is the sensitivity (nA/µM) of RSNO sensor toward NO. 
 
The excellent stability of the proposed RSNO sensor compared to any of the 
previously reported amperometric RSNO sensors modified with NO generating catalysts 
(e.g., copper37 and/or organodiselenide38-based RSNO sensor; up to 2 weeks)  likely 
stems from the greater stability of the active organoditelluride species (DTDTCA) 
employed within the catalytic layer of this sensor.  Considering the redox mechanism 
involved for NO generating catalysts (i.e., copper ions, RSeSeR, or RTeTeR), the least 
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stable forms of the catalysts (i.e., Cu(I), RSe- (selenolate), or RTe- (tellurolate)) in their 
redox cycles very likely determine their catalytic lifetimes, which is reflected in the 
RSNO sensors’ stabilities.  In fact, the organoditelluride species (DTDTCA) used in this 
study possesses a unique structure that can be further stabilized in the reduced form (RTe-
, where R = thiophenecarboxylic acid) by the aromatic resonance that can occur (see 
Figure 6.1(B)).  This decreases the possibility of side reactions to form Te (Se) element 
and/or the adduct of small molecular thiolate (RS-, a reducing agent), RSTe- (RSSe-)45, 46 
that can be washed out from the membrane phase.  Indeed, the amperometric RSNO 
sensors reported in previous studies did not possess such a structural benefit for the NO 
generating catalyst, resulting in reduce long-term stability.38   Further, the fact that RSNO 
sensitivity can actually remain the same while the inherent amperometric NO response of 
the RSNO sensor decreases with time suggests that the mass transfer into the catalytic 
layer of the RSNO and reducing agent may actually increase as a function of time, as the 
layer becomes more fully hydrated and the crosslinked catalytic polymeric material 
reorganizes and/or the cellulose membrane hydrolyzes.  
6.3.2. Direct amperometric detection of S-nitrosothiols 
As depicted in Figures 6.5 and 6.6, the new organoditelluride-based RSNO 
sensor is capable of directly detecting various RSNO species from sub-µM to µM levels, 
which are the suggested ranges for RSNO species in blood,47 although their exact 
concentrations in blood plasma are still in debate.48, 49  The measurements of RSNO 
species by the sensor exhibit reasonable detection limits (~0.1 µM) with respect to the 
LMW RSNOs including GSNO, CySNO, and SNAP.  An attractive feature of the 
proposed RSNO sensor is that the responses toward GSNO and CySNO were nearly 
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equal in the range of 0.1 – 4 µM as illustrated by their respective calibration curves (see 
Figures 6.6(A) and (B)).  
 
 
Figure 6.5 The typical dynamic amperometric responses detected by the RSNO sensor at 
low concentrations of various RSNOs, known as endogenous RSNO species in blood 




Figure 6.6 Calibration curves for the representative low molecular weight (LMW) 
RSNOs with various concentrations ((A) sub-µM, (B) µM levels) in the working buffer 
solution at RT. 
 
Such homogeneous responses toward the various LMW endogenous RSNOs were 
reported previously for low concentrations (< 1 µM) of RSNOs using orgnodiselenide-
based RSNO sensor.38   In contrast, the Cu-based RSNO sensor reported earlier exhibits a 
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much greater amperometric response toward CySNO than GSNO as well as other RSNO 
species.37 
6.3.3. Role of transnitrosation reaction in amperometric response    
An interesting phenomenon observed in the detection of AlbSNO is that the 
current signals continuously increase, without yielding a final steady-state response (see 
Figure 6.5(C)).  Due to the large molecular weight of AlbSNO (69 kD) compared to the 
molecular cutoff (MWCO, 50 kD) of the dialysis membrane mounted on the RSNO 
sensor, it is unlikely that AlbSNO passes through this membrane and reacts directly with 
the organoditelluride catalyst.  However, a transnitrosation reaction between AlbSNO and 
excess GSH reducing agent (50 µM GSH is already present in the working buffer 
solution) can provide a low molecular RSNO species from the higher molecular weight 
AlbSNO species.50   This speculation is further confirmed by employing CySH in place 
of GSH as a reducing agent in the working buffer  (see Figure 6.7). In this case, the 
calibration curves for LMW RSNOs measured by the RSNO sensor (see Figrue 6.7(A)) 
exhibit enhanced sensitivities in the presence of CySH compared to GSH, in addition to a 
reversed order of sensitivity in the case of SNAP.   
Such increases in the sensitivity toward the LMW RSNOs are also likely 
associated with a transnitrosation reaction, because the current signals for LMW RSNOs 
at various concentrations in the presence of CySH respond much slower in reaching 
steady-state amperometric signals (compared to when using GSH as reducing agent), 
especially, the very long response time with respect to SNAP additions.  Figure 6.7(B) 
clearly shows the effects of various CySH concentrations on the real-time detection of a 
fixed concentration of GSNO when compared directly using GSH as the reducing agent 
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via the exact same RSNO sensor.  The elongated response time that appears when CySH 
is employed as a reducing agent implies that the transnitrosation reaction plays a 
significant role in creating the increase of surface NO levels and the apparent increase in 
sensitivity of the proposed RSNO sensor.  In fact, it has been reported that CySH and its 
residues in many proteins are widely involved in biological transnitrosation reactions.51, 52 
Thus the equilibrium constant for transnitrosating reaction with cysteine is likely more 
favorable than for GSH.50, 53, 54  
 
   
Figure 6.7 (A) Calibration curves for GSNO, CySNO, and SNAP as measured with new 
RSNO sensor in the presence of a different reducing agents (GSH or CySH) in the 
working buffer solution at RT; (B) The real-time measurements of GSNO (4 µM) via the 
RSNO sensor by injecting GSH or CySH in the working buffer solution at RT; arrows 
indicate the time the corresponding RSH concentration is added. 
 
In contrast, any considerable S-nitrosylation of GSH from the GSNO, CySNO, or 
SNAP is not obvious from the response patterns observed, which is also supported by the 
fact that a significant background NO level in the bulk solution is not detected by the NO 
sensor when simultaneously monitored with the RSNO sensor in the same solution (see 
Figure 6.2(B)).  However, as shown Figure 6.5(C), the S-nitrosylation of GSH from 
AlbSNO as an analyte does appear to take place.50   Therefore, there are somewhat 
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complicated relationships of S-nitrosylation between endogenous RSNOs, which are 
important in understanding the characteristics of RSHs/RSNOs in biological systems.  
Although further studies are necessary to fully understand the transnitrosation equilibria 
involved between all endogenous RSH/RSNO species, based on the observed 
experimental results presented here, the proposed RSNO sensor can directly detect 
various LMW RSNOs at low concentrations (0.1 – 4 µM) in the presence of GSH (50 
µM), and there is also some sluggish yet considerable amperometric response observed 
toward protein RSNOs due to transnitrosation chemistry with the added reducing agent 
(GSH).  
Another interesting observation made in this work is the effect of GSH 
concentration on the observed sensitivity of the proposed RSNO sensor.  As discussed in 
Chapter 4, the reducing agent, RSH, participates in the rate-determining step of 
organoditelluride-mediated RSNO denitrosation reaction (see Figure 4.2 in Chapter 4).  
Hence, the RSNO sensor’s sensitivity is expected to be influenced by the concentration of 
RSH in the working buffer. Indeed, as shown Figure 6.7(B), the addition of GSH (up to 
40 µM) into the working buffer solution greatly improves the sensitivity of the RSNO 
sensor without changing the response time.  At higher concentrations of GSH, the effect 
levels off, and saturates, with no change in observed response to further increase in the 
concentration of GSH.   Therefore, the amount of GSH recommended for use in the 





6.3.4. Direct detection of endogenous S-nitrosothiols in blood  
Initially, both the RSNO and NO sensors, which were pre-calibrated for their 
inherent responses with respect to a NO standard solution (see Figure 6.8), were 
concurrently placed in a new working buffer solution (70 mL) at 35 °C and their baseline 
amperometric signals were recorded.  Upon adding the fresh sheep whole blood (30 mL) 
into the working buffer solution, the RSNO sensor detects the RSNO/NO levels in the 
blood sample, while the control NO sensor only detects the NO levels in the same blood 
sample (see Figure 6.8).  The change in current signal observed between the two sensors 
can be converted to the NO equivalent levels by means of the prior NO calibration 
curves, yielding a noticeable gap between two sensors in terms of surface NO 




Figure 6.8 Calibration curves of both the (a) RSNO and (b) NO sensors for the individual 
current responses toward the NO standard solutions added in the working buffer solution 
at 35 ºC, where the sensitivities were calculated to be 6.8 nA/µM for the NO sensor and 
3.3 nA/µM for the RSNO sensor. 
 
 Finally, the injection of a GSNO standard solution into the same blood sample 
illustrates clearly that the two sensors exhibit their expected functions, with the RSNO 
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sensor having significant response, while little or no response is seen from the control 
NO sensor in the same blood sample after the RSNO additions  (see Figure 6.9(B)). 
From the initial response of he RSNO to the added blood, and the change in current 
detected when the sample is further spiked with several additions of GSNO, it is possible 
to utilize the method of multiple standard addition55, 56 to determine the total GSNO 
equivalent concentration in the original blood sample. 
 
 
   
Figure 6.9 (A) The real-time amperometric detections using both the (a) RSNO and (b) 
NO sensors for endogenous RSNOs in the sheep whole blood sample in the working 
buffer solution at 35 ºC (30 mL blood, 70 mL PBS buffer, 50 µM GSH, and 0.1 mM 
EDTA); arrow indicates the moment the fresh sheep whole blood was injected; (B) 
calibration curves of two ((a) RSNO and (b) NO) sensors for their intrinsic amperometric 
responses toward GSNO standard solutions added in the same blood sample at 35 ºC.  
 
Based on the NO and GSNO calibration curves, the current difference between 
the two sensors translates to ~2.6 µM GSNO equivalents in the sheep blood.   Given the 
studies shown above (see Figure 6.5(C)) some fraction of this value would come from 
the AlbSNO present in the blood, which yields amperometric response via the 
transnitrosylation chemistry with the GSH reducing agent.  If conditions can be found 
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where this reaction proceeds with near 100% efficiency, then the sensor value reported 
would be a measure of the total RSNO species in the plasma phase of the blood.   Efforts 




 In this work, a new type of RSNO sensor has been prepared by employing a 
crosslinked organoditelluride-tethered PAH polymer within a dialysis membrane support 
mounted as an outer layer of a planar amperometric NO sensor.  Due to the catalytic 
activity of organoditelluride-linked hydrogel for the decomposition of RSNO species to 
NO in the presence of appropriate RSH reducing agent, various LMW RSNO/RSH 
species that can pass through the diffusion barrier and liberate NO to increase the local 
NO levels within this catalytic layer, results in an increase in current proportional to the 
RSNO concentration present in solution.  Compared to previously reported RSNO 
sensors based on immobilized Cu(II), organodiselenide and enzyme layers,57 this new 
organoditelluride modified sensor has a much longer operational lifetime, presumably 
due the the enhanced stability of the catalyst employed.  It has been further shown that a 
transnitrosation reaction between high molecular weight RSNO species and the necessary 
low molecular weight thiol reducing agent, actually yields an increase in LMW RSNO in 
the test solution that allows some amperometric response to the HMW AlbSNO species.   
The sensor provides an output signal in diluted whole blood samples that is likely 
proportional to the level of total RSNO species in the plasma phase of the blood sample. 
With further optimization of response times and more studies to determine conditions 
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where the catalytic layer can directly liberate NO from HMW endogenous RSNOs by 
changing the sensor configurations and/or via more efficient transnitrosation reactions, 
the proposed sensor could ultimately provide a useful new tool for rapidly determining 
total RSNO species concentrations whole blood samples, without pretreatment steps that 
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Conclusions and Future Directions 
 
7.1. Conclusions 
The research in this dissertation has introduced a new strategy for preparing the 
biomaterials to improve their hemocompatibility.  The polymers possessing appended 
catalytic sites, where the catalyst can liberate NO from endogenous S-nitrosothiols 
(RSNOs) to nitric oxide (NO) in the presence of reducing agents such as free thiols 
(RSHs) already present in blood, are able to provide elevated NO levels at the 
polymer/blood boundary.  Hence, these new types of polymeric materials are termed NO 
generating polymers (NOGPs).  Owing to the variety of vasoprotective activities of NO,1-
4 as observed for healthy endothelial cells (EC),5 the NOGPs may offer surfaces that are 
resisted to thrombus formation, smooth cell proliferation, and bacterial infection, etc.1-4 
7.1.1. NO generating catalysts 
Two distinctive catalysts have been employed in this research.  One was the metal 
ion-based NO generating catalyst, Cu(II)-cyclen (cyclen; 1,4,7,10-tetraazacyclododecane) 
as described in Chapters 2 and 3.  The incorporation of the catalytic redox chemistry 
between Cu(II)/Cu(I) and RSNO/RSH6 into the polymeric phase made it possible for this 
type of NOGP to catalyze spontaneous NO generation in contact with blood. 
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The other catalyst was the organoditelluride (RTeTeR)-based species that has been 
discovered in this work to be a NO generating catalyst (see Chapter 4).  The catalytic 
mechanism of this species (5,5’-ditelluro-2,2’-dithiophenecarboxylic acid, DTDTCA) 
was studied in detail. Mechanistic studies indicate that: DTDTCA (ArTeTeAr) is reduced 
by thiolate (RS-) to afford telluro-sulfide (ArTeSR) intermediate and tellurolate (ArTe-), 
and then ArTe- decomposes RSNO to produce NO, RS-, and ½ (ArTeTeAr); ArTeSR is 
again reduced by RS- to form ArTe- and RSSR (the rate-limiting step).  The 
organoditelluride compound is also known to participate in a disproportion reaction of 
ArTeSR to ½ (ArTeTeAr) and ½ (RSSR)7,8 and the oxidation of ArTe- to ½ (ArTeTeAr) 
mediated by oxygen9 (see Chapter 4). 
7.1.2. Polymer matrices 
The low molecular weight (LMW) endogenous RSNO/RSH species (e.g., S-
nitrosoglutathione (GSNO), S-nitrosocysteine (CySNO), glutathione (GSH), and cysteine 
(CySH)) can easily diffuse into the polymeric phase and react with the catalytic sites in 
the NOGPs.  Therefore, in order to maximize the catalytic efficiency of the NOGPs, the 
catalytic sites were created in both the surface and bulk phases of the polymers through 
homogeneous reactions with the polymers and the NO generating catalysts.  In these 
immobilization steps, the covalent attachments were performed to minimize the potential 
catalyst leaching.  In addition, because the hydrophilic polymer would be beneficial to 
provide a good environment for the substrates to diffuse into (and thus the catalytic 
efficiency could be maximized) a variety of hydrophilic polymers were employed in this 
study such as hydrogel types of polymers and hydrophilic polyurethanes (PU).  
155 
For example, a Cu(II)-cyclen complex modified with a polymerizable functional 
group, a methacrylate moiety, was crosslinked with poly(2-hydroxyethyl methacrylate) 
(pHEMA), a representative classic hydrogel,10-12 yielding a new type of functional 
hydrogel containing the NO generating catalyst (Chapter 2).  Further, a biomedical grade 
polymer, hydrophilic thermoplastic PU13-15 modified with free amine groups was 
conjugated with the another cyclen monomer appended with a free carboxylic acid to 
afford the PU-based NOGP (Chapter 3).  The new RTeTeR species (DTDTCA) was also 
linked to various polymers including thermoplastic PU and poly(allylamine 
hydrochloride) (PAH), as well as the interpenetrating polymer network (IPN) using a 
cellulose membrane and the DTCTCA-tethered PAH (Chapters 5 and 6).  
7.1.3. Catalytic NO generation of the NOGP 
The NO generation of the various NOGPs newly developed in this research was 
measured by two specific techniques; chemiluminescence NO analyzer (NOA) and 
amperometric RSNO sensor16, 17 (see Chapters 2 – 6).  
To demonstrate the catalytic activities of the NOGPs, typical procedures for the 
NOA experiments were performed.  When a given small sized NOGP was immersed into 
the endogenous RSNO/RSH species in PBS buffer, pH7.4, the baseline NO level was 
increased and reached to a steady-state NO level; then, by removing the piece of the 
NOGP from the reaction solution, the NO level returned to the original baseline.  The 
catalytic reaction mediated by the NOGP was further confirmed by continuing the 
insertion/removal processes via the NOA measurements.  Indeed, the catalytic NO 
generation properties of a variety of the NOGPs developed in this work were successfully 
demonstrated by the NOA measurements. 
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To demonstrate the spontaneous NO generation mediated by the NOGPs in 
contact with blood, an amperometric RSNO sensor configuration,16, 17 in which an NO 
sensor is modified with the various NOGPs, was used.  The RSNO sensors were 
fabricated by mounting a thin film of given NOGP onto the distal tip of a planar NO 
sensor.18, 19   Because the NOGP film in the RSNO sensor provides a catalytic layer 
responsible for the NO generation, the RSNO species in the sample solution that diffuse 
into the catalytic layer decomposes to NO, and the NO levels within this layer are locally 
increased in proportional to the RSNO levels.  Hence, the NO oxidation reaction occurs 
at the platinized platinum anode and yields a current signal that is in proportional to the 
RSNO concentrations in the sample solutions.  The NO sensors modified with “blank” 
polymers (without any NO generating catalysts) were used for control experiments, and 
did not yield RSNO responses.  The RSNO sensors modified with the various NOGPs 
successfully demonstrated their ability to spontaneously generate NO when in contact 
with fresh blood.  
As an application example of the organoditlluride-based NOGPs, more detailed 
studies of a given amperometric RSNO sensor design16, 17 based on using a DTDTCA-
tethered PAH were carried out for the direct detection of various RSNO species (see 
Chapter 6).  This proposed RSNO sensor could reversibly detect low molecular weight 
(LMW) endogenous GSNO and/or CySNO at 0.1 µM levels.  Both GSNO and CySNO 
yield comparable responses.  The remarkable feature of this new RSNO sensor is a very 
long operational lifetime (up to a month) probably due to the excellent stability of 
DTDTCA-linked PAH in the outer dialysis membrane of the device (see Chapter 6). 
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7.1.4. Potential catalyst leaching 
To investigate the potential catalyst leaching from the NOGPs, various soaking 
experiments were carried out.  In this work, after soaking the NOGPs in a given solution, 
such as the excess amount of GSNO/GSH or the animal blood, for certain time periods, 
the catalyst content either in the polymer or the solution was analyzed primary by 
inductively coupled plasma-high resolution mass spectrometry (ICP-HRMS).  
In the case of Cu(II)-cyclen based NOGPs, due to the strong metal binding 
affinities of RSH and/or RSSR20, 21  (formed during the NO generation reactions), the 
excess amount of GSNO/GSH caused the significant loss of copper in the films of the 
NOGPs (ca. 30 % loss of copper for 15 d, see Chapter 2), resulting in the considerable 
decrease in the NO flux (see Chapters 2 and 3).  However, after soaking in sheep plasma, 
no significant changes in the NO fluxes were observed (Chapters 2 and 3).  These data 
indicate that the blood components may not influence the demetalation and/or 
deactivation of copper catalysts in the Cu(II)-cyclen based NOGPs, while the LMW 
endogenous RSH and/or RSSR species may be largely responsible for the demetalation 
processes from these polymeric materials. 
The catalyst leaching from the organditelluride-immobilized polymer was also 
examined by measuring the tellurium (Te) amount in the solution after soaking in excess 
GSNO/GSH (see Chapter 5).  First, the one side-tethered RTeTeR species (among two 
carboxylic acid groups in DTDTCA) can be easily released from the polymeric matrix, 
and this process is likely responsible for the 10 % loss of Te after soaking for 1 d.  Then, 
the disconnection of the ditelluride bond during the catalytic reaction also causes the 
physically crosslinked polymers and/or low molecular weight polymers (> 50k, the 
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molecular weight cutoff of the cellulose membrane employed in this IPN) to further 
fragment to dissolve in the solution phase, yielding the additional 10 % loss over 2 
weeks.  In fact, the rate of Te loss was opposite to the GSH/GSNO levels in the solution 
phase (see Chapter 5).  This experiment proposes the good stability of the DTDTCA in 
the polymer matrix during this redox cycle, allowing it to exhibit long-term catalytic 
activity (see Chapter 6). 
 
 
7.2. Future directions 
7.2.1. Coatings for stents 
Vascular stents to reduce the restenosis (re-occlusion of blood vessel) compared 
to balloon angioplasty (enlarging an artery partially blocked by atherosclerotic plaque),22, 
23 however, it has been reported that stent stenosis (in-stent restenosis) occurs in about 10 
- 60 % of cases24-27 due mainly to the neointimal hyperplasia22, 28 resulting from the 
inflammatory reactions.  This process is quite complex and not fully understood, but it is 
known that the main mediator is the excessive proliferation of vascular smooth muscle 
cells.22, 29 Since NO plays a key role in inhibiting the vascular smooth muscle cell 
proliferation in vivo, the NOGPs may offer an approach in such medical devices to 
enhance their hemocompatiblitiy.  
For example, to make the Cu(II)-cyclen complex-based NOGP more applicable as 
a coating for stents, the modified intermediate, cyclen-N-propyl methacrylate  (3) (see 
Scheme 7.1) that have been synthesized in this research (see Chapter 2) may be useful to 
anchor such coatings on metal surfaces.  Scheme 7.1 shows how this intermediate can be 
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employed in the surface modification of commercial stents.  Based on the proposed 
scheme and using the key intermediate, this work will be further conducted by Dr. 
Lahann and his researchers at the Department of Chemical Engineering in the University 
of Michigan as well as the researchers in Michigan Critical Care Consultants Inc. (MC3, 
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Scheme 7.1 The proposed scheme for the anchoring the Cu(II)-cyclen complex on the 
surface of stent coated with the functionalized poly-para-xylylene (PPX) (2) using the 
cyclen-N-propyl methacrylate monmer (3) developed in this research (see Scheme 2.1 in 
Chapter 2). 
 
In this proposed scheme, an ultra-thin polymer coating (~ 200 nm) is formed on 
the surface of a stainless steel stent using functionalized poly-para-xylylene (PPX) 
monomers30 (1) (hydroxy methyl-PPX, or amino-PPX, see Scheme 7.1) via the chemical 
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vapor deposition (CVD)31 process.  This polymer can be further derivatized with an 
anchoring methacrylate group (2).  Thus, the polymerization of the intermediate (3) on 
the surface of the stent coated with the functionalized polymer 2 will afford another 
hydrogel layer containing the modified cyclen.  Copper ion incorporation into the surface 
polymer 4 will result in the final NO generating polymer coating 5. 
7.2.2. Coatings for indwelling sensors 
The development of an implantable glucose sensor that can continuously monitor 
glucose levels of the diabetic patients in vivo is an important biomedical goal.32-36   The 
major barriers are identified to be the inflammatory responses of the body causing the 
sensors to yield unreliable analytical results and/or decreasing their sensitivities.37, 38   NO 
is a naturally occurring anti-inflammatory agent;39 thus a locally elevated NO level at the 
implanted sensor’s surface could be achieved by a thin coating of a suitable NOGP, and 
this may maintain the proper function of the sensor for extended time periods.  
To evaluate the effectiveness of the NOGPs in such application, a needle-type 
subcutaneous glucose sensor coated with the NOGPs will be tested in this laboratory.  
For example, thermoplastic polyurethanes (PUs) tailored with the Cu(II)-cyclen complex 
(see Chapter 3) has a good solubility in organic solvents such as THF.  Thus, this NOGP 
composed of biomedical PU matrix affords various benefits in terms of the process as 
well as sterilization.  This new NOGP will be dip-coated on the needle-type indwelling 
glucose sensors to form a thin protective layer that can provide the locally increased NO 
levels at the polymer/blood interface.  Prior to use, it will be tested to see how the NOGP 
coatings could affect the functions of the glucose sensors by comparing the control 
sensors coated with the “blank” polymers (without the NO generating catalyst). 
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7.2.3. Catalytic layers for amperometric S-nitrosothiol sensors 
 As presented in Chapter 6, the amperometric RSNO sensors16, 17 outfitted with an 
organoditelluride-tethered polymer have already been shown to be useful to directly 
detect the various RSNO species.  In addition, very interesting results were observed 
regarding the transnitrosation effects as well as the size-limit of detecting RSNO species 
(only LMW RSNO species can be reversibly detected).  In order to measure all RSNO 
levels in biological samples including the LMW RSNO species such as GSNO and 
CySNO, and high molecular weight (HMW) RSNO species such as S-nitrosoalbumin 
(AlbSNO) and S-nitrosohemoglobin (HbSNO), new approaches must be considered.  
Originally, the catalytic layer has been designed to be located between the gas permeable 
membrane (GPM) and outer dialysis membrane (see Figure 6.1 in Chapter 6).  Hence, 
the MWCO of dialysis membrane determines the sizes of analytes that can diffuse into 
the catalytic layer, and then to be detected.  Therefore, one potential strategy to 
accomplish this goal is to modify the configurations of the catalytic layers in the 
proposed RSNO sensor, in which the immobilized catalytic layer will be tethered at the 
outmost layer; that is, not over the GPM, but the outer surface of the dialysis membrane.  
Then, this catalytic layer likely reacts with all RSNO species regardless of the molecular 
sizes.  In addition, it would be interesting to observe how the different configurations of 
the catalytic layers in the proposed RSNO sensors will result in the amperometric 





7.3 Considerations for future research and applications of NOGPs 
 The fundamental idea of creating NOGPs was successfully demonstrated mainly 
via use of appropriate synthetic chemistry in this thesis work.  Both Cu(II)-cyclen-based 
and organoditelluride-based NOGPs clearly exhibit catalytic NO production from the 
naturally occurring RSNO species under physiological conditions as well as spontaneous 
NO generation when in contact with fresh animal blood.  Hence, these NOGPs have the 
potential to become useful biomaterials to enhance the hemocompatible of blood 
contacting devices for long-term applications.   
Among major concerns, however, that must be addressed before such NOGPs can 
be seriously considered for clinical applications, is the catalyst leaching (copper ions or 
organotellurium/tellurium species in this work) into the contacting biological fluids.   
Although the Cu(II)-cyclen complex has a high copper ion binding stability, the complete 
prevention of metal ion leaching from such a metal-ligand complexed polymeric material 
is not possible, since there is always a low equilibrium concentration of copper ions 
present that can interact with the biological environment.  As shown in this work, catalyst 
leaching when soaking the Cu(II)-cyclen-based NOGPs in solutions containing excess of 
GSH/GSNO resulted in a significant decrease of copper content of the polymer (25 – 35 
%) after 15 days.  This loss was coupled with a substantial reduction in the NO 
generating capability (more than 50 %) of the polymer.  It is likely that the copper ions 
mostly at the surface of polymer are leached out under such conditions; however, the 
majority of copper ions within the interior of the polymeric phase are still able to 
decompose RSNOs to NO.  
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In the case of the organoditelluride-based NOGP, Te leaching is relatively low, 
provided the polymer is properly prepared (e.g., by pre-treatment with excess RSH to 
remove uncoupled halves of the DTDTCA species).   Tellurium leaching is minimal due 
to the good redox stability of the prepared organoditelluride species (DTDTCA).  In fact, 
the catalytic function of the final polymer was well maintained  (ca. one month) as 
demonstrated by the amperometric RSNO sensor equipped with such a DTDTCA-based 
NOGP (see Chapter 6).  Considering the high toxicity of tellurium and potential toxicity 
of organotellurium species compared to the copper ions, the copper-ligand based NOGP 
is more likely suitable for the application of medical devices, and the organoditelluride-
based NOGP would be more useful for in vitro applications, including the preparation of 
RSNO sensors. 
For in vivo applications of NOGPs (e.g., coatings for extracorporeal circuits, 
vascular grafts, etc.), the side effects that may be caused by the additional production of 
NO and consumption of endogenous RSNOs via NOGPs need to be considered as well.   
The therapeutic window of NO (ranges between effective and toxic dosage) has not been 
examined in any detail.  Further the levels of endogenous RSNO levels (reported to be 
ranged from a few nM to sub-mM) as well as the possibility of individual differences in 
these values are not yet understood.  Based on the recent animal studies in our laboratory, 
extracorporeal circuits coated with NOGPs possessing a relatively large surface area 
caused rapid consumption of the endogenous RSNOs (after 1 h), suggesting that 
production of endogenous RSNOs was much slower than consumption by the NOGP 
coated circuit.  Hence, the supplementation of the animal with exogenous RSNO may be 
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necessary to observe the optimal benefit of the NOGP coating to reduce thrombus and 
platelet loss.   In the extracorporeal circuit application, this is quite feasible.    
All questions with respect to the longer-term NO generation capability as well as 
the side effects (including the potential toxicity) that may occur by the employment of 
NOGP must be answered by clinical investigations, first with appropriate animal models, 
and then potentially in human studies.  The good news derived from this dissertation 
work is that chemistry can enable development of a variety of NOGPs and tune their NO 
generating properties by adjusting the amount of NO generating catalyst loaded in the 
polymer matrix.  To achieve the ultimate goal of clinical in vivo application of these new 
NOGP materials, many scientists including chemists, biologists, biomedical engineers, as 
well as clinical researchers will need to collaborate closely to answer the many 
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